











This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
• This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
• A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
• This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
• The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
• When referring to this work, full bibliographic details including the author, title, 


















                   For the degree of Doctor of Philosophy 
                     The University of Edinburgh 








I would like to express my sincere gratitude to my principle supervisor Professor 
Christopher Gregory for his constant guidance and encouragement. I greatly 
appreciate all his contributions of time and ideas which makes my PhD experience 
fruitful and stimulating. His joy and enthusiasm for research is inspirational for me, 
especially during tough times of my PhD.  
 
My sincere thanks also go to my second supervisor, Dr. Lesley Forrester, for her 
guidance and constructive advice for the ES cell work. It is also difficult to overstate 
my gratitude to my daily supervisor, Dr. John Pound, who provided constant 
encouragement, reliable help, sound advice, excellent teaching and numerous great 
ideas throughout my PhD study. Special thanks to Dr. Catriona Ford for her teaching 
and encouragement, helpful discussions, and insightful comments. I particularly wish 
to thank Mrs Helen Taylor for enlightening me the trick for ES cell culture and useful 
advice to generate ESDM. I would also like to thank Jorine Willems for all the help she 
gave me during the time we worked together and helping me with cold-shock induced 
apoptotic cells for the phagocytosis assay; Lynsey Melville for performing procedures 
on animals to harvest mouse primary macrophages; David Dorward for supplying me 
with human neutrophils; our nice secretary, Ms Gillian MacLeod, for assisting me in 
different ways. I also thank all the present and previous members of the Inflammation 
and Cancer group for their friendship and encouragement. 
 
Lastly but most importantly, I wish to thank my parents and my boyfriend for their 
constant support and unconditional love without which the thesis wouldn’t have been 






The thesis and the work presented within were original work by me, unless otherwise 
acknowledged. All sources of information in the thesis have been acknowledged by 
reference. The work has not been submitted in any previous application for a degree. 
 
 
























Tumours are not autonomous transformed cell populations, but rather a society 
composed of both malignant and normal, including immune, cells that together foster 
tumour growth and development. Tumour-associated macrophages have been reported 
to enhance tumour growth, progression and metastasis. In high-grade non-Hodgkin’s 
lymphomas, prototypically the B-cell neoplasm, Burkitt’s lymphoma (BL), infiltrating 
macrophages engulf large numbers of apoptotic tumour cells. Evidence suggests that 
apoptotic BL cells can condition the tumour microenvironment to promote lymphoma 
development by selectively attracting macrophages while inhibiting neutrophil 
infiltration and by stimulating macrophages to produce the B-cell growth and survival 
factor. 
 
Tumour cells grow in a hypoxic and nutrient-deficient environment and the resultant 
cellular stress can induce apoptosis. It is therefore possible that hostile environmental 
conditions in the tumour also contribute to the generation of a pro-tumour 
microenvironment. This thesis describes investigations which examined this 
hypothesis. 
 
BL cells were cultured at high density to mimic conditions of metabolic stress existing 
in the tumour environment. Cell-free supernatants from such stressed BL cells 
demonstrated potent chemoattractive activity for mononuclear phagocytes. 
Supernatants from BL cells that were protected from apoptosis by over-expression of 
bcl-2 had similar ability, confirming that chemoattractant release was 
apoptosis-independent. The observation that apyrase and suramin could inhibit the 
chemotactic activity of these supernatants suggested that nucleotides might be the 
apoptosis-independent chemoattractant. Detection of ATP in stress supernatants by 
bioluminescence assay was consistent with this proposal. Significantly, supernatants 
 4
from BL cells and those transfected with bcl-2 were both found to inhibit neutrophil 
migration, suggesting the occurrence of a neutrophil migration inhibitory factor whose 
release was apoptosis-independent. Furthermore, stress supernatants could promote 
BL cell proliferation in vitro, which was apoptosis and cell line-independent. 
 
In order to study the role of TAM in the tumour microenvironment, a novel 
macrophage model was devised using mouse embryonic stem cells (ES cells). Cells 
derived from ES cells generated in vitro expressed macrophage-specific markers and 
were free of dendritic cells and undifferentiated ES cells. ES cell-derived macrophages 
(ESDM) could migrate towards apoptotic BL cells and engulf them. However, ESDM 
migrated to stress supernatants with decreasing efficiency as they matured. 
Preliminary data indicated that the phagocytic ability of ESDM to engulf apoptotic 
cells increased as they matured, consistent with distinct roles for circulating 
monocytes and tissue macrophages with regard to this function.  
 
Considering the high yields and purities of ESDM described here, together with their 
non-malignant nature and genetic versatility these cells should provide a superior 
source of undifferentiated mononuclear phagocytes with which to elucidate the 
molecular mechanisms underlying tumour infiltration and microenvironmental 
conditioning by TAM. 
 
In conclusion, this work suggests that under conditions of pre-apoptotic stress, BL 
cells have the capacity to regulate their micro-environment upstream of their apoptosis 
programme to promote net tumour growth through paracrine signals that attract 
supportive macrophages and inhibit destructive neutrophils and through release of 
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Chapter 1 Introduction 
 
1.1 Tumour microenvironment  
The prototypical concept that the microenvironment is a crucial regulator of 
tumourigenesis was first proposed by Paget in his famous ‘seed and soil’ theory, as 
cited by Stephen, when Paget was trying to investigate the distribution of metastatic 
breast cancer, (Stephen 1889). He thought that all cancer cells possess the ability to 
develop further, but could only grow into a secondary cancer in certain organs which 
could sustain the new growth. The hypothesis ‘languished in the shadows’ for almost a 
century. However, the biology of the tumour microenvironment has been widely 
studied since, especially over the past decade, and tumours have increasingly been 
recognized as organs rather than a collection of relatively autonomous and 
homogeneous cancer cells. Today the tumour microenvironment is thought to 
comprise both malignant cells and normal cells, such as fibroblasts, epithelial cells, 
endothelial cells, cells of the innate and adaptive immune system as well as the 
subsequently generated cytokines and chemokines. It should be noted that, as 
genetically mutated cells, malignant cells have the inherent ability to sustain 
proliferation, restrain cell death, induce angiogenesis and further activate invasion and 
metastasis. Nevertheless, studies into the functions of each component of the tumour 
microenvironment in tumourigenesis suggest that they all participate in the process of, 
and  have proved to be important, in the development of tumours (Hanahan and 
Weinberg 2011).  
 
1.1.1 Tumour-associated inflammation 
As cited by Balkwill and Mantovani, Rudolf Virchow made the first proposal about the 
role of inflammation in cancer at 1863. He hypothesized that the emergence of cancer 
occurred at the site of chronic inflammation (Balkwill and Mantovani 2001). However, 
 20
the hypothesis was largely neglected for a long time, and the importance of 
inflammation in tumourigeneis has not been well accepted until the last decade.  The 
presence of inflammation, demonstrated by the markers of inflammatory cells and 
mediators, has been detected in almost all the tumours, although  with different 
intensities  (Pages, Galon et al. 2010). Different types of inflammation are present in 
tumours, and they are associated with different stages of tumourigenesis with various 
tumour promoting effects (Grivennikov, Greten et al. 2010). Although a direct causal 
relationship between inflammation and cancer has not yet been validated, the 
connection between inflammation and cancer has been summarized in two pathways: 
an extrinsic pathway and an intrinsic pathway (Allavena, Garlanda et al. 2008). The 
extrinsic pathway refers to chronic inflammation or infection at certain sites that can 
facilitate the initiation of neoplasia as well as tumour invasion and metastasis. The 
intrinsic pathway is induced by oncogene activation which subsequently causes 
neoplasia and produces inflammatory mediators to generate an inflammatory 
microenvironment within a developed solid malignancy.  These two pathways are 
interconnected and lead to the activation of transcription factors in tumour cells, 
mainly nuclear factor- κB (NF- κB), signal transducer and activator of transcription 3 
(STAT3) and hypoxia-inducible factor 1 α (HIF1α) and the resulting production and 
release of inflammatory cytokines and chemokines. These inflammatory mediators 
can further recruit immune cells from blood and alter their activation status (Karin 
2006; Allavena, Garlanda et al. 2008).  
 
Both innate and adaptive immune cells can be detected in the tumour 
microenvironment, including tumour-associated macrophages, tumour-associated 
neutrophils, T cells, mast cells and B cells. The environment is further enriched by 
cytokines and chemokines released from them, such as IL-12, IFNγ (anti-tumour) and 
IL-6, IL-23 (pro-tumour) (de Visser, Eichten et al. 2006; Lin and Karin 2007).  
However, the pro- or anti-tumour effect of the inflammatory component within the 
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tumour microenvironment depends on the combination and the activation status of 
immune cells as well as those immune mediators (Smyth, Dunn et al. 2006).   
 
Tumour-associated macrophages   
Tumour-associated macrophages (TAM) are the major immune component of the 
tumour microenvironment and an important source of cytokines. In more than 80% 
human tumours, a high content of macrophages is associated with poor prognosis 
which is supported by pathological evidence and genetic profiling (Bingle, Brown et al. 
2002; Tsutsui, Yasuda et al. 2005). Macrophage deficiency is also found to correlate 
with decreased tumour mitosis and poor vascularisation in an in vivo murine model 
(Nowicki, Szenajch et al. 1996). But there are exceptions. For example, depletion of 
liver macrophages (Kupffer cells) was found to support the growth of metastatic 
carcinoma, suggesting that Kupffer cells played an important role in suppressing 
tumour growth in the liver (Heuff, Oldenburg et al. 1993). Nevertheless, the vast 
majority of data from human and animal models indicate that tumour-associated 
macrophages promote tumour progression and metastasis (Qian and Pollard 2010). 
   
Macrophages are cells with plasticity that can adapt their cell profiles according to the 
specific immunological environment (Mantovani, Sica et al. 2005). Two extremes of 
macrophage activation continuum have been designated: M1 and M2. The M1 
phenotype can be induced by IFNγ alone or combined with microbial products, such as 
LPS, and macrophages activated in this way can release pro-inflammatory cytokines, 
such as TNF-α, IL-12 and IL-23, express high levels of major histocompatibility 
complex (MHC) molecules and inducible nitric oxide synthase and have cytotoxic 
activity against neoplastic cells. On the other hand M2, or ‘alternatively activated’ 
macrophages are induced by Th-2 type cytokines, such as IL-4, IL-10, and IL-13.  M2 
macrophages release anti-inflammatory cytokines, such as IL-10, express high levels 
of arginase and scavenger receptor A, have poor antigen-presenting capability but 
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enhanced debris clearance ability and promote wound-healing (Mantovani, Sozzani et 
al. 2002).  
 
TAM can exhibit different activation statuses and functions in the tumour 
microenviroment. During tumour initiation, immune cells, including macrophages 
which exhibit a M1 phenotype and NF-κB signalling, are  essential for this process 
(Karin and Greten 2005).  Deletion of IKKβ, which phosphorylates NF-κB bound 
IκB and liberates NF-κB  dimers to enter the nucleus to activate its transcriptional 
functions, in myeloid cells reduced tumour incidence by almost 50% and showed 
tumours with smaller sizes in a murine colitis associated cancer model (Greten, 
Eckmann et al. 2004). NF-κB promotes the transcription and release of inflammatory 
cytokines, such as IL-6, IL-8 and TNF-α, as well as inducible nitric oxide synthase 
(iNOS). It has been hypothesized that these immune cells generate reactive oxygen 
and nitrogen species to induce further mutations or genetic instability in adjacent 
developing tumour cells, thus forming a pro-tumour microenvironment (Pang, Zhou et 
al. 2007; Colotta, Allavena et al. 2009).   
 
After initiation, when tumours gradually progress, in most, but not all tumours 
investigated, TAM switch from M1 to a phenotype polarized to the M2 type  
(Torroella-Kouri, Silvera et al. 2009; Mantovani and Sica 2010). The phenotype 
switch is suggested to be dependent on nuclear overexpression of p50 which is a 
NF-κB inhibitory homodimer (Saccani, Schioppa et al. 2006; Porta, Rimoldi et al. 
2009). In cancers that arise without association with obvious inflammation, 
tumour-associated macrophages still exhibit an alternatively activated state and they 
are believed to be recruited into tumours from blood monocytes (Mantovani, Bottazzi 
et al. 1992). Several chemokines have already been identified as the possible 
chemoattractive signals. CCL2 (MCP-1) was the first discovered monocyte 
chemoattractant which was derived from human ovarian cancer (Negus, Stamp et al. 
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1995). CCL5, as well as CCL2, are found to attract tumour-associated macrophages in 
breast cancer (Soria and Ben-Baruch 2008). However, in glioma, CCL7 (MCP-3) 
instead of CCL5 was responsible for the macrophage infiltration (Okada, Saio et al. 
2009). CSF-1 has been confirmed in vivo as a mononuclear phagocyte 
chemoattractant in a murine breast carcinoma model (Lin, Nguyen et al. 2001; 
Wyckoff, Wang et al. 2007). The tumour microenvironment is rich in chemokines and 
cytokines, other factors, like fractalkine, CXCL8, CXCL12, and VEGF, have also 
been suggested to be implicated in the process of recruiting monocytes (Balkwill 2004; 
Allavena, Garlanda et al. 2008; Truman, Ford et al. 2008; Mantovani, Savino et al. 
2009).   
 
However, after tumour initiation or after monocytes are recruited into tumour sites, the 
signals that are responsible for tuning the phenotype of macrophages to M2 are not 
sufficiently understood. Various in vitro investigations have been performed. For 
example, using a co-culture assay, human ovarian cancer cells were able to polarize 
macrophages to a M2 phenotype, indicating that the signals can derive from tumour 
cells (Hagemann, Wilson et al. 2006).  Further in vitro assays suggested that the effect 
of polarization of macrophages was from soluble factors released by tumour cells 
(Kuang, Wu et al. 2007). CCL2 and IL-6, the most prevalent cytokines in the tumour 
microenvironment, can induce polarization to a M2-type during the differentiation of 
human  blood monocytes to macrophages in vitro (Roca, Varsos et al. 2009). In vitro 
co-culture also suggested that metastatic melanoma derived VEGF could induce the 
polarization of peripheral blood mononuclear cells from Th1 to Th2 response (Nevala, 
Vachon et al. 2009). The production of IL-10 and CSF-1 by a variety of tumours has 
been accepted which thus are speculated to be involved in the transition of 
macrophages from M1 to M2 (Hamilton 2008; Sato, Terai et al. 2011). The only direct 
demonstration of the mechanism of macrophage polarization in vivo was performed in 
the MMTV-PyMT (the expression of polyoma middle T oncoprotein under the control 
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of mouse mammary tumour virus) mouse model. It has been shown that IL-4, 
produced by CD4-positive T cells, accumulates in the tumour environment and 
contributes to the polarization of macrophages into M2 (DeNardo, Barreto et al. 2009).  
Therefore, further investigations are still required to understand the mechanisms of the 
well-known M2 polarization of TAM. 
 
M2 type TAM  have been found to contribute to tumour progression by supporting 
various stages of tumour development, including angiogenesis, tumour invasion and 
metastasis  as well as suppressing adaptive anti-tumour immune response (Solinas, 
Germano et al. 2009). Among all the functions, angiogenesis is the most studied and 
well-known pro-tumour function of TAM. In human cancers, the accumulation of 
TAM is associated with increased angiogenesis in many tumours such as glioma, 
breast, bladder and prostate carcinoma (Leek, Lewis et al. 1996; Nishie, Ono et al. 
1999; Hanada, Nakagawa et al. 2000; Lissbrant, Stattin et al. 2000). Macrophage 
depletion using liposome-encapsulated clodronate has been found to inhibit 
angiogenesis in different tumour xenograft models including melanoma, lung 
carcinoma and rhabdomyosarcoma (Zeisberger, Odermatt et al. 2006; Gazzaniga, 
Bravo et al. 2007; Kimura, Watari et al. 2007). TAM are normally recruited into the 
hypoxic regions of tumours which induces the expression of HIF-1-dependent 
molecules in macrophages, most with pro-angiogenic effects, such as VEGF and FGF 
family members (Salcedo, Wasserman et al. 1999; Lewis and Hughes 2007; Murdoch, 
Muthana et al. 2008).  TAM from breast cancer exhibited an enriched transcription of 
angiogenic factors as demonstrated by high-density gene expression analysis (Ojalvo, 
King et al. 2009).  
 
The role of TAM in tumour invasion and metastasis has been known for a long time 
and macrophages have been described as an ‘obligate partner for tumour cell 
migration, invasion, and metastasis’ (Condeelis and Pollard 2006). The first 
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conclusive demonstration of TAM having a role in metastasis was performed in a 
macrophage-deficient mouse model of breast cancer (Lin, Nguyen et al. 2001). 
Absence of macrophages did not affect the growth of the primary tumour but delayed 
the development into invasive, metastatic malignancy. Further investigations 
suggested a paracrine loop between macrophages and tumour cells in mammary 
tumours. Tumour cells synthesize CSF-1 which recruits macrophages and induces 
them to produce epidermal growth factor (EGF) which, in turn, activates tumour cell 
migration (Wyckoff, Wang et al. 2004). This paracrine loop is also instrumental in the 
macrophage-assisted tumour cell intravasation (Wyckoff, Wang et al. 2007).  The 
effect of macrophages in promoting metastasis has been demonstrated in a murine 
ovarian tumour model which might be mediated by stromal VEGF production 
(Robinson-Smith, Isaacsohn et al. 2007).  On the other hand, TAM can produce a 
range of matrix metalloproteases (MMP), such as MMP-2, MMP-7, MMP-9 and 
MMP-12, modulating the extracellular matrix to facilitate the metastasis process 
(Mantovani, Allavena et al. 2008). 
 
The initiation and progression of tumours indicates the lack of immunological 
limitation and TAM are believed to have immunosuppressive and pro-tumour 
functions considering their M2 phenotype, although their roles in vivo have not been 
clearly demonstrated. Gene transcription studies of TAM indicated an upregulation of 
immunosuppressive cytokines IL-10 and TGF-β and a downregulation of 
proinflammatory cytokines, such as IL-1β, IL-6 and TNF-α thus demonstrating the M2 
phenotype. The defective activation of NF-κB but functional interferon regulatory 
factor (IRF-3)/signal transducer and activator of transcription 1 (STAT1) is suggested 
to lead to the differential gene expression of TAM (Biswas, Gangi et al. 2006). 
Furthermore, several mechanisms have been identified to contribute to the inhibitory 
effect of TAM on the cytotoxic T cell response. Factors derived from tumours 
(hepatocellular carcinoma) and autocrine TNF-α and IL-10 can induce the expression 
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of PD-L1 (programmed cell death 1 ligand 1) proteins on the surface of the monocytes 
and the PD-L1 positive monocytes can effectively suppress cytotoxic T cell immunity 
thus contributing to the tumour growth in vivo (Kuang, Zhao et al. 2009). In ovarian 
carcinoma, macrophages and tumour cells produced chemokine CCL22 which 
mediates the influx of Treg cells into tumours. Treg cells are known to mediate 
immune tolerance and suppress the cytotoxic T cell response (Curiel, Coukos et al. 
2004). 
 
Taken together, TAM represent an important immune cell infiltrate in the tumour 
microenvironment and they play important roles in tumour progression, which has 
been suggested to recapitulate the trophic role of macrophages during development 
(Pollard 2009).   
 
1.1.2 Metabolic stress   
1.1.2.1 Metabolic stress in tumours 
One of the key hallmarks of cancer is the sustained proliferative ability caused by 
genetic mutations (Hanahan and Weinberg 2011); this de-regulated and uncontrolled 
tumour cell proliferation demands constant and sufficient supplies of oxygen and 
nutrients. However, in rapidly growing tumours, insufficient oxygen and nutrient 
supply and consequently metabolic stress are prevalent throughout tumour 
development (White 2007). As tumours develop, before reaching 1mm in diameter, 
there is no blood supply through vasculature and the only source of oxygen and 
nutrients is passive diffusion whose limit is 150-220 μm thickness of tumour cell 
layers (Folkman 2006). Therefore, there is always oxygen and nutrient deficiency in 
the centre of the tumour mass. Using hypoxia as a marker for metabolic stress, hypoxia 
could be readily detected in the tumour mass 2 days after injection of tumour cells 
(Nelson, Tan et al. 2004). As the tumour progresses, angiogenesis will be switched on 
and the supply through newly established vasculature can significantly mitigate the 
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metabolic stress in tumours. However, unlike the healthy blood vessels in normal 
tissues, the vasculature in tumours is often abnormal and fragile which might 
intermittently collapse, causing continual disruption of nutrient supply into established 
tumours. Besides, tumour cells more than 200 μm away from open microvessels still 
suffer from shortages of oxygen and nutrients which thus form the ‘perivascular cuffs’ 
composed of viable tumour cells near the vessel and necrotic tumour cells away from 
the vessel, evidently demonstrating the metabolic burden of the tumour cells away 
from the supply tunnel (Judah 2003). An emerging hallmark of cancer is the ability of 
tumour cells to reprogramme their energy metabolism to undergo ‘aerobic glycolysis’ 
(Warburg and Dickens 1930; Warburg 1956; Warburg, House et al. 1956; Hanahan and 
Weinberg 2011), an inefficient way to produce ATP from glucose, compared with the 
mitochondrial oxidative phosphorylation in normal cells which is 9-fold more efficient 
but nonetheless a way of sustaining ATP production under hypoxic conditions. The 
short supply of energy and low efficiency of energy production, together with the 
highly proliferative nature of tumour cells, exacerbates the metabolic stress. 
 
1.1.2.2 Metabolic stress and relevant cellular stress response 
Through evolution, cells develop sets of machinery to respond to the stress of the 
environment. There are two main responses. One is the cellular homeostasis response 
which serves to adapt the cellular homeostasis to a particular environmental change, 
and the effect is permanent until the environment changes again. The other is the 
cellular stress response which, by sensing damages to the intracellular 
macromolecules or the redox (reduction-oxidation) condition caused by different 
types of stress, the cell will either repair the damaged macromolecules and restore the 
redox potential inside the cells to promote cell survival if damage is minor, or remove 
seriously damaged cells by inducing programmed cell death. The two responses are 
interconnected and complementary in response to environmental stresses (Kultz 
2005).  
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In the cellular response to stress, some common regulatory proteins involved in 
different stress responses are conserved between species, including heat shock 
proteins (Kultz 2005). Heat shock proteins (Hsp) are molecular chaperones which, 
based on their molecular weight, can be categorized into Hsp100, Hsp90, Hsp70, 
Hsp60 and small Hsp (sHsp) families. As molecular chaperones, Hsp proteins can be 
induced and activated by many types of stresses to perform their functions of ‘protein 
holding’ and ‘protein folding’ thereby preventing protein aggregation and providing a 
transient protection (Calderwood, Khaleque et al. 2006). Hsp70 and Hsp90 families 
are principal holding proteins and can perform their cytoprotective function by binding 
to unfolded sequences in polypeptide substrates (Wegele, Muller et al. 2004; Mayer 
and Bukau 2005). After the holding proteins release their substrates, the folding 
proteins like Hsp60 and other chaperone proteins will start the ATP-dependent 
protein-folding process (Spiess, Meyer et al. 2004; Young, Agashe et al. 2004). 
However, sHsp, like Hsp27, can mediate both protein-holding and protein-folding in 
an ATP-independent manner (Jakob, Gaestel et al. 1993).   
 
Apart from these indirect mechanisms for cellular protection, different lines of 
evidence have demonstrated that Hsp27 and Hsp70 can directly inhibit apoptosis as 
well. In the intrinsic apoptosis pathway, Hsp27 can inhibit the formation of the 
apoptosome and the activation of downstream caspases by binding to both cytochrome 
c and procapase-3 and by inhibiting the second mitochondria-derived activator of 
caspases (Smac) release from mitochondria (Bruey, Ducasse et al. 2000; Pandey, 
Farber et al. 2000; Concannon, Orrenius et al. 2001; Chauhan, Li et al. 2003). Hsp can 
inhibit the extrinsic apoptosis pathway by inhibiting DAXX, an adaptor protein 
linking the Fas receptor and the downstream signalling components (Charette and 
Landry 2000). Hsp70 can perform its anti-apoptotic activity at different stages of 
apoptosis signalling. Hsp70 can inhibit apoptosis by preventing cytochrome c release 
from mitochondria (Steel, Doherty et al. 2004).  Hsp70 can also perform its 
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anti-apoptotic function by preventing Apaf-1 oligomerization and the recruitment of 
procaspase-9 to the Apaf-1 apoptosome (Beere, Wolf et al. 2000; Saleh, Srinivasula et 
al. 2000). Furthermore, Hsp70 has been shown to be able to bind to procaspases-3, -7 
therefore suppressing the caspase-dependent apoptotic signalling (Komarova, 
Afanasyeva et al. 2004). Taken together, heat shock proteins are molecules with 
pro-survival and anti-apoptotic functions.  
  
Another factor closely involved in the cellular stress response is p53.  p53, also 
named tumour protein 53 (or TP53) after its molecular weight of 53 kDa, is one of the 
best known tumour suppressor proteins (Levine, Momand et al. 1991) and is also a 
transcription factor which regulates genes in a variety of different responses (Laptenko 
and Prives 2006). p53 has a role in receiving stress signals intracellularly and assessing 
the damage caused by stress which consequently leads to a cell fate decision. p53 can 
respond to a wide range of stresses, including nutrient deprivation, telomere erosion, 
hypoxia, DNA damage, ribosomal stress and oncogene activation (Levine, Hu et al. 
2006).   In the face of low or constitutive stress, p53 can arrest cell-cycle progression 
to allow the self repair of the cell and to promote cell survival by regulating cell cycle 
regulatory proteins such as p21. For example, it has been demonstrated that a low 
glucose level resulting from metabolic stress can activate p53 which contributes to the 
short-term survival of the cell under starvation conditions (Jones, Plas et al. 2005). If 
the stress is acute and intense, p53 can induce apoptosis to eliminate the damaged cells 
(Vousden and Lane 2007). p53 induces the expression of apoptotic proteins, such as 
BH3-domain proteins NOXA and PUMA, which lead to caspase activation and 
apoptosis (Jeffers, Parganas et al. 2003; Villunger, Michalak et al. 2003). On the other 
hand, p53 can also function as a BH3-only protein in the apoptosis pathway 
independent of transcription (Vousden 2005).  
 
In the context of tumours, rapidly proliferating tumour cells are prone to suffer from 
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starvation-induced metabolic stress and several lines of evidence support the role of 
metabolic stress in inducing apoptosis of tumour cells. For example, in 
non-angiogenic lung carcinoma micro-metastases, high rates of tumour cell apoptosis 
can be detected in the midst of proliferating tumour cells where metabolic stress 
persists (Holmgren, O'Reilly et al. 1995). However, after the angiogenic switch, when 
tumours acquired oxygen and nutrient supplies from freshly developed vasculature, a 
marked (3- to 4- fold) decrease in tumour cell apoptosis was observed. The 
mechanisms underlying the trigger of apoptotic cell death by metabolic stress have not 
been determined. It has been suggested that metabolic stress could signal through the 
BH3-domain protein Bim (Nelson, Tan et al. 2004; Tan, Degenhardt et al. 2005). 
However, the mechanism of Bim activation following metabolic stress has not been 
clearly deciphered. Another possible mechanism of metabolic stress-induced 
apoptosis is through the apoptosis function of p53 as mentioned above (White 2007). 
In tumours with defects in apoptosis, metabolic stress could trigger autophagy which 
is an interruptible programmed cell death providing energy for cell survival by 
consuming self cellular organelles. Further inhibition of autophagy in tumours with 
apoptosis deficiency  could lead to tumour cell death by necrosis (Degenhardt, 
Mathew et al. 2006).  
 
1.2 Apoptosis and its micro-environmental 
conditioning 
1.2.1 Cell death   
The field of cell death has developed rapidly over the past 20 years and the definition 
of cell death by the Nomenclature Committee on Cell Death has shifted from 
morphological observation to biochemical and functional characterisation. Based on 
morphology, there are three well-defined types of cell death: apoptotic cell death, 
‘autophagic’ cell death and necrotic cell death. Although other types of cell death have 
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been described, like mitotic catastrophe, cornification, anoikis, pyroptosis, entosis, 
they are either a characteristic of a very specific physiological process or have 
overlapping phenotypes with other types of death and have insufficient 
characterisation to be identified as a distinct type of cell death (Kroemer, Galluzzi et al. 
2009). A new molecular definition of cell death based on the understanding of the 
biochemical and functional mechanisms of cell death was proposed (Galluzzi, Vitale 
et al. 2012). Cell death described in this section is focused on the three 
well-understood types of cell death with brief introduction of their molecular features. 
 
The term apoptosis was first proposed by Kerr et al.(Kerr, Wyllie et al. 1972) to 
describe an active molecular process and it is morphologically characterised by the 
shrinkage of cellular volume, condensation of chromatin, fragmentation of the nucleus 
and formation of apoptotic bodies by membrane blebbing. There are two defined 
pathways of apoptosis: intrinsic and extrinsic.  
 
The intrinsic pathway is normally activated by cellular stresses, like DNA damage and 
reactive oxygen species, which subsequently cause mitochondrial membrane 
permeabilization - the control event of intrinsic apoptosis (Kroemer, Galluzzi et al. 
2007).  The permeability of the outer mitochondrial membrane is under the tight 
control of anti-apoptotic members of the Bcl-2 family, such as Bcl-2 and Bcl-xL, 
which inhibit the release of mitochondrial factors, such as cytochrome c, from the 
mitochondrial intermembrane space. Whereas pro-apoptotic members of the Bcl-2 
family, such as Bax and Bak, under the control of Bcl-2 homology (BH)-3-only 
proteins, including Bid, Bad, Bim, Bik, HRK, PUMA and NOXA,  tend to translocate 
to mitochondria and oligomerize within the mitochondrial outer membranes, forming 
pores thus leading to the release of mitochondrial factors into the cytosol (Gross, 
McDonnell et al. 1999). Cellular stress activates BH3-only proteins and when the 
activation exceeds the inhibitory effect administered by anti-apoptotic Bcl-2 family 
 32
members the result is Bax/Bak pore formation on the mitochondrial outer membrane, 
leading to the efflux of intermembrane space proteins into the cytosol (Taylor, Cullen 
et al. 2008).  The released cytochrome c subsequently initiates the formation of the 
apoptosome by interacting with oligomerised apoptotic protease activating factor-1 
(Apaf-1) and caspase-9. Apoptosome formation activates caspase-9 which eventually 
activates the executioner caspase, caspase-3 and leads to apoptotic cell death 
(caspase-dependent intrinsic apoptosis) (Li, Nijhawan et al. 1997; Zou, Henzel et al. 
1997). Another consequence of the Bax/Bak pore formation is the release of other 
mitochondrial intermembrane space (IMS) proteins, such as apoptosis-inducing 
factors (AIF), endonuclease G (ENDOG) and high temperature requirement protein 
A2 (HTRA2).  These factors can mediate intrinsic apoptosis in a caspase-independent 
manner. AIF and ENDOG can translocate from the cytosol to the nucleus and induce 
chromatin condensation and nucleosomal fragmentation of DNA (Susin, Lorenzo et al. 
1999; Joza, Susin et al. 2001; Li, Luo et al. 2001; Buttner, Eisenberg et al. 2007). 
HTRA2 can trigger apoptosis in a caspase-independent manner by performing its 
serine protease activity (Hegde, Srinivasula et al. 2002).  
 
There are two types of the extrinsic apoptosis pathways. One pathway is activated by 
the ligation of lethal ligands, such as CD95 ligand, tumour necrosis factor superfamily 
and TNF-related apoptosis inducing ligand, to the corresponding death receptors on 
the cellular membrane surface (extrinsic apoptosis by death receptors) (Wajant 2002). 
The ligation can activate initiator caspases, caspase-8 or -10 which can either directly 
cleave executioner caspases (caspase-3, -6 and -7) (in type I cells, lymphocytes) or 
signal through the mitochondrial-dependent apoptosis pathway by way of cleaving 
and activating BH3-only protein Bid and subsequently inducing mitochondrial outer 
membrane permeabilisation (MOMP) before activating executioner caspases (in type 
II cells) (Srinivasula, Ahmad et al. 1996; Scaffidi, Fulda et al. 1998; Yin, Wang et al. 
1999; Barnhart, Alappat et al. 2003). Another mechanism that activates the extrinsic 
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apoptosis pathway is mediated by ‘dependence receptors’, including netrin receptors 
which can lead to apoptosis when their ligands are not sufficient (Mehlen and 
Bredesen 2011). The activation of dependence receptors activates PP2A (protein 
phosphatase 2A) and DAPK (death-associated protein kinase) before activating the 
initiator caspase, capase-9 and then effector caspases, caspase-3 (-6, -7) (extrinsic 
apoptosis by dependence receptors) (Bialik and Kimchi 2006; Mille, Thibert et al. 
2009; Guenebeaud, Goldschneider et al. 2010).  
 
However, recent developments in apoptosis research suggests two other possible but 
controversial pathways can trigger apoptosis (Green 2011). One is triggered by 
pathogen- or damage-associated molecular patterns to activate the initiator caspase, 
caspase-1 (Fernandes-Alnemri, Wu et al. 2007; Franchi, Eigenbrod et al. 2009). 
Caspase-1 activation can lead to cell death independently of caspase-3 activation 
(Brennan and Cookson 2000).  In many cases, activated caspase-1 can cleave and 
activate the executioner caspase, caspase-7 and lead to apoptosis (Lamkanfi, 
Kanneganti et al. 2008). One feature of this type of cell death is that the active 
caspase-1 processes and promotes the secretion of interleukin-1β (IL-1β) and IL-18 
(Sansonetti, Phalipon et al. 2000). However the designation of this type of cell death is 
controversial and it is also referred as pyroptosis (Galluzzi, Vitale et al. 2012).  
 
Another controversial type of apoptosis is activated by specific cellular stresses, such 
as metabolic stress. The stress signals initiate the assembly of an activation platform 
named the PIDDosome which is composed of an adaptor protein, RAIDD 
(receptor-interacting protein-associated ICH-1/CED-3 homologous death protein with 
a death domain) and another protein PIDD (p53-induced protein with a death domain). 
Inactive caspase-2 monomers are recruited to the PIDDosome where they dimerise 
and are activated. Activation of caspase-2 leads to apoptotic cell death via the 
mitochondrial pathway by cleaving and activating Bid  (Bouchier-Hayes 2010). 
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However a new idea has emerged that the activation of caspase-2 has to reach a certain 
threshold before engaging caspase-2-dependent apoptosis. The low levels of caspase-2 
activation can induce other cellular responses, such as regulation of cell cycle 
progression (Galluzzi, Vitale et al. 2012). The controversy over the classification of 
the above two types of cell death needs to be further clarified in the future. 
 
Autophagic cell death is defined by its morphology which does not include chromatin 
condensation but involves a massive cytoplasmic vacuolization. However, this term 
has been misinterpreted as cell death executed by autophagy while its true meaning is 
cell death with autophagy (Kroemer and Levine 2008).  Its molecular definition is 
based on the lipidation of microtubule-associated protein 1 light chain 3 or an increase 
in the degradation of autophagic substrates such as sequestosome 1 (SQSTM1). 
 
Necrotic cell death was described as a passive process resulting from extensive 
damage to cells with a loss of plasma membrane integrity and organelles swelling. 
Recent development indicates that necrosis can occur in a regulated manner, named 
regulated necrosis (Degterev, Huang et al. 2005; Hitomi, Christofferson et al. 2008; 
Cho, Challa et al. 2009; He, Wang et al. 2009; Zhang, Shao et al. 2009). The molecular 
features of regulated necrosis include death receptor signalling, caspase inhibition and 
RIP 1 and/or RIP3 activation (Galluzzi, Vitale et al. 2012).     
 
1.2.2 Micro-environmental conditioning by apoptotic cells 
In normal tissues, apoptosis is an important regulatory mechanism to clear old or 
damaged cells and maintain cell homeostasis in a non-phlogistic manner.  Meanwhile, 
apoptotic cells can trigger a series of responses in both phagocytes and 
non-phagocytes with which they interact, which in turn affects the micro-environment 
of these cells thus the effects of apoptosis are far more extensive and complex than 
simply a regulated cell death program.   
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1.2.2.1 The interactions between apoptotic cells and 
mononuclear phagocytes 
A key event in the non-phlogistic clearance of apoptotic cells is the immediate 
engulfment of dying cells to prevent secondary necrosis by either professional 
phagocytes or neighbour cells with engulfment ability. The swift engulfment of 
apoptotic cells is essential to immunological tolerance whereas delay or failure of 
clearance will result in inflammation and autoimmune diseases (Savill, Dransfield et al. 
2002; Henson and Hume 2006; Elliott and Ravichandran 2010). The clearance process 
has been artificially rationalized into three phases termed ‘3Rs”: recognition, response 
and removal (Gregory and Pound 2010).   
 
Recognition 
Since phagocytes can be neighbouring cells as well as recruited professional 
phagocytes, the recognition process requires not only altered molecular patterns on the 
surfaces of apoptotic cells (‘eat-me’ signals), but also chemoattractants released from 
apoptotic cells to recruit professional phagocytes in situ (‘find-me’ signals) (Gregory 
and Pound 2010; Ravichandran 2011). Several chemoattractants released from 
apoptotic cells have been identified, ranging from lipids and proteins to nucleotides, 
either in the soluble or microparticle-associated fashion.  Two soluble lipid mediators, 
phospholipid lysophosphatidylcholine (LPC) and sphingosine-1-phosphate (S1P) are 
released from apoptotic cells and can recruit mononuclear phagocytes in vitro (Lauber, 
Bohn et al. 2003; Gude, Alvarez et al. 2008). Another factor, fractalkine (CX3CL1), 
can be released from apoptotic Burkitt’s Lymphoma cells in a microparticle-associated 
manner at early stages of apoptosis and its function as a chemoattractant  has been 
examined both in vitro and in vivo (Truman, Ford et al. 2008). Recently, ATP and UTP 
have been demonstrated to be released by apoptotic cells through pannexin-1 channels 
and their functions as chemoattractants was examined both in vitro and in vivo (Elliott, 
Chekeni et al. 2009; Chekeni, Elliott et al. 2010). Other mononuclear phagocyte 
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chemoattractants, such as ribosomal protein S19 (Yamamoto 2007), EMAPII (Shalak, 
Kaminska et al. 2001), MCP-1 (Kobara, Sunagawa et al. 2008) have also been 
identified.   
 
The apoptosis programme is reflected on the cell membrane as alterations in the 
membrane composition (appearance or loss of certain molecules) thus distinguishing 
apoptotic cells from viable cells. The molecules that have newly appeared on the 
membrane of apoptotic cells, which are required for recognition by phagocytes are 
called ‘eat-me’ signals (Grimsley and Ravichandran 2003). The best known ‘eat-me’ 
signal is phosphatidylserine (PS) which moves to the outer leaflet of the plasma 
membrane during apoptosis (Fadok, Voelker et al. 1992).  There are also membrane 
molecules inhibiting the recognition process, the loss of which can lead to successful 
recognition, and these molecules are named ‘don’t-eat-me’ signals. For example, 
CD31 and CD47 are identified to be ‘don’t-eat-me’ signals (Brown, Heinisch et al. 
2002; Gardai, McPhillips et al. 2005). In the meantime, the recognition also requires 
phagocytes to be equipped with certain pattern recognition receptors, such as PS 
receptors (BAI1, TIM-4, and stabilin-2) (Miyanishi, Tada et al. 2007; Park, 
Tosello-Trampont et al. 2007; Park, Jung et al. 2008), CD14 (Devitt, Moffatt et al. 
1998), CD36 and integrins (Savill, Hogg et al. 1992) as well as some bridging 
molecules, like milk fat globule-EGF  factor 8 (MFG-E8). The complex tethering 
interaction between apoptotic cells and phagocytes forms the basis of further 
responses and is termed the ‘phagocytic synapse’ (Fadok, Bratton et al. 2001). 
 
Response and removal 
The recognition of apoptotic cells and the formation of tight tethering leads to the 
activation of two partially redundant pathways upstream of the Rho family GTPase 
Rac1, resulting rearrangement of actin and subsequent engulfment and internalization 
of apoptotic cells by phagocytes (Kinchen 2010).  In mammalian cells, the  first 
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pathway involves a transmembrane scavenger receptor MEGF-10, an adaptor protein 
(GULP) and an ABC transporter (ABCA1 or ABCA7), and the key mediators in the 
second pathway include an adaptor protein CrkII and a guanine nucleotide exchange 
factor Dock 180-ELMO (Kinchen and Ravichandran 2007). The internalized corpses 
will then enter the lysosomal digestion procedure for degradation and recycling.  
 
Non-phagocytic effects 
Apart from the phagocytic response, mononuclear phagocytes have other responses to 
apoptotic cells which affect the surrounding microenvironment. Mononuclear 
phagocytes generally have anti-inflammatory responses to apoptotic cells in vitro and 
different mechanisms of inducing these responses have been identified.  Several lines 
of evidence indicate that by interacting with apoptotic cells, either binding or 
engulfing, mononuclear phagocytes can increase the secretion of anti-inflammatory 
cytokines, such as TGF-β and IL-10, and decrease the secretion of pro-inflammatory 
cytokines, such as TNF-α and IL-1β (Voll, Herrmann et al. 1997; Fadok, Bratton et al. 
1998; McDonald, Fadok et al. 1999). Further investigations confirmed that 
mononuclear phagocytes only require direct contact with apoptotic cells to release 
anti-inflammatory mediators and the process is independent of the phagocytic event 
and any soluble factors (Cvetanovic and Ucker 2004; Lucas, Stuart et al. 2006).  The 
contact-dependent anti-inflammatory effect ensures the induction of a local 
anti-inflammatory microenvironment surrounding the apoptotic cells rather than a 
systematic suppression of inflammation. However, molecules required for the contact 
between apoptotic cells and phagocytes have not been fully delineated although one 
molecule identified to be required for this process is PS (Huynh, Fadok et al. 2002; 
Gaipl, Beyer et al. 2003).  
 
Other than the immuno-regulatory effect, exposure of mononuclear phagocytes to 
apoptotic cells can modulate the microenvironment in other ways. Hepatocyte growth 
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factor, which is a growth factor for bronchial epithelial cells and alveolar type II cells, 
can be released from macrophages that have engulfed apoptotic neutrophils in an acute 
lung injury model (Morimoto, Amano et al. 2001).  Endothelial progenitor cells (EPC) 
can function as amateur phagocytes to engulf apoptotic cells and the engulfment 
promotes the proliferation and differentiation of the EPC, possibly facilitating the 
repair or construction of the endothelium although the molecular mechanism of this is 
unknown (Hristov, Erl et al. 2004). Another study demonstrated that the phagocytosis 
of apoptotic bodies leads to the secretion of VEGF from macrophages to promote the 
survival and growth of endothelial cells (Golpon, Fadok et al. 2004). These studies 
suggest that apart from clearing cell debris, conditioning of macrophages by apoptotic 
cells can contribute to the microenvironment in more ways than expected, including 
immune regulation, cell survival and growth as well as angiogenesis.   
 
1.2.2.2 The interactions between apoptotic cells and other 
neighbouring cells 
Apoptotic cells can also be cleared by cells other than professional phagocytes, such as 
neighbouring homotypic cells (Wyllie, Kerr et al. 1980; Parnaik, Raff et al. 2000), 
mesenchyal and epithelial cells (Saunders 1966; Wood, Turmaine et al. 2000; Monks, 
Rosner et al. 2005). Similar to professional phagocytes, non-professional phagocytes, 
such as epithelial cells and fibroblasts, and some non-phagocytic cells, such as 
neuronal and lymphoid lineage cells, also exhibit contact-dependent 
anti-inflammatory effects upon their exposure to apoptotic cells. However, unlike the 
interaction with professional phagocytes, the effect is independent of 
phosphatidylserine (PS), although the molecules essential to the contact process are 
still undefined. A model involving MAPK signalling has been speculated to be the 
mechanism underlying the ubiquitous apoptotic cell recognition by both phagocytes 
and nonphagocytes. Recognition of apoptotic cells activates p38 and JNK signalling 
pathways and inhibits ERK1/2, leading to the formation of inactive AP1 complexes 
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which sequester limiting transcriptional co-activators and exert transcriptional 
trans-repression (Cvetanovic, Mitchell et al. 2006).  
 
1.2.2.3 Micro-environmental conditioning signals derived 
directly from apoptotic cells 
Macrophages are not the only source of anti-inflammatory cytokines in the apoptotic 
environment; apoptotic cells can themselves release anti-inflammatory cytokines, 
such as IL-10, TGF-β, contributing to the immunosuppressive micro-environment 
(Gao, Herndon et al. 1998; Chen, Frank et al. 2001). On the other hand, each of these 
anti-inflammatory mediators can enhance the ability of macrophages to clear apoptotic 
cells, ensuring the immediate and successful clearance (Szondy, Sarang et al. 2003; 
Ogden, Pound et al. 2005). Furthermore, it has been shown that TFG-β can exert an 
inhibitory effect on innate immunity and tune the phenotypes of macrophages and 
neutrophils from M1, N1 to M2, N2, respectively (Flavell, Sanjabi et al. 2010).  Other 
factors released from apoptotic cells are found to influence microenvironment in 
multiple ways. Lactoferrin which can be released from apoptotic cells, can suppress 
inflammation by inhibiting the migration of inflammatory neutrophils and eosinophils 
towards apoptotic cells (Bournazou, Mackenzie et al. 2009; Bournazou, Pound et al. 
2009) and it also has multiple immunomodulatory and anti-inflammatory properties 
(Legrand, Elass et al. 2005). Fractalkine, a mononuclear phagocyte chemoattractant 
released from apoptotic cells, has been shown to have anti-inflammatory activities on 
monocytes as well as microglia, macrophages in the central nervous system (Zujovic, 
Benavides et al. 2000; Ollivier, Faure et al. 2003; Cardona, Pioro et al. 2006). 
Fractalkine has also been shown to have anti-apoptotic, pro-survival and 
pro-proliferation effects on human vascular smooth muscle cells (White, Tan et al. 
2010).   
 
A compensatory proliferation in surrounding cells induced by apoptotic cells has been 
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observed in Drosophila. However, this compensatory proliferation was only observed 
in response to apoptosis induced by stress or damage instead of developmental 
apoptosis. This phenomenon was observed more than three decades ago, in which 
X-ray irradiated cells underwent pyknosis while stimulating remaining survival cells 
to undergo additional proliferation (Haynie and Bryant 1977). The underlying 
mechanism was revealed in recent years. In apoptotic cells, two mechanisms have 
been found to be responsible for triggering compensatory proliferation depending on 
the developmental state of the apoptotic cells. The initiator caspase, Dronc, mediates 
the compensatory proliferation induced by apoptotic proliferating tissues whereas, 
effector caspases, DrICE and Dcp-1 mediate the compensatory proliferation induced 
by differentiating tissues (Kondo, Senoo-Matsuda et al. 2006; Wells, Yoshida et al. 
2006; Fan and Bergmann 2008). Therefore, it has been proposed that apoptosis in 
proliferating and differentiating tissues leads to the activation of two different 
signalling pathways. In differentiating tissues, where effector caspases, DrICE and 
Dcp-1, are involved, Hedgehog is upregulated and released to mediate the 
neighbouring cell proliferation. In proliferating tissues, where the initiator caspase is 
in charge, Wingless (Wg; Drosophila Wnt homolog) and Decapentaplegic (Dpp; 
Drosophila homolog of TGF-β) are the possible compensatory proliferation mediators, 
and p53 and Jun N-terminal kinase (JNK) signalling are suggested to mediate their 
release (Fan and Bergmann 2008). 
 
1.3 The tumour microenvironment in non-Hodgkin's 
lymphoma 
1.3.1 Non-Hodgkin’s lymphoma 
Non-Hodgkin’s lymphomas (NHL) are a collection of more than 60 heterogeneous 
malignant neoplasms composed of mainly aberrantly proliferating lymphocytes, 
exhibiting distinct morphological, immunophenotypic and molecular genetic features. 
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Some lymphomas can develop both within lymphoid organs, such as lymph nodes and 
spleen, and at extranodal sites. The standard system for the classification of NHL is 
known as the ‘Revised European-American Classification of Lymphoid Neoplasms’ 
(REAL) classification, which takes into account not only the immunologic features, 
but also genetic mutations together with the clinical manifestations. There are 13 most 
frequent NHL (Armitage and Weisenburger 1998). Despite all the discrepancy 
between them, they share the common property of being lymphocyte malignancies, 
either B cells or T cells, arising from cells at various stages of differentiation with 
disruption of different phases of normal development.   
 
1.3.2 The tumour microenvironment in non-Hodgkin’s 
lymphoma 
In contrast to Hodgkin’s lymphoma (HL) which is characterized by the classical 
Reed-Sternberg cells and the presence of only a few malignant cells (often less than 
1% of cells in the tumour tissue) with abundant benign infiltrated immune cells 
(neutrophils, macrophages, eosinophils, mast cells, T and B cells), most of the cells in 
the NHL are malignant. Therefore, unlike the well recognized and studied roles of the 
tumour microenvironment in HL (Aldinucci, Gloghini et al. 2010), the role of the 
tumour microenvironment in NHL has largely been overlooked. For many years, the 
research and treatment for NHL has been focused on the genetically mutated 
neoplastic cells, since almost every NHL has been found associated with specific 
genetic mutations that disrupt the balance between normal cell birth and cell death.  
 
With the gradually recognized role of the tumour microenvironment in favouring 
tumour progression, especially epithelial-related tumours, the microenvironment of 
NHL has gained increasingly more attention with time. The landmark discovery was 
made by gene profiling of follicular lymphoma and diffuse large B-cell lymphoma 
(DLBCL) which identified the correlation between the tumour-associated 
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non-malignant immune cells at diagnosis and the length of survival after various 
standard treatments. In DLBCL, Lenz et al. demonstrated that the ‘stomal-1’ gene 
cluster, which is rich in genes of extracellular matrix proteins and cells of monocytic 
lineage, is associated with a favourable prognosis whereas the ‘stromal-2’ cluster 
which is rich in genes involved in endothelial cell biology and adipocyte function 
indicates inferior survival (Lenz, Wright et al. 2008). Gene profiling of follicular 
lymphoma suggested that the tumour heterogeneity might originate from the 
infiltrated non-malignant cells: two signatures, both belonging to the 
microenvironment of the tumour, were related to prognosis; the ‘immune response-1’ 
signature, composed mainly of T cell genes, was linked to a favourable outcome and 
the ‘immune response-2’ signature, enriched with myeloid cell genes, indicated poor 
prognosis (Dave, Wright et al. 2004). All the above findings emphasized an important 
interplay between the tumour microenvironment and malignant cells and suggested 
that different components of the tumour microenvironment, including lymphoid 
stromal cells, macrophages, T cells, dendritic cells as well as chemokines and their 
receptors might all contribute to the development and progression of malignancy 
(Coupland 2011).  
 
One of the hallmarks of cancers is their inherent ability to suppress cell death, 
including apoptosis (Hanahan and Weinberg 2011). However, oncogene activation, 
such as c-myc and e2f, does not only result in sustained proliferative signalling, it is 
also coupled with apoptosis, especially when growth factor is limited (Evan, Wyllie et 
al. 1992; Lowe, Cepero et al. 2004). The presence of apoptosis within tumours is 
broadly accepted (Wyllie 1985) and it is evidently demonstrated in several classes of 
NHL, prototypically Burkitt’s lymphoma (Hori, Xiang et al. 2001; Zenger, Abbey et al. 
2002; Park, Kim et al. 2005; Wang and Boxer 2005). In malignant NHL, apoptosis 
indices correlate significantly with lethality (Leoncini, Del Vecchio et al. 1993). 
Apoptotic index (AI) has been found associated with the grade of NHL, and high AI 
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predicts high grade of NHL (Symmans, Cangiarella et al. 2000).  Nevertheless, the 
role of apoptosis in tumour microenvironmental conditioning has not been well 
studied. The abundance of apoptotic cells in NHL is always associated with a high rate 
of infiltrated macrophages. The histological stained tumour sections always contain a 
darkly stained, almost homogeneous background of tumour cells scattered with lightly 
stained macrophages with abundant cytoplasm, forming a characteristic ‘starry-sky’ 
pattern (Berard 1969; Hori, Xiang et al. 2001). Nevertheless, the functions of the 
massively infiltrated macrophages are still mostly unknown, aside from the clearance 
of apoptotic cells demonstrated by some tumour cell debris inside the cytoplasm of 
macrophages. In order to better understand the tumour microenvironment of NHL, 











               
 
 Figure 1.1 Microenvironment in Burkitt’s lymphoma. 
 A) ‘Starry-sky’ morphology in BL (Kindly provided by Dr. John Pound). B) 
Apoptotic cells in BL revealed by TUNEL staining. C) Macrophages in BL 
revealed by CD68 staining. (B and C were kindly provided by Dr. Catriona 
Ford. D) The absence of neutrophils in BL revealed by Gr1 staining (Taken 










1.3.3 Burkitt’s lymphoma (BL) as a prototypical model of 
NHL microenvironment 
1.3.3.1 Burkitt’s lymphoma 
Burkitt’s lymphoma (BL) is a highly aggressive, B-cell NHL named after Dennis 
Burkitt who first described the disease in Africa (Burkitt 1958). This type of BL later 
designated as endemic BL according to WHO, often arises in 4-7 year old African 
children and is normally associated with Epstein-Barr virus (EBV) which was the first 
virus to be described in association with human tumour pathogenesis. BL is also found 
at a low prevalence in sporadic areas around the world (sporadic BL); the exception 
being HIV positive patients (immunodeficiency-associated BL) which have a high 
incidence, around 40% (Ferry 2006). There are three variants based on their 
morphology and immunohistochemistry, classical BL, BL with plasmacytoid 
differentiation and atypical/Burkitt’s-like lymphoma. Despite their difference in the 
nuclear pleomorphism and the cytoplasmic immunoglobulin, all three variants share 
some common morphological features: uniform and medium-sized neoplastic cells 
with abundant, RNA rich cytoplasm which is deep blue on Giemsa stain. The tumour 
cells are admixed with numerous pale stained infiltrated macrophages on H&E stain 
with many phagocytosed apoptotic tumour cells. The interspersed light-stained 
macrophages among the deep blue tumour cells compose the renowned ‘starry-sky’ 
morphology (Berard 1969).  
 
The ‘starry-sky’ histological pattern is a prominent feature of BL but it is not specific 
to BL; other neoplasms, for example poorly differentiated malignant lymphomas and 
certain cases of acute leukaemia, share a similar histological appearance (Berard 1969). 
The defining feature of BL is the translocation of the c-myc gene, either juxtaposed 
with the IgH gene (80%) or with the gene for the kappa or lambda light chain (20%). 
The translocation results in the c-myc expression under the regulation of the 
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transcriptionally active Ig enhancer, which leads to de-regulated over-expression of 
the c-myc gene (George 1983). Myc protein is a DNA-binding transcription factor and 
its target genes constitute 15% of known genes therefore the over-expression of Myc 
protein can increase cell growth and proliferation as well as apoptosis and cell 
senescence, which is consistent with the high rates of proliferation as well as apoptosis 
in BL both in vivo and in vitro (Dang, O'Donnell et al. 2006; Allday 2009). 
 
Evidence accumulated over time suggests that BL was derived from peripheral 
germinal centre B-cells. Biopsies from non-endemic BL were selectively involved 
with germinal centres, indicating there was some relationship between neoplastic cells 
and normal germinal centre B lymphocytes (Mann, Jaffe et al. 1976). Further evidence 
was provided by comparing immunofluorescence staining of a spectrum of cell surface 
antigens in endemic BL and a population of tonsillar germinal centre B cells which 
carried similar surface markers, positive for CD10, CD20 and CD77 while negative 
for CD23 and CD39 (Gregory, Tursz et al. 1987). In contrast to mature, circulating B 
cells, BL cells share other similar properties to germinal centre B cells, including 
prominent cell loss and lack of expression of the anti-apoptotic protein bcl-2 (Pezzella, 
Tse et al. 1990; Henderson, Rowe et al. 1991; Liu, Johnson et al. 1992). Further 
finding of the presence of hypermutated regions in translocations in sporadic BL 
proved further that germinal centre B cells were the origin of the neoplasm (Cario, 
Stadt et al. 2000).   
 
1.3.3.2 Burkitt’s lymphoma microenvironment 
Despite the c-myc translocation and its perennial activation, rather than being a 
tumour of autonomous growth, cross-talk between neoplastic B cells and their 
microenvironment is an integral part in the tumour pathogenesis. In the BL 
microenvironment, there is a delicate balance between pro- and anti-apoptotic signals. 
Histological analysis of BL sections has revealed a high rate of innate apoptosis 
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(Ogden, Pound et al. 2005). Since apoptotic cells are engulfed instantly and degraded 
rapidly by professional and amateur phagocytes in vivo (Savill 1997), the frequent 
detection of apoptotic tumour cells in the presence of abundant infiltrated 
macrophages suggests there is a high rate of apoptotic cell death occurring in BL. 
When cultured in vitro, cells derived from BL show a similar tendency to apoptosis 
(Gordon, Knox et al. 1993). However, their inherent tendency to undergo apoptosis 
has to be balanced by anti-apoptotic signals from the BL micro-environment and 
therefore net tumour growth can be achieved. In vitro investigations using a group I 
BL cell line to model the BL micro-environment suggested that survival signals can be 
generated from different components of the BL micro-environment including 
fibroblasts, follicular dendritic cells, macrophages and activated T cells and even from 
BL cells themselves (Levens, Gordon et al. 2000). It was also discovered that 
macrophages conditioned by IL-10, expressed by both tumour cells and infiltrated 
macrophages, can release B cell-activating factor of the TNF family/B lymphocyte 
stimulator (BAFF/BLyS) which is a B cell survival factor to promote BL cell growth 
and proliferation (Ogden, Pound et al. 2005). 
 
Previous work has identified that the persistence of apoptotic BL cells in the BL 
micro-environment, instead of being a tumour-suppressive mechanism, can actually 
promote tumour growth. On the one hand, apoptotic BL cells can regulate the immune 
cell infiltration by releasing a combination of chemokines to selectively recruit 
immune cells: 1) fractalkine is a ‘find-me’ signal to attract mononuclear phagocytes 
(Truman, Ford et al. 2008); 2) lactoferrin is a ‘keep-out’ signal to inhibit neutrophil and 
eosinophil infiltration (Bournazou, Mackenzie et al. 2009; Bournazou, Pound et al. 
2009). On the other hand, macrophages, conditioned by IL-10, exhibit an enhanced 
ability to clear apoptotic cells (Ogden, Pound et al. 2005). Since clearance of apoptotic 
cells was found to polarize macrophages, recruited macrophages in BL can provide an 
important mechanism in tumour microenvironmental conditioning. As mentioned 
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earlier, lactoferrin has multiple immunomodulatory and anti-inflammatory properties 
(Legrand, Elass et al. 2005), whereas fractalkine has anti-inflammatory activities as 
well as anti-apoptotic, pro-survival and pro-proliferation effect (Zujovic, Benavides et 
al. 2000; Ollivier, Faure et al. 2003; Cardona, Pioro et al. 2006; White, Tan et al. 2010), 
they might also contribute to tumourigenesis in currently unidentified ways.    
 
Although the presence of apoptosis in BL and its role in tumour microenvironmental 
conditioning is recognized, the mechanisms driving apoptosis in situ are not 
completely understood, apart from the identified role played by c-myc. BL often 
presents as a rapidly growing solid tumour and is among the fastest growing tumours 
observed, with a short in vitro doubling time of 19-36 hours (Iversen, Iversen et al. 
1974) and more than 95% of cells have been observed to be actively engaged in cell 
cycle progression, as revealed by positivity for Ki-67 staining of BL sections (Cooper, 
Frank et al. 1966). Unlike normal cells, which can check and regulate the rate of 
proliferation and metabolism in response to hypoxia and nutrient limitation (Lum, 
Bauer et al. 2005; Brahimi-Horn, Chiche et al. 2007; Semenza 2007), BL cells have 
de-regulated over-expression of myc oncogene which continually drives cellular 
proliferation despite limited supplies of oxygen and nutrients, exacerbating the  
metabolic stress in the tumour mass. However, the role of metabolic stress in 
triggering the induction of apoptosis in BL has not been addressed.  
 
Although apoptotic cells can release ‘find-me’ signals to attract mononuclear 
phagocytes, the stage of apoptosis at which the cells start to release those ‘find-me’ 
signals has yet to be identified. However, some studies have demonstrated that the 
release of chemoattractants (eg. LPC and ATP) can be dependent on the apoptotic 
effector protease, caspase-3 (Lauber, Bohn et al. 2003; Chekeni, Elliott et al. 2010), 
suggesting that there is cross-talk between the apoptosis program and the mechanisms 
controlling chemoattractants release. It is appreciable that the early release of 
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‘find-me’ signals would facilitate the mobilization and infiltration of the responsive 
phagocytes to locate and clear apoptotic cells quickly.  In vivo analysis of surface 
membrane PS positive BL cells also reveals the presence of very early apoptotic cells 
with condensed chromatin and loss of electron density of the cytoplasm as well as cells 
with characteristics of other  stages of apoptosis, including late apoptotic cells with 
advanced chromatin condensation, nuclear pyknosis and cellular fragmentation (Van 
den Eijnde, Boshart et al. 1997). Thus, another question raised is whether early stage 
apoptotic cells or even pre-apoptotic cells can release ‘find-me’ and ‘keep-out’ signals 
to regulate the infiltration of phagocytes, and therefore participate in the tumour 
microenvironmental conditioning. 
 
1.3.3.3 Burkitt’s lymphoma cell lines 
Various BL cell lines have been established in vitro from both EBV positive and 
negative Burkitt’s lymphoma in an attempt to study BL properties in vitro and they 
have been categorized into three different groups according to their cell surface 
phenotypes (Rowe, Rooney et al. 1985). Group I BL lines grow as a single cell 
suspension and express the BL marker CD10 and CD77 without any B cell activation 
markers, which reflects the biopsy features. Group II cultures contain small cellular 
aggregates and express some of the activation markers, like CD23, CD30, CD39 and 
CD70, apart from the BL marker CD10 and CD77. Group III lines are normally 
present as large cellular clumps and only expressed high levels of activation markers 
without any of the BL markers. Despite the variations between the three groups of cell 
lines, they all display a c-myc chromosome translocation, t(8:14) or t(8:22), 






1.4 Generation of macrophages from murine 
embryonic stem cells 
For the study of macrophages in vitro, especially their interaction with apoptotic cells, 
an appropriate model is required. Currently commonly used in vitro macrophage 
models are derived from two main sources: tumour-derived cell lines and primary cells 
isolated from animals both of which have their own advantages and disadvantages. 
Tumour-derived cell lines, such as RAW267.4 and THP-1 cells, are at different stages 
of maturation so differ in phenotypes and functions. Although they have the advantage 
of genetic tractability and a limitless supply of homogenous population of cells, their 
oncogenic nature makes them somewhat different from the normal state. For example, 
some cancer cell lines cannot be activated by IFN-γ which is an important factor 
regulating macrophage functions (Stojdl, Lichty et al. 2000). However, they still 
preserve some functions of their normal counterparts which make them still widely 
used as macrophage or macrophage precursor models. On the other hand, 
macrophages from primary sources, either peritoneal macrophages or macrophages 
derived from primary precursor cells in human blood or murine bone marrow, reflect 
normal macrophages with normal physiology. However, the cells derived from living 
organisms are always limited in numbers, thus restraining the availability for 
experiments. Furthermore, primary cells have limited replicative ability and are 
resistant to genetic manipulation which confines them from being applied in the 
studies of the molecular mechanisms in macrophage research (Oliveira, Lima et al. 
2003). 
 
Advances in the culture and directed differentiation of embryonic stem cells (ES cells) 
provides a better in vitro macrophage model. ES cells are pluripotent cells derived 
from the inner cell mass of blastocysts which can differentiate into any type of cells 
except those of the placenta. Since the derivation process is different from 
conventional transformation methods, ES cells preserve their normal physiology and 
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can therefore contribute to embryo development if returned to the embryo 
environment (Smith 2001).  Cell lineages, belonging to the mesoderm, endoderm and 
ectoderm have already been generated from murine ES cells (Keller 2005). 
Furthermore, another advantage of ES cells is their amenability to genetic 
manipulation in both gain-of-function and loss-of-function studies. Gain-of-function 
can be achieved by over-expression of specific genes (Chambers, Colby et al. 2003) 
and conventional homologous recombination and RNAi can result in loss-of-function 
(Hamaguchi, Woods et al. 2000; Ma, Ramezani et al. 2003).  The expression can be 
controlled both temporally and spatially by using site-specific recombinases which 
can avoid the potential effect of genetic manipulation on ES cell differentiation (Kyba, 
Perlingeiro et al. 2002).  Therefore, macrophages derived from ES cells have the 
advantage of being normal cells with high purity as well as the limitless feature of in 
vitro cell lines. Furthermore, they can be applied to molecular mechanism studies that 
require genetic manipulation. 
 
1.5 Aims of the project 
As discussed above, macrophages conditioned by apoptotic cells can acquire some 
vital functions similar to those of tumour-associated macrophages, such as 
anti-inflammatory and immunosuppressive effects, release of survival and growth 
factors and participation in angiogenesis, together with the direct microenvironmental 
conditioning effects by apoptosis, it is reasonable to speculate that in NHL, apoptotic 
cells can condition the tumour microenvironment to promote tumour growth (Gregory 
and Pound 2010; Gregory and Pound 2011). Since the delay or failure to clear 
apoptotic cells in vivo can lead to the activation of the immune system and may cause 
anti-tumour immune responses (Nagata, Hanayama et al. 2010), it is also rational to 
hypothesize that apoptotic cells might release microenvironmental conditioning 
signals at a very early stage, such as stressed, pre-apoptotic stage, to ensure the prompt 
clearance of apoptotic cells as well as the timely conditioning of the microenvironment. 
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The main aim of the project was to test the hypothesis that stressed, pre-apoptotic cells 
can contribute to tumour microenvironmental conditioning in Burkitt’s lymphoma. 
Considering the microenvironment of BL which is characterised by a high rate of 
spontaneous apoptosis, abundant infiltration of macrophages but no neutrophil 
infiltration (Truman, Ogden et al. 2004; Bournazou, Pound et al. 2009), the 
microenvironmental conditioning effects assessed were focused on the recruitment of 
macrophages and neutrophils and the generation of the anti-apoptotic/mitogenic 
signals which are essential for net tumour growth under the circumstances of a high 
rate of spontaneous apoptosis. 
 
In order to generate an in vitro model of pre-apoptotic tumour cells and mimic the 
physiological trigger (metabolic stress) that induces apoptosis in the tumour 
microenvironment, a high density stress model was devised which employed a group I 
BL cell line. The mechanisms underlying the apoptosis-inducing effect of high density 
stress was also examined. Secondly, cell-free supernatants generated from stressed BL 
cells were assessed for their ability to recruit macrophages and neutrophils and the 
identity of the molecule responsible for the recruitment and its release mechanism 
were examined. Finally, the effect of the cell-free supernatants generated from stressed 
BL cells on the survival/proliferation of viable cells was assessed to examine the 
presence of any anti-apoptotic/mitogenic signals as well as their identities. 
 
Although interactions between apoptotic cells and phagocytes have been widely 
studied, the underlying molecular interactions have not been fully elucidated. Further 
understanding of these may be facilitated by using ESDM, especially because of their 
amenability to genetic manipulations. Therefore, the second aim of the project was to 
develop an optimal protocol for in vitro differentiation of murine ESC into ESDM. 
ESDM were characterised phenotypically and their functions, including chemotaxis 
towards and phagocytosis of apoptotic cells, were investigated. 
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Chapter 2 Materials and Methods 
2.1 Cells 
2.1.1 Isolation and culture of primary cells  
2.1.1.1 Mouse bone marrow-derived macrophages (BMDM) 
preparation 
Mouse femurs (Balb/c) were removed by dissection, and cleaned in ethanol in a sterile 
hood. The bones were then placed into DMEMsupp (see Appendix 1) and the ends were 
cut off the bones. Bone arrow was flushed with DMEMsupp using a 10ml syringe (BD 
Plastipak) and a 26G needle (BD Microlance) into a 50ml conical tube (BD Falcon). 
Cells were then passed through a 23G needle (BD Microlance) using a syringe and 
plated onto 95 mm Petri dishes in 20 ml DMEMsupp. The medium was changed after 2 
hours and then after 4 days. On day 7, differentiated macrophages were used for 
experiments. 
 
2.1.1.2 Peritoneal cell preparation 
Peritoneal lavage was performed in Balb/c mice using sterile PBS and the cells were 
centrifuged and re-suspended in 20 ml DMEMsupp. Then they were plated onto 95 mm 
Petri dishes for 2 hours before use.  
 
2.1.1.3 Human blood leukocyte separation 
Human leukocytes were obtained from peripheral blood of healthy donors. Peripheral 
venus blood was drawn using 19-gauge needle from an antecubital vein and 
transferred to polypropylene centrifuge tubes containing 3.8% (w/v) sodium citrate for 
anticoagulation. Anticoagulated blood was centrifuged at 350g for 20 min with brake- 
off to fractionate plasma.  
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The supernatant which was platelet-rich plasma was collected into sterile glass 
universal bottles supplemented with CaCl2 (final concentration 40 mM) and incubated 
at 37°C for 1 h to clot and generate autologous serum. Autologous serum was 
heat-inactivated at 56°C for 45 min and centrifuged at 2000g for 10 min to remove any 
precipitate. 
 
Plasma-free cell pellet was uniformly resuspended in dextran (final concentration 
0.6%, w/v) (Pharmacia, Buckinghamshire, UK) and left to stand undisturbed for 15-30 
min to allow erythrocytes to sediment under gravity. The supernatant which was rich 
in leukocytes was collected and centrifuged at 220g for 6 min. Three different 
concentrations of Percoll (55%, 68% and 79%) were prepared from the stock 
(Pharmacia) using phosphate buffered saline (PBS) (Ca2+/Mg2+-free). For each 30 ml 
of blood, 68% Percoll was carefully layered over 5 ml 79% in a conical polypropylene 
tube. The leukocytes pellet was resuspended in 55% Percoll (Cells from 30 ml of blood 
should be resuspended in 3 ml of 55% Percoll) and 3 ml of the cell suspension was 
layered on top of the gradient. The gradient was centrifuged at 700g for 20 min with 
brake-off. The mononuclear phagocytes were at the 55%/68% Percoll interface and 
polymorphonuclear cells (neutrophils and eosinophils) at the 68%/79% Percoll 
interface.   
 
Mononuclear phagocytes were harvested after removing most of 55% Percoll layer. 
Harvested mononuclear cells were washed and centrifuged at 220g for 5 min. The 
pellet was resuspended in serum-free Iscove’s Modified Dulbecco’s Medium 
containing penicillin, streptomycin and glutamine (IMDM+P/S+Glu) at 4 × 106 
cells/ml. Cells were pated onto 25 cm2 tissue culture flasks (10 ml per flask) and 
incubated for one hour at 37°C/5%CO2. The medium was then aspirated and 
IMDM+P/S+Glu containing 10% heat-inactivated autologous serum was added. The 




Polymorphonuclear cells were harvested after removing most of 68% Percoll layer. 
Harvested polymorphonuclear cells were analysed by cytospin and neutrophils 
represented >95% of the population (Figure 4.7 A). The cells were used directly for 
chemotaxis assays.  
 
2.1.2 Maintenance of cell lines  
2.1.2.1 Culture of human Burkitt’s lymphoma (BL) cells 
Two human BL cell lines were used, BL2 (EBV-negative) (Lenoir, Vuillaume et al. 
1985) and BL2-bcl2. BL2-bcl2 are BL2 cells stably transfected with bcl2 to suppress 
apoptosis (Wang, Grand et al. 1996). The BL2-bcl2 line used in the present study was 
a stable bcl-2 transfectant established by C D Gregory and S. Douglas. The cells were 
cultured in suspension in BL media (Appendix 1). These cell lines were cultured at 
37°C, 5% CO2 and maintained in the exponential phase (105-106/ml). 
 
2.1.2.2 Culture of human monocytic cell lines, THP-1 and 
MonoMac 6 
THP-1 cells were established from the blood of a boy with acute monocytic leukemia 
(Tsuchiya, Yamabe et al. 1980). The cells were cultured in THP-1 culture medium (see 
Appendix 1) at 37°C, 5% CO2 and maintained in the exponential phase (10
5-106/ml).  
 
MonoMac6 cells were established from peripheral blood of a patient with monoblastic 
leukemia with characteristics of mature monocytes (Ziegler-Heitbrock, Thiel et al. 
1988).  The cells were cultured in MonoMac6 culture medium (See Appendix 1) at 
37°C, 5% CO2 and maintained in the exponential phase (0.3-1.0 × 10
6/ ml).  
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2.1.2.3 Culture of murine embryonic stem cells (ES cells)   
Murine embryonic stem cell line E14, derived from the 129/Sv mouse strain, was used. 
It was originally derived on a feeder layer and has now been adapted to grow on 
gelatine-coated tissue culture dishes (Handyside, O'Neill et al. 1989). Fetal calf serum 
(FCS) was batch tested using a colony forming assay and was designated normal 
(growth-supporting) FCS and Diff (differentiation-promoting) according to the 
variance in its ability to promote ES cell self-renewal. Normal FCS was used for 
routine ES cell culture and Diff was used for ES cell differentiation. ES cells were 
cultured in ES cell culture medium (GMEMFCS, see Appendix 1). Its sterility was 
tested by tryptose phosphate broth (Gibco) before use. ES cells were cultured in 
GMEMFCS supplemented with 100 units /ml leukemia inhibitory factor (LIF) at 37 C, 
5% CO2. ES cells were seeded at the density of 1×10
6 cells in 10 ml media in 
gelatinized T25 cm2 flask and were usually ready to be passaged 2 days later when the 
cells were confluent. The LIF–containing supernatant was from COS7 cells 
transfected with a LIF-expressing plasmid and its efficacy was tested according to 
published methods (Jackson, Taylor et al. 2010). 
 
2.1.2.4 Culture of L929 cells and in-house production of L929 
cell-conditioned medium (L929 CM) 
Colony stimulating factor-1 (CSF-1) is highly expressed in the mouse lung fibroblast 
line L929 (Burgess, Metcalf et al. 1985) and L929 cell-conditioned media is widely 
used as a source of CSF-1. L929 cells were thawed and expanded in L929 cell culture 
medium (Appendix 1). The adherent cells were passaged 1 in 30 every 3 to 4 days at 
confluence using trypsin/EDTA to detach the cells. To harvest the conditioned medium, 
cells were cultured 3 days after they became confluent. The conditioned medium was 
harvested directly from the adherent monolayer of cells and filtered through a 0.22μm 
membrane to remove cell debris. The L929 CM was stored at - 20C. 
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2.2 Induction and evaluation of apoptosis 
2.2.1 Induction of apoptosis by UV-irradiation  
In order to induce apoptosis, 100mJ/cm2 UV-B was used as a trigger (Truman 2005). A 
UV meter (SLS) was used to determine the intensity of UV exposure and the meter 
was placed under the cover of the flask used for the cells to mimic the exact intensity 
of UV irradiation that the cells would receive. Time required for UV treatment was 
calculated as follows (in seconds): 100,000 μJ/meter reading = time required. 
UV-treated BL2 cells were returned to culture at 37C (in a humidified 5% CO2 
atmosphere) for 3 hours to induce high rate of apoptosis. 
 
2.2.2 Induction of apoptosis by staurosporine  
BL2 cells from exponentially growing cultures were centrifuged for 5 min at 400g and 
washed twice in Dulbecco’s PBS (without Ca2+ /Mg2+/ phenol red, PAA) and once in 
serum-free RPMI 1640 (with L-glutamine and penicillin/streptomycin). The cells 
were resuspended in serum-free RPMI 1640 at 1×106 cells/ml and apoptosis was 
induced by addition of 1 µM staurosporine (Calbiochem) followed by 3 hour 
incubation at 37 C, 5% CO2.  
 
2.2.3 Induction of apoptosis by cold-shock  
BL2 cells were washed in serum-free RPMI 1640, resuspended at 5x106 cells/ml in 
HypoThermosol (BioLife Solutions, Bothell, WA, USA) in a 50 ml conical tube (BD 
Falcon) and incubated at 4˚C for 18hrs. Cells were then washed twice in serum-free 
RPMI, resuspended at 2x106 cells/ml in ESDMCult and cultured for 90 min at 37˚C, 5% 





2.2.4 Assessment of apoptosis by Annexin 
V-FITC/Propidium iodide staining 
The level of apoptosis was evaluated by binding of Annexin V (AxV)-FITC 
(Invitrogen) and uptake of propidium iodide (PI) (Sigma-Aldrich), by FCM on a 
Beckman XL flow cytometer. In short, 0.5×106 cells were put in a polystyrene 75×12 
mm tube, washed with 1ml ice-cold Annexin V binding buffer (10 mM HEPES, 140 
mM NaCl, 2.5 mM CaCl2 in dH2O, pH 7.4), centrifuged and re-suspended in 100 μl 
binding buffer. 2.5 μl of Annexin V-FITC was added per tube and incubated for 15 min 
in the fridge. 400 μl of binding buffer was further added into the tube after incubation. 
10 μl of propidium iodide (20μg/ml stock) was added to each tube 45 seconds prior to 
flow cytometric analysis. 
 
2.2.5 Assessment of apoptosis by measuring 
mitochondrial membrane potential     
Measurement of mitochondrial membrane potential was performed by flow cytometry 
using a Mito-ID® Membrane Potential Cytotoxicity Kit, Enzo Life Sciences.  In brief, 
0.8×106 cells/ml BL2 cells treated with 4 µM carbonyl cyanide 
3-chlorophenylhydrazone (CCCP) for 30 mins were used as a positive control for the 
membrane potential loss. CCCP was equilibrated to room temperature before use. 
0.8×106 cells/ml staurosporine treated BL2 cells were used as a positive control for 
apoptosis. Untreated BL2 cells (0.8×106 cells/ml) were used as a negative control. One 
hour stressed cells were assessed. All the samples were centrifuged and washed once 
with 4ml 1× Assay Solution.  10 ml of 1 × Assay Solution was composed of 1ml 10 × 
Assay Buffer, and 0.2 ml 50× Assay Buffer into 8.8 ml deionized water. The 
supernatant was carefully removed and the pellet was gently resuspended in 50 µl 
Mito-IDTM MP Detection Reagent. Samples were incubated in dark and protected from 
light for 15 min at room temperature before being analyzed via flow cytometry using a 
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488nm laser with the FL1 channel for the green fluorescent signal of the dye, the FL2 
channel for the orange fluorescent signal from the dye. 
 
2.3 Detachment of macrophages from Petri dishes 
Cell culture media was removed and macrophages were washed twice with Hank’s 
BSS (without Ca2+ /Mg2+/ phenol red, PAA) and incubated in the detachment buffer 
(Appendix 1) at 4C for 20 mins before being detached with a cell lifter (Corning). 
Cells were washed twice with Hank’s BSS (without Ca2+ /Mg2+/ phenol red) before 
use. 
 
2.4 Cytocentrifugation  
ESDM were detached, washed and blocked in Dulbecco’s PBS (without Ca2+ /Mg2+/ 
phenol red, PAA) with 10% normal mouse serum (v/v, NMS) (Harlan) at 4C for 30 
mins. After cytocentrifuging on a cytospin (300rpm, 5 mins) (Thermo Shandon), the 
slides were dried and fixed in ice-cold acetone at 4C for 10 mins. The slides were 
air-dried again before further staining.  
 
2.5 Diff-Quick staining 
Slides were dipped in Diff-Quick solution I 10 times and then in solution II 10 times 




2.6.1 Immunoperoxidase staining of macrophages  
The primary antibodies and isotype controls used were from Serotec and included 
rat-anti-mouse CD68 (MCA1957, purified, working concentration 5μg/ml), 
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F4/80(MCA497GA, purified, 2μg/ml) and CD11b (MCA711, purified, 2μg/ml). The 
negative control for CD68 was Rat IgG2a (MCA1212, purified, 5μg/ml), for CD11b 
and F4/80 was rat IgG2b (MCA1125, purified, 2μg/ml). The secondary antibody was 
biotinylated anti-rat IgG (H+L) (mouse absorbed) (Vector, BA-4001). The 
concentration used was 2.5μg/ml. 
 
After being washed twice in PBS, slides were blocked in Dakoprotein (Dako) for 10 
minutes at room temperature. Slides were then incubated with primary antibodies 
overnight at 4C, followed by two washes in PBS and incubation with secondary 
antibodies for 30 minutes at room temperature. After two more washes, Vector ABC 
reagent, which is conjugated to peroxidase, was added to the slides for 30 minutes at 
room temperature, and Dako DAB chromagen was added for 5 minutes at room 
temperature. Finally, the slides were washed with distilled water and counterstained in 
haematoxlin for 2.5 minutes, washed in distilled water again and air-dried before 
mounting with Histomount (Friel, Fisher et al. 2006). 
 
To quantify the percentage of positively stained cells, 10 non-overlapping fields from 
one slide at 200× magnification were chosen and the numbers of both positively and 
negatively stained cells were quantified per field. Data were expressed as the 
percentage of positive cells ±SD per field.  
 
2.6.2 Immunofluoresence staining of macrophages 
analysed by flow cytometry 
Macrophages were detached and blocked with normal mouse serum (NMS) (10% v/v) 
in staining buffer (normal goat serum (NGS, 5% v/v, Biosera) in Dulbecco’s PBS 
(without Ca2+ /Mg2+, PAA)) on ice for 10 minutes. 3 x 105 cells were stained in 100μl 
final volume per sample at 4C for 30 mins. Antibodies against F4/80 (0.5μg /ml, 
PE-conjugated, Caltag), CD11b (1μg /ml, PE-conjugated, BD Pharmingen) and 
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CD11c (2.5μg /ml, FITC-conjugated, eBioscience) were used to analyse the phenotype 
of macrophages. The unfixed samples of BMDM were analysed with FACS Calibur 
(Becton-Dickinson), and the unfixed samples of ESDM and peritoneal cells were 
analysed with Epics XL (Beckman Coulter). The forward and side light scatter data 




2.7.1 TNF-alpha sandwich ELISA assay 
The level of TNF-alpha in ESDM culture supernatant was examined by sandwich 
ELISA (DuoSet ELISA Development kit, R&D systems). Fresh ESDMcult (see 
Appendix 1) was used as a negative control and ESDM supernatant from cells 
stimulated with recombinant mouse Interferon-gamma (5ng/ml, R&D systems) and 
E.coli 0111 B4 LPS (1ng/ml, Sigma) for 24 hours was a positive control. All the 
samples and standards were set up in triplicate. The assay was performed following the 
manufacturer’s instructions. In brief, 96-well ELISA plates (Mantovani, Allavena et 
al.) were coated with capture antibody (goat anti-mouse TNF-α, 0.8μg/ml, 100μl per 
well), sealed, and incubated overnight at room temperature (RT). Plates were washed 3 
times with wash buffer (0.05% Tween 20 in PBS, pH 7.2-7.4) and blocked with 
reagent diluent (1%BSA in PBS, pH 7.2-7.4, 300μl per well) at RT for 1 hour before 
being thoroughly washed 3 times. 100μl of supernatant or standard was added per well 
and incubated for 2 hours at RT. Following 3 washes, 100μl of the Detection Antibody 
(biotinylated goat anti-mouse TNF-α, 0.2μg/ml, 100μl per well) was added per well 
and incubated for 2 hours at RT. The plates were washed 3 times and were incubated 
for 20 minutes with 100μl of Streptavidin-horseradish-peroxidase (1:200 dilution) per 
well at RT. After another 3 washes, 100μl of substrate solution (1:1 mixture of H2O2 
and Tetramethylbenzidine) was added per well for 20 minutes at RT. The reaction was 
stopped by adding 50μl of stop solution (2N H2SO4) to each well. Absorbances were 
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measured on an Anthos 96-well plate reader at a wavelength of 450nm. 
 
2.7.2 S1P competitive ELISA 
S1P ELISA was performed using a Sphingosine-1-Phosphate Assay Kit purchased 
from Echelon and following the manufacturer’s instruction. The assay was based on 
the principle of a competitive ELISA. In brief, a 96-well plate was pre-coated with S1P 
and blocked at room temperature for 1 hour to reduce non-specific binding. Diluted 
S1P standards and samples were mixed with the provided biotin-labelled anti-S1P 
antibody before the mixture was added to the S1P-coated plate. S1P on the plate and in 
the samples competed for binding to the antibodies. Following 1 hour incubation at 
room temperature and four washes with PBS, streptavidin-HRP was added to the plate 
to bind to the biotin-labelled anti-S1P antibodies that were bound to the plate. After an 
additional 1 hr incubation at room temperature and washes, TMB substrate was added 
to the plate for 30 min incubation before the reaction was stopped by addition of 1 N 
sulphuric acid. Absorbances were measured on an Anthos 96-well plate reader at a 
wavelength of 450nm. 
 
2.8 Western blotting 
2.8.1 Whole cell lysate preparation 
Cells were collected from experimental cultures, centrifuged at 400 g for 5 min and 
supernatant was removed as much as possible. Cell pellets were resuspended in lysis 
buffer (1 mM EDTA, 10 mM HEPES, 1% Triton-X-100) (12.5 µl of the buffer per 
1×106 cells) and transferred to eppendorf tubes. 1 in 12.5 diluted protease inhibitor 
cocktail (Sigma P8340) was added per sample before samples were vortexed 
intensively for 20 seconds. Samples were then incubated on ice for 30 min, followed 
by centrifugation at 14,000 g, 4C for 10 min. Cellular debris-free supernatant was 
transferred to fresh 1.5 ml eppendorf tubes and stored at - 80C. 
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2.8.2 Bradford protein assay 
Protein concentrations in whole cell lysate samples were assessed using Bradford 
assay (Bio-Rad). Samples were thawed and diluted 1/ 20 or 1/50 in PBS. Human IgG 
diluted in PBS (ranging from 1mg/ml to 15.63 µg/ml), were used as standards. The 
standards and samples were set up in triplicate, 10 µl per well into 96-well plate. 190 
µl filtered 1 in 5 dilution of Bradford’s assay solution was supplemented to each well. 
The assay colour developed instantly and was read on plate reader at 595 nm. Protein 
concentrations were calculated according to standard curves. 
 
2.8.3 Sample preparation 
Each sample contained 30 µg cell lysate proteins, 2.5 µl 4 ×NuPAGE Sample Buffer 
(Invitrogen) and 1 µl 10 ×NuPAGE Reducing Agent, and the total volume was made 
up to 10 µl by adding dH2O. Samples were denatured at 70C for 10 min before 




Electrophoresis of samples was performed using the Invitrogen NuPAGE system and 
reagents, according to the manufacturer’s protocol. SeeBlue Plus2 pre-stained 
standard (Invitrogen) was used as the molecular weight standard. Prepared samples 
were loaded into NuPAGE pre-cast 15-well 1.0 mm 10% Bis-Tris gels and gels were 
run at a constant voltage of 200 V for 1 hr in NuPAGE MOPS SDS buffer.  
 
2.8.5 Western Blotting 
Afterwards, proteins on gels were transferred on to PVDF membranes using 10% 
methanol in the NuPAGE transfer buffer, at 30 V for 75 min. The membranes were 
blocked in 5% milk/PBS-0.1%Tween-20 for 1 hr at room temperature. Next, the 
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membranes were probed with different primary antibodies overnight at 4 C and 
antibodies used were in Table 2.1. 
Table 2.1 
Primary antibodies Producers Catalog no. Dilution used Band size 
Mouse anti-hu/mo Hsp27 Abcam Ab2790 1/1000 24kDa 
Mouse anti-hu/mo Hsp70 Abcam Ab5439 1/5000 70-78 kDa 
Mouse anti-hu/mo Hsp90 Abcam Ab1429 2 μg/ml 90kDa 
Moue anti-hu/mo HIF-1α Novus 
Biologicals 
NB100-131 1/1000 100-120kDa 
Rabbit anti-hu/mo caspase 3 Cell 
Signalling 
Technology 
9662 1/1000 35kDa, 
19+17kDa 
Mouse anti-α actin  Sigma A1978 1/10000 40kDa 
Rabbit anti-phospho-Akt 
















4691 1/2000 60kDa 
 
Primary antibodies were diluted in 5% milk/PBS-0.1%Tween-20 (TBS-Tween system 
was used for blotting phosphor-Akt). Subsequently, the probed membranes were 
washed 6 ×5 min in PBS with 0.1%Tween-20 and incubated in secondary antibodies 
diluted in 5% milk/PBS-0.1%Tween-20 for 1 hr at room temperature. List of 
Secondary antibodies is in Table 2.2. 
Table 2.2  
Secondary antibodies Producers Catalog no. Dilution used 
anti-mouse-HRP Amersham NXA931 351908 1/10,000 
Anti-rabbit-HRP Sigma A6154 1/5000 
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The blots were then washed 6 × 10 min in PBS with 0.1% Tween-20. Specific protein 
bands were visualised using Amersham ECL reagents (GE Healthcare) and developed 
onto X-Ray film using a film developer (Konica SR×101A Developer, Med Imaging 
Ltd). 
 
2.9 High density stress model 
BL2 or BL2/bcl-2 cells were harvested from exponentially growing cultures and 
washed with Dulbecco’s PBS (without Ca2+ /Mg2+/ phenol red, PAA) twice, and with 
serum-free RPMI 1640 once. The cells were then resuspended in serum-free RPMI at 
100 million cells/ml and put into either T25 or T75 cm2 tissue culture flask. The cells 
were cultured at 37 C (in a humidified 5% CO2 atmosphere) for 1 hour or for longer.  
 
2.10 Glucose level measurement 
Glucose level in the culture medium was measured using Accu Check Aviva Nano 
(Roche) following the manufacturer’s instructions. Briefly, for one measurement, the 
meter was switched on and one test strip was inserted into the testing slot. A small 
amount of liquid was pipetted and loaded onto the test strip. Displayed reading was 
recorded.  
 
2.11 Generation of stress supernatant 
After one hour of high density stress, cells were harvested and centrifuged at 400g, 
4°C for 5 min to remove cells. The supernatant was then centrifuged at 870g, 4°C for 
10 min to remove cell debris and stored at -80°C.  
 
2.12 ATP concentration measurement  
ATP concentration was measured using bioluminescent assay kit (Sigma) following 
the manufacturer’s instructions. The assay was based on the principle that the light 
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emitted during the oxidation of D-luciferin, catalysed by firefly luciferase, is 
proportional to the amount of ATP present when ATP is the limiting reagent. White 
plates (non-treated, Nunc) were soaked in 1N hydrochloric acid (Acors Organics, 1N 
standard solution) for at least 4 hr to reduce the background luminescence and rinsed 
with deionized water several times before dried completely. Assay mix, which 
contained luciferase and luciferin, was diluted 1 in 100 with dilution buffer and 100 µl 
was loaded into each well of pre-treated white plate (assay mix and dilution buffer 
were provided with the kit). ATP standards were serially diluted with sterile water 
(Baxter) from 1×10-6 M to 1×10-8 M and sterile water was a standard blank control. 
Stressed BL2 and BL2/bcl-2 supernatants were examined and serum-free RPMI was a 
blank control. 100 µl of either ATP standards or samples was added to the pre-loaded 
assay mix solution using multichannel pipette, immediately before the plate was read 
on the luminescence reader (BioTek, Synergy HT).  
 
2.13 ATP channel antagonists  
In the experiment examining channels responsible for ATP release, after washing, BL2 
cells were treated with several ATP channel antagonists (Table 2.3) before stress. After 


















Sigma C4790-1g 100 µM Connexin and 
pannexin 
channels 
Probenecid Sigma P8761-25G 1 mM Pannexin 
Channel 
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Gadolinium chloride and carbenoxolone disodium salt were dissolved in water to 
make up stock solutions, 50 mM and 100 mg/ml respectively. Arachidonic acid and 
probenecid were dissolved in DMSO to make up stock solutions, 30 mM and 1 M 
respectively (Liu, Sabirov et al. 2008; Chekeni, Elliott et al. 2010). They were added 
directly to BL2 cells to make the working concentrations immediately before 
experiment.  
 
Since Gd3+ is known to interfere with the luciferin-luciferase reaction (Boudreault and 
Grygorczyk 2002), the luciferin-luciferase assay mix was supplemented with 600 µM 
EDTA when the samples were treated with Gd3+.  
 
2.14 Isolation and incubation of microparticles from 
stress supernatant 
Stress supernatant was transferred to ultracentrifuge tubes and centrifuged at 100,000g, 
4ºC, for 30 min. The supernatant was removed, and the cell pellet, which was a greasy, 
almost transparent dot sticking on the side of the ultracentrifuge tube, was resuspended 
in serum-free RPMI 1640 of the same volume as the original stress supernatant and 
vortexed until the pellet was dissolved. Since the whole ultracentrifuge process was 
non-sterile, in order to culture isolated microparticles for ATP measurement, 
resuspended microparticle solution was passed through a 0.22 µm syringe filter before 
incubation. Microparticles were incubated at 37°C, 5% CO2 for 1 hr, 5 hr, 8 hr, and 24 
hr, and ATP level at each time point was measured using ATP bioluminescent assay. 
The separated microparticle-free stress supernatant was used as a control.  Fresh 
serum-free RPMI 1640 was the 0 hr control.  
 
2.15 Cell proliferation assay 
Cells were seeded at 0.2x106/ml in medium appropriate to the cells being used in the 
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assay and were cultured at 37 C (in a humidified 5% CO2 atmosphere) for up to 96 hr. 
Viable and total cell concentrations were determined using Trypan Blue exclusion 
every 24 hr.  
 
In the serum-free culture system, the cell proliferation assay was performed in 
different concentrations of X-VIVO 20 (Lonza) which was diluted in serum-free 
RPMI 1640. 
 
2.16 Cell cycle analysis using propidium iodide 
Cell cycle was monitored by measuring DNA content using the DNA-binding 
fluorescent dye propidium iodide (PI). Each sample contained 1.5x106 cells. Samples 
were washed once in Dulbecco’s PBS (without Ca2+ /Mg2+/ phenol red, PAA) and 
centrifuged at 870g for 5 min. Cell pellets were resuspended in 300 μl PBS to a single 
cell suspension and drop-wise 700 μl ‘fridge-cold’ absolute ethanol (VWR) to each 
sample while vortexing. Samples were then kept at 4°C in the fridge for at least 30 min 
for fixation.  After washing three times with 1 ml PBS, samples were resuspended in 
380 μl PBS and stained by adding 20 μl 1mg/ml PI.  They were incubated at room 
temperature for 30 min in dark before binding analysis on an Epics XL flow cytometer 
(Beckman Coulter).  
 
2.17 Preparation of S1P 
Sphingosine-1-phosphate was purchased from Avanti Polar Lipids. 2.64 ml of 
methanol (Fisher Scientific) was added into 1 mg of S1P and was heated in a 50°C 
water bath, vortexed and sonicated in a water-bath sonicator (Decon) until S1P was 
dissolved. The solution was aliquoted at 100 μl per glass vial and dried to powder 
under a stream of N2 gas. Glass vials were then sealed with stoppers and foil caps with 
a crimper before storing frozen at – 80°C. Each dried aliquot contained 100 nmol of 
S1P.  
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To dissolve S1P aliquots for experiments, no more than 1 hr before use, 1ml 
serum-free RPMI containing 4 mg/ml low-endotoxin bovine serum albumin (BSA) 
(PAA) (carrier protein) was added to each vial of S1P and warmed in a 37°C water bath 
for 20 min. The vial was vortexed vigorously until S1P was dissolved. The solution 
was 0.22 μm filtered before being added to cells for use in the cell proliferation assay.  
 
2.18 Limulus amoebocyte lysate (LAL) assay 
In-house-produced L929 conditioned media was endotoxin screened by chromogenic 
LAL assay (QCL-1000, Lonza), following the manufacturer’s instruction. The 
principle of the assay is as follows: Gram-negative bacterial endotoxin can catalyze 
the activation of a proenzyme in the LAL which can further catalyze the colourless 
substrate into a yellow product. The absorbance of the final product is in proportion to 
the amount of endotoxin present which can be calculated from a standard curve. 
Disposable endotoxin-free glass assay tubes (10×75 mm, Cambrex #25-415) were 
used. Four concentrations of LAL were prepared to make the standard curve: 0.1, 0.25, 
0.5 and 1.0 EU/ml, and LAL reagent water was used as the blank control. All the 
standards and samples were analysed in duplicate. Samples or standards were 
dispensed into assay tubes (50 μl per tube) in a 37C waterbath. At time 0 (T=0), 50μl 
of LAL was added to each assay tube and the solutions were mixed thoroughly. 
Reagents were pipetted in the same order from tube to tube and at the same rate to 
ensure the exact timing for each reaction tube. At T=10 minutes, 100μl of substrate 
solution (pre-warmed to 37C) was added and mixed thoroughly. At T=16 minutes, 
100μl of stop reagent was added and mixed before the absorbance was read at 405 nm 
on an Anthos 96-well plate reader.   
 
2.19 Self-renewal assay 
In order to determine the presence of undifferentiated ES cells present in a cell 
suspension, a self-renewal assay was performed. ESDM and E14 cells were seeded, at 
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different densities, 103, 104, 105 and 106 cells per well, in duplicate, onto gelatin-coated 
6-well plates in GMEMFCS containing 100 units /ml LIF. The cells were cultured for 1 
day at 37 C (in a humidified 5% CO2 atmosphere) before being transferred to 
GMEMFCS with or without LIF. After a further culture of 5 days at 37 C (in a 
humidified 5% CO2 atmosphere), culture media was removed and colonies were fixed 
and stained for alkaline phosphatase (AP leukocyte kit, Sigma) which is highly 
expressed by undifferentiated ES cells (Pease, Braghetta et al. 1990). The procedures 
carried out were as follows: colonies were fixed with 1 ml fixative per well (25ml 
citrate solution, 65ml acetone, and 8ml 37% v/v formaldehyde) which was warmed to 
room temperature before use. Citrate solution was supplied with the kit. The fixative 
was applied for 30 seconds before being carefully washed away with deionized water 
for 45 seconds. The substrate (Appendix 2) was mixed thoroughly and 1ml was 
applied into each well, followed by 15 minutes incubation in the dark. After staining, 
the colonies were rinsed carefully with water, drained and air dried before they were 
examined microscopically for stem cell, mixed, or differentiated colonies.  
 
The colonies were categorised and scored based on the status of alkaline phosphotase 
staining. E14 cells were used as a positive control for different colonies. ESDM 
growing in GMEMFCS with LIF for one day and then in ESDMcult for five days were 
used as a control for ESDM viability during the assay process.   
 
2.20 Flow cytometry-based phagocytosis assay 
2.20.1 Labelling of BL2 cells with far-red fluorescent dye 
BL2 cells from culture were centrifuged at 400g for 5 minutes at RT and washed twice 
in Dulbecco’s PBS (without Ca2+, Mg2+, without Phenol Red, PAA). Cell pellet was 
resuspended in serum free RPMI at 20×106 cells/ml. Resuspended cells were mixed 
with far-red fluorescent dye DDAO-SE (Invitrogen) at the ratio of 1μl of dye per 
10×106 cells and incubated at 37C (in a humidified 5% CO2 atmosphere) for 15 
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minutes. The cells were centrifuged, resuspended at 4×106 cells/ml in serum free 
RPMI and placed into tissue culture flasks.  
 
2.20.2 Induction of labelled BL2 cell apoptosis   
As described in sections 2.2.1 and 2.2.3. Afterwards, the cells were centrifuged and 
resuspended in ESDMcult at 2×10
6 cells/ml. 
  
2.20.3 Assessment of apoptosis by Annexin 
V-FITC/Propidium iodide staining  
As described in section 2.2.4. 
 
2.20.4 ESDM preparation  
A new ES cell line, GFP#7a, which expresses eGFP constitutively (Gilchrist, Ure et al. 
2003), was used and it was established from the ES cell line E14tg2a subclone IV.  
ESDM expressing endogenous eGFP were derived from GFP#7a following the same 
differentiation protocol and used as phagocytes in the phagocytosis assay. The assay 
was adapted from the published flow cytometry-based phagocytosis assay (Jersmann, 
Ross et al. 2003)  
 
D7 ESDM were detached, washed and resuspended in fresh ESDMcult at 4×10
5 
cells/ml and seeded into 48-well plates (0.5ml per well). Plates were incubated at 37C 







2.20.5 Phagocytosis incubation and sample preparation 
for flow cytometry  
Before the assay, medium was removed from ESDM by aspiration and ESDM were 
washed gently with PBS before 0.5ml of prepared BL2 cell suspension 
(DDAO-SE-labelled and incubated for 3 hours after UV-treatment) was loaded. The 
phagocytosis incubation was either 0.5 or 1 hr at 37C (in a humidified 5% CO2 
atmosphere). ESDM only and BL2 cells only were used as controls. All the samples 
were set up in triplicate.  
 
After incubation, media was removed and wells were washed gently with PBS once. 
0.5 ml of Trypsin/EDTA (PAA) was added to each well, followed by 15 minutes of 
incubation at 37C (in a humidified 5% CO2 atmosphere) and then 15 minutes of 
incubation on ice to detach ESDM. Finally, the cells were harvested from each well by 
vigorous pipetting for analysis by flow cytometry.  
 
2.21 Chemotaxis assay 
Chemotaxis was assayed using an adapted from Boyden chamber assay (Figure 2.1). A 
transwell, which is a cylindrical cell culture insert (6.5 mm diameter), was placed 
inside a well of a 24-well plate; the insert contained a porous, polycarbonate 
membrane which divided the well into upper and lower chambers. Polycarbonate 
membrane transwells with either 5μm or 8 μm pore size (Costar Corning), depending 
on the migratory cells, were used in the assay.  RPMI 1640 (Gibco) supplemented 
with L-glutamine (2mM, PAA), penicillin (100 IU/ml, PAA), and streptomycin 
(100μg/ml, PAA) was used as chemotaxis assay medium. 100 μl input migratory cells 
were seeded in the upper chamber and 600 μl chemoattractants were loaded in the 
lower chamber. Time for incubation at 37 C (in a humidified 5% CO2 atmosphere) 
varied depending on cell type.  Samples are set up in duplicate.   
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The detailed protocols for the assay are given below.  
 
2.21.1 Initial ESDM chemotaxis protocol based on which 
optimization was performed:  
The chemotaxis assay was performed with transwells of 8μm pore size membrane. 
Recombinant human C5a (R&D systems) (10 ng/ml) was used as a positive control 
and assay medium, a negative control. C5a and negative control were loaded into 
lower chambers and incubated with transwells at 37ºC for 2 hr to allow equilibration 
before loading ESDM.  ESDM were detached from Petri dishes, washed twice with 
Hank’s BSS and once in assay medium before resuspending in assay medium at 2 × 
106/ml. ESDM were added to the upper chambers and were incubated at 37 C (in a 
humidified 5% CO2 atmosphere) for 4 hr. At the end of the assay, non-migrated cells 
were removed from the inside of transwells with cotton buds and the transwells were 
fixed with 100% methanol for 10 min, air-dried and subsequently stained with 
Diff-Quick Blue (Reagena, Finland) for 20 min.  
 
Since migrated ESDM adhered to the underside of the transwell (no cells were 
observed in lower chambers), the migration of ESDM was presented as the mean of 
the number of migrated cells per high power field from ten random areas (×400 
magnification) on the underside of the transwell using an inverted microscope 
(Axiovert 25, Zeiss, UK). 
 
2.21.2 ESDM chemotaxis assay protocol after optimization 
Only two steps were altered from the initial protocol. 1) ESDM were detached from 
Petri dishes on day 6 and cultured in 20 ml fresh ESDMcult medium in suspension 
culture in Teflon pots for 24 hr before ESDM were harvested and prepared for 
experiments. 2) No equilibrium was performed and ESDM and chemoattractants were 
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loaded at the same time.  
 
2.21.3 THP-1 chemotaxis assay 
For THP-1 chemotaxis assay, 5 μm pore size membrane was used and THP-1 cells 
were prepared at 2 × 106/ml. Most of the migrated THP-1 cells were in lower 
chambers (very few were attached to the underside of transwells), therefore, at the end 
of the assay, 450 μl of media from one lower chamber was harvested for cell counting 
using flow cytometry. The data were presented as the mean fold increase compared to 
the control.  
 
Suramin sodium salt (Sigma) was dissolved in water and 1mM freshly-made suramin 
solution was used to antagonize P2 receptors on THP-1 cells (working concentration 
100 μM) at room temperature 30 mins before chemotaxis assay.   
Apyrase (New England Biolabs) was 1 in 2000 diluted with working concentration of 
25 mU/ml.  
 
2.21.4 Neutrophil chemotaxis assay 
For neutrophil chemotaxis assay, 5 μm pore size membrane was used and neutrophils 
were prepared at 1 × 106/ml.  100 nM fMLP 
(N-formyl-L-methionyl-L-leucyl-L-phenylalanine, Sigma) was used as a positive 
control, and assay medium was a negative control. The assay incubation time was 60 
min. At the end of the assay, migrated neutrophils on the membrane were stained and 
quantified under microscope.  
  
2.21.5 Preparation of other chemoattractants   
Recombinant human CCL5 (Prospec) was reconstituted at 100 μg/ml in sterile 
deionized water and the aliquots were stored at -20°C. Recombinant human VEGF  
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(R& D systems) was reconstituted at 10μg/ml in sterile PBS containing 0.1% low 
endotoxin BSA and aliquots were stored frozen at – 20°C. They were diluted in assay 
medium to working concentration for experiments. Recombinant CCL2 (R&D) was 
reconstituted at 100 μg/ml in sterile PBS and the aliquots were stored at -20°C. fMLP 
(N-formyl-L-methionyl-L-leucyl-L-phenylalanine, Sigma) was reconstituted in 
DMSO to a 10 mM stock solution and aliquots were stored at -20°C. 
 
2.22 Statistical analysis 
Results from multiple experiments are presented as means + standard errors of the 
means (SEM). Mann-Whitney test was performed to compare the difference between 
two groups of quantitative data and calculate the P value. P values of 0.05 or less were 
considered statistically significant. Data analysis was performed using GraphPad 











5 µm or 8 µmpore size 
polycarbonate membrane 




          Figure 2.1 Schematic diagram of chemotaxis assay.  
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Chapter 3 Results: High density stress- 
modelling the pre-apoptosis induced by 
metabolic stress 
 
3.1 High density stress model 
In an attempt to address the question whether stressed (pre-apoptotic) cells can 
promote tumour growth via microenvironmental conditioning, a stress model that 
induced pre-apoptotic cells was required. In solid tumours, metabolic stress is a 
common feature due to nutrient, growth factor, and oxygen deprivation (Judah 2003) 
and it has been shown that such stress is a potent trigger of apoptotic cell death 
(Degenhardt, Mathew et al. 2006), therefore, to mimic the in vivo tumour 
microenvironment and model the pre-apoptosis caused by metabolic stress, a stress 
model was established in which cells were incubated at high density for 1 hr.   
 
3.2 One hour high density stress did not induce 
apoptosis of BL2 cells 
Before and after BL2 cells were subjected to one hour high density stress, the exposure 
of phosphatidylserine on the outer plasma membrane leaflet and the loss of 
mitochondrial membrane potential, which are events happening in the early stage of 
apoptosis (Castedo, Hirsch et al. 1996), were assessed.  
 
Staining with AxV and PI was performed before and after treatment of the cells 
(Vermes, Haanen et al. 1995). Untreated cells were used as controls. The early 
apoptotic cell population, which was AxV positive and PI negative, did not increase 
after the one hour stress, indicating that one hour high density stress did not induce the 
apoptosis of BL2 cells (Figure 3.1).  
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A cationic mitochondrial membrane potential dye, which exists as fluorescent green 
aggregates in the cytosol and fluorescent orange aggregates in the energized 
mitochondria, was used. The dye is released from mitochondria when the 
mitochondrial membrane potential is compromised and diffuses into the cytosol, 
becoming exclusively fluorescent green (Figure 3.2). Unstained BL2 cells were 
negative in both orange (FL2) and green (FL1) fluorescence channels, excluding the 
possible influence by the autofluorescence of BL2 cells. Untreated cells were used as 
controls. Control cells were positive for both green and orange fluorescence, 
suggesting that they had energized mitochondria. When BL2 cells were treated with 
carbonyl cyanide 3-chlorophenylhydrazone (CCCP), which is a mitochondrial 
membrane potential perturbation agent, they lost the orange fluorescence and became 
only positive for green fluorescence, suggesting that the mitochondria lost their 
membrane potential. BL2 cells, which were treated with staurosporine for three hours, 
became exclusively fluorescent green as well, indicating that apoptotic cells lost their 
mitochondrial membrane potential. However, for one hour stressed BL2 cells, they 
were still double positive for green and orange fluorescence, implying that these cells 
still had intact mitochondrial membrane potential and they did not undergo apoptosis.  
 
Results from the above two independent assessments were consistent in their 




















































 Figure 3.1  1 hour high density stress did not induce the  






 BL2 cells were subjected to one hour high density stress (1h BL2). 
PS exposure on cell surface was assessed by AxV staining and cell 
membrane permeability was assessed using trypan blue exclusion. 
Cells before high density stress were controls (ctrl BL2). A) Light 
scatter plot of AxV/PI staining. One representative result from over 
twenty similar is shown. B) Summary graph shows the percentage of 
viable (AxV-PI-), early apoptotic (AxV+PI-) and late apoptotic 
(AxV+PI+) cells in ctrl BL2 (black bars) and 1h BL2 (red bars). Error 
bars indicate SEM for three experiments.  
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 Figure 3.2  1 hour high density stress did not affect mitochondrial 






 The mitochondrial membrane potential of BL2 cells after 1 hour high 
density stress was assessed by a dual-emission mitochondrial 
membrane potential-sensitive dye whose fluorescence emission 
shifts from orange to green upon the collapse of the membrane 
potential. CCCP-BL2 : BL2 cells treated with CCCP (a membrane 
potential perturbation reagent); BL2+stauro 3h: BL2 cells treated with 
staurosporine and incubated for 3 hours; ctrl BL2: BL2 cells before 
high density stress; 1h BL2: BL2 cells from 1 hour high density 
stress. One representative experiment of three is shown.  
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3.3 One hour high density stress generated 
pre-apoptotic cells which were committed to 
apoptosis 
Since one hour stress did not induce apoptosis in BL2 cells, further experiments were 
carried out to identify whether cells had been committed to apoptosis under these 
conditions. BL2 cells harvested from exponential phases were put into one hour high 
density stress and afterwards, the cells were cultured at lower density: 1 × 106 cells/ml, 
for up to eight hours. Apoptosis and cell death were assessed by AxV/PI staining every 
2 hours (Figure 3.3). The results show that immediately after one hour’s stress, BL2 
cells were not induced to undergo apoptosis. However, there was a significant increase 
in early apoptosis after two hours in lower density culture, both in serum-free RPMI 
and RPMI with serum, and the apoptotic cells gradually underwent secondary necrosis 
with time. The viable cells in the population started proliferating when back in low 
density culture. This result indicated that during the one hour high density stress, some 
BL2 cells were pre-apoptotic and committed to undergo apoptosis and this 
commitment could not be reversed either by low density culture or by factors in serum.  
 
3.4 Commitment to apoptosis during stress can be 
inhibited by overexpression of bcl-2 
To confirm that commitment to apoptosis had occurred during one hour exposure to 
high density stress, BL2 cells stably transfected to express bcl-2 protein (BL2/bcl-2) 
and therefore resistant to apoptosis, were employed. Immediately after one hour stress, 
there was no increase in early apoptotic BL2/bcl-2 cells shown by AxV/PI staining 
(Figure 3.4). When stressed BL2/bcl-2 cells were brought back to low density culture, 
there was no increase in early apoptotic cells, no matter in serum-free RPMI or in 
RPMI with serum, indicating that bcl-2 over-expression inhibited the commitment to 










































 Figure 3.3 One hour stress generated pre-apoptotic cell which were 





 1 hour stressed BL2 cells were seeded at 1x106 cells/ml in either 
serum-free RPMI (A) or RPMI with serum (B) for different length of 
time and cell death was assessed by AxV/PI staining. Ctrl: BL2 cells 
before stress; 0h: BL2 cells after 1 hour stress; 2h: 1hr stressed cell 
were seed at 1x106 cells/ml in serum-free RPMI or RPMI with serum 
for 2 hours. Red bars represent early apoptotic cells. Data presented 










































 Figure 3.4 Commitment to apoptosis during stress can be 






 1hour high density stressed BL2/bcl-2 cells were seeded at 1x106 
cells/ml in either serum-free RPMI (A) or RPMI with serum (B) for 
different length of time and cell death was assessed by AxV/PI 
staining. ctrl: BL2/bcl-2 cells before stress; 0h: BL2/bcl-2 cells after 1 
hour stress; 2h: 1hr stressed cells were seed at 1x106 cells/ml in 
serum-free RPMI or RPMI with serum for 2 hours. Red bars represent 





Therefore, although one hour high density stress did not increase the early apoptotic 
cell number, it generated some pre-apoptotic cells, which, when cultured at low 
density, could execute the apoptosis program and this effect could be inhibited by 
overexpression of bcl-2. 
 
3.5 Characterisation of high density stress  
3.5.1 Longer stress induced non-apoptotic BL2 cell death 
To further characterise the stress model, BL2 cells were subjected to high density 
stress for longer, up to seven hours and cell death was assessed by AxV/PI staining 
(Figure 3.5A). After one hour there was slight increase in early apoptosis. However, 
data presented here was only a representative of three independent experiments and as 
demonstrated in Figure 3.1B, the increase of early apoptosis after one hour stress was 
not statistically significant. This might be caused by the variations in the percentages 
of viable BL2 cells applied in each experiment. Further analysis of apoptosis induction 
after stress was performed using Western blot to examine caspase 3 expression and 
activation (Figure 3.5 B). Constant levels of pro-caspase 3 (35 kDa) were detected in 
all the samples, however, similar to 0 hr, there was no active caspase 3 (17-19 kDa) 
detected at 1hr and 4hr, confirming the previous observation that apoptosis was not 
induced directly after high density stress.  The slight increase in the level of PS 
exposure in Figure 3.5A was therefore not a valid indication for apoptotic cells, since it 
has been shown previously that AxV binding in BL cell line was not a reliable 
indicator of apoptosis (Holder, Barnes et al. 2006). However, there is a defect in the 
experimental design. Despite the fact that the same antibodies against pro- and active 
caspase-3 have been used successfully in Western blot to detect active caspase-3 in 
apoptotic cells (C.Ford, personal communication), a positive control, such as 
staurosporine induced apoptotic cells, is still needed in this study to demonstrate that 
the absence of active caspase-3 was not caused by lack of binding of the antibodies.  
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With time, the apoptotic cells gradually underwent secondary necrosis and there was 
no further increase in early apoptosis (Figure 3.5 A). When BL2/bcl-2 cells were 
subjected to longer high density culture, there was no increase in early apoptosis after 
one hour. Around three hours, these cells started to become permeable to PI (Figure 
3.5C). The above results suggested that long term culture at high density induced 
non-apoptotic cell death. 
 
3.5.2 Characterisation of stressors in high density stress 
In order to clarify the nature of high density stress, the model was further analysed by 
incubating BL2 cells at high density for 1 hour and 4 hours. The changes of BL2 cells 
at these two time points were assessed to identify the key stressors.  
 
First, stressed BL2 cell lysates were examined using Western blot for the expression of 
heat shock proteins (Hsp), given that the induced expression of Hsp is a common 
feature in response to extensive stressors. Hsp70 and Hsp 90 were expressed at 
constant levels in all samples (Figure 3.6A). Hsp27 was found in all 3 samples, 
however, the protein level gradually decreased during stress with time. 
 
Furthermore, the existence of hypoxia was analysed by detecting HIF-1α expression 
levels by western blot, however, the expected product band, which is around 100-120 
kDa, was not detected at any of the samples (Figure 3.6B). A 65 kDa band and a 
doublet at 90-95 kDa was found at a constant level in all 3 samples, however, their 
identities were still unknown. Thus, it is likely that hypoxia was not a stressor in the 
model. However, considering that a positive control, such as cells treated with hypoxia, 
was missing here, it could not exclude the possibility of the ineffectiveness of the 
antibodies. Therefore, further detection of HIF-1α in the presence of a positive control 
should be performed. 
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In the end, measurement of glucose level in longer stress indicates that glucose level in 
the media dropped significantly from 12mM to around 5mM within one hour, and 
almost depleted around four hour, in both BL2 and BL2/bcl-2 culture (Figure 3.6C). 
The rapid glucose depletion during the stress was consistent with the lack of apoptosis 
during stress, given that apoptosis is an ATP-dependent programme (Leist, Single et al. 
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A), C). BL2 and BL2/bcl-2 cells were subjected to high density stress 
for up to 7 hours and cell death was assessed by AxV/PI staining every 
hour. B) 1 hour and 4 hour stressed BL2 cells whole cell lysates were 
prepared and immunoblotted with rabbit anti-human caspase 3. β-actin 
was detected as a loading control. 0 hr was BL2 cells before stress. 
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 BL2 cells were subjected to high density stress for 1 hour and 4 hours. 
A), B) : 1 hour and 4 hour stressed whole cell lysates were prepared 
and immunoblotted using mouse anti-human Hsp27, mouse 
anti-human Hsp70, mouse anti-human Hsp90 (A), mouse anti-human 
HIF-1α (B). β-actin was detected as a loading control. 0hr was BL2 
cells before stress. C) Glucose levels were measured in stress cell 
cultures after 1 hour and 4 hours during stress. 0 hr was the glucose 
level in fresh serum-free RPMI 1640 medium. Representative data 
from one of two independent experiments is shown.  
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Chapter 4 Results: Stressed tumour cells 
released ATP to selectively recruit 
mononuclear phagocytes and inhibit 
neutrophil infiltration 
 
4.1 ATP is a chemoattractant for THP-1 cells    
Although it has been identified that ATP is a novel mononuclear phagocyte 
chemoattractant (Elliott et al., 2009), recent studies on both macrophage (Kronlage, 
Song et al. 2010) and neutrophil chemotaxis (Chen, Corriden et al. 2006; McDonald, 
Pittman et al. 2010) raised doubts that instead of being a chemoattractant, ATP 
functions only as an autocrine signal to help cells navigate in chemotactic grandients 
(Junger 2011). Therefore, chemotaxis assays were performed to examine whether ATP 
was a mononuclear phagocyte chemoattractant or a navigation signal which promotes 
chemokinesis.  
 
As introduced before (Chapter 1, 1.1.1 Tumour-associated macrophages), some TAM 
are derived from monocytes recruited from blood (Mantovani, Bottazzi et al. 1992), 
thus THP-1 cells, whose phenotype are mainly monocytic, were used in the assay. First, 
the migratory ability of THP-1 cells to ATP was assessed and four different 
concentrations of ATP were used, ranging from 0.09 µM to 90 µM (Figure 4.1A). The 
migratory response of THP-1 cells towards ATP produced a bell-shaped 
dose-dependent response and the optimal concentration was 0.9 µM. To confirm the 
response was indeed chemotaxis instead of chemokinesis, 0.9 µM ATP was loaded 
into upper wells (Figure 4.1B). Comparing with the potent response towards 0.9 µM 
ATP in lower wells, there was no migratory response to ATP in upper wells, suggesting 
that ATP did not induce random migration of THP-1 cells and the response to ATP was 


































































 A) Chemotaxis assays were performed using THP-1 cells and different 
concentrations of ATP. Assay medium was the control. The data presented 
are the mean fold increase compared to the control+SEM, n=3. *, P<0.01, 
compared with the control (Mann-Whitney test).  B) THP-1 cells were added 
to the upper wells of the chambers and migration assessed when ATP (0.9 
μm) was added to the upper or lower wells. Migration in the absence of ATP 
was control. The data are the mean fold increase compared to the control 
from duplicate analyses. 
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4.2 Effect of apyrase on mononuclear phagocyte 
chemotaxis 
Since it has been found that macrophage chemotaxis in response to a gradient of 
chemoattractant required autocrine purinergic signalling which functioned as a 
navigation system, recombinant apyrase, an enzyme which can remove the gamma and 
beta phosphate from nucleoside triphosphates and diphosphate, was used to 
investigate the effect of purinergic signalling disruption on THP-1 chemotaxis. Two 
most commonly used THP-1 cell chemoattractants CCL2 and CCL5, whose 
chemoattractive ability are resistant to the hydrolase function of apyrase, were adopted 
as chemoattractants.  Various concentrations of CCL2 and CCL5 were assessed 
(Figure 4.2). ATP stimulated a potent migratory response by THP-1 cells whereas 
responses to CCL2 and CCL5 were very weak or absent. This might be caused either 
by the inactivity of recombinant CCL2 and CCL5 proteins or by lack of receptor 
expression on THP-1 cells. Therefore, the chemoattractive activity of CCL2 was 
further examined using another human monocytic cell line, MonoMac6.  
 
MonoMac6 cells could migrate to CCL2, and the response also produced a bell-shaped 
dose-dependent response (Figure 4.3A). The data excluded the possibility of CCL2 
activity loss, and suggested that THP-1 cells used in the assay might be a clone of cells 
with defects in CCL2 receptor expression. Thus, MonoMac6 cells were used to 
examine the effect of apyrase treatment on chemotaxis. Before the assay, CCL2 was 
treated with apyrase or its control buffer (Figure 4.3B). According to the data, the 
control buffer could interact with CCL2 to induce higher chemotaxis response 
compared with pure CCL2; however the mechanism for this is unknown. Apyrase 
diminished this elevated chemotactic response suggesting apyrase might disrupt the 
autocrine/paracrine purinergic signalling of MonoMac6 cells to partially impair their 
migratory ability.  However, the effect of ATP on MonoMac6 migration as a 



























































































 Chemotaxis assays were performed to identify whether CCL2 (A) 
and CCL5 (B) were chemoattractants for THP-1 cells. Assay 
medium was used as a negative control and 0.9µM ATP was 
used as a positive control. The data presented is the mean fold 
increase of duplicate samples compared to the control. Data from 






































































   Figure 4.3 Apyrase partially decreased the migration of MonoMac6 








 A) The migration of MonoMac6 cells to different concentrations of 
CCL2 was examined. Assay medium was used as a negative control. 
The data presented are the mean fold increase compared to the 
control±SEM, n=3. *, P<0.05, compared with the control 
(Mann-Whitney test). B) Assay medium and 50ng/ml CCL2 were 
treated either with apyrase or with apyrase control buffer. Assay 
medium and 50ng/ml CCL2 alone were used as controls. The data 
presented are the mean fold of increase compared to the control. Data 
shown is from one experiment.  
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4.3 THP-1 cells migrated to stressed BL2 supernatant  
Having validated that ATP was a chemoattractant for THP-1 cells and disruption of 
purinergic signalling could impair macrophage chemotaxis, chemotaxis assays were 
carried out to examine whether stressed BL2 supernatant could help to condition 
tumour microenvironment by attracting mononuclear phagocytes and whether ATP 
was a chemoattractant responsible for the attraction (Figure 4.4). The results 
demonstrated that stressed BL2 supernatant could induce high level of migratory 
response from THP-1 cells. When the supernatant was treated with apyrase, the 
chemoattractive effect was abolished. This could be explained, in part, by the 
disruption of the autocrine purinergic signalling in THP-1 cells, as the data presented 
above in which apyrase was only able to partially reduce the response to CCL2  
(Figure 4.3 B). On the other hand, the abrogation of response indicated that aside from 
interrupting autocrine purinergic signalling, apyrase also affected chemoattractants in 
stressed BL2 supernatant, which possibly were nucleoside triphosphates (ATP, UTP) 
(Figure 4.4A).  
 
Suramin is an antagonist of the P2 family (P2X and P2Y) of nucleotide receptors. 
When THP-1 cells were treated with suramin, the chemoattractive ability of the stress 
supernatant was significantly decreased (Figure 4.4B). The inability of suramin to 
completely prevent THP-1 chemoattraction to stress supernatants could be due to its  
relatively low potency and its inability to block all P2Y receptors: P2Y4 and P2Y6 
receptors, which are receptors for ATP, uridine triphosphate (UTP) (P2Y4) and uridine 
diphosphate (UDP) (P2Y6) (Ralevic and Burnstock 1998) are highly resistant to 
suramin-dependent inhibition. Taken together, these observations indicate that 
stressed BL2 supernatant can attract THP-1 cells and nucleoside triphosphates are a 




















































































 Chemotaxis assays were performed to assess the chemoattractive 
capability of supernatants from stressed BL2 cells. Supernatant was 
treated with apyrase (A) or THP-1 cells were treated with suramin (B) 
to examine the contribution of nucleotides to the chemoattractive 
response. Controls in (A) and (B) were the migration of THP-1 cells 
to assay medium. Data presented are the means of the fold increase 
compared to the control ±SEM, n=3 (Mann-Whitney test).  
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4.4 THP-1 cells migrated to stressed BL2/bcl-2 
supernatant    
It has been previously demonstrated that the release of nucleoside triphosphates from 
apoptotic cells to chemoattract mononuclear phagocytes is a caspase-dependent 
process (Elliott, Chekeni et al. 2009). Since the one hour stress model has been shown 
not to induce apoptosis, in order to elucidate whether chemoattractant release in 
stressed BL2 supernatant was due to spontaneous apoptosis in BL2 cells, BL2/bcl-2 
cells, which had inherent resistance to apoptosis due to the over-expression of bcl-2, 
were stressed and their supernatant was assessed. Comparable to stressed BL2 cells, 
stressed BL2/bcl-2 supernatant exhibited a similarly potent ability to attract THP-1 
cells, which could also be abolished by apyrase treatment and significantly decreased 
by suramin exposure (Figure 4.5). The data suggested that the release of the 
chemoattractants in stress supernatants was not attributed to spontaneous apoptosis. 
 
4.5 Apoptosis-independent ATP release from stressed 
BL cells 
In order to examine whether ATP contributed to the chemoattractive ability of the 
stress supernatants, the presence of ATP was measured using an ATP bioluminescent 
assay (Figure 4.6A).  Around 200 nM and 300 nM ATP were present in stressed BL2 
and BL2/bcl-2 supernatants respectively, but the difference between these was not 
statistically significant. The presence of ATP indicated that ATP might be one of the 
chemoattractants in stress supernatants.  
 
Since there was no increase in the dead cell number after stress (Figure 3.2B), ATP 
should not come from a gross leakage of the pool of cytosolic ATP. Although it has 
been demonstrated that the release of chemoattractants in stress supernatants was not 
attributed to apoptosis, there was still the possibility that ATP could be released from  
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low level of spontaneous apoptotic cells in the population, considering the high cell 
density used in the stress model. Therefore, stressed BL2 and BL2/bcl-2 cells were 
analysed for their apoptotic cell number after stress relative to the amount of ATP 
released from 1 ml of 100x106 cells (Figure 4.6B). Although the difference in 
apoptotic cell number between BL2 and BL2/bcl-2 was not significant (P=0.1420, 
calculated by paired Mann-Whitney test), the data still demonstrated clearly that there 
were more apoptotic cells in stressed BL2 cells than in BL2/bcl-2 cells and despite this, 
stressed BL2 supernatant had much lower levels of ATP than stressed BL2/bcl-2 
supernatant, suggesting that ATP release in the stress model was not 
apoptosis-dependent. 
 
4.6 Stress supernatants inhibited neutrophil migration 
Neutrophil infiltration cannot be seen in Burkitt’s lymphoma and lactoferrin released 
from apoptotic BL cells has been found to be a neutrophil infiltration inhibitory factor 
in this system (Bournazou, Pound et al. 2009). Since stressed cells can release 
chemoattractants to recruit mononuclear phagocytes, it was therefore interesting to 
determine whether stressed cells could further condition the tumour microenvironment 
by regulating neutrophil infiltration. Given that there was ATP in the stress 
supernatants and it has been shown that the autocrine signalling of ATP and adenosine 
helps neutrophils to navigate towards a chemoattractant gradient and accelerate the 
migration velocity (Chen, Corriden et al. 2006), the migratory responses of neutrophils 
to stress supernatants along with pure ATP were assessed. fMLP was used as a positive 
control (Figure 4.7). Within the concentrations examined, especially high 
concentrations of ATP (9 µM and 90 µM) induced a migratory response; however, the 
possibility of chemokinesis had not been excluded.  Compared with the negative 
control, stress supernatants, including BL2 and BL2/bcl-2, despite containing ATP, 
could inhibit neutrophil migration suggesting that stressed BL could release neutrophil 
infiltration inhibitory factor(s) independent of apoptosis. However, the identification 
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of the factor(s) requires further investigation. 
 
However, a drawback of these experiments is that the controls used in the assays 
(assay medium, serum-free RPMI) for stress supernatant is not the optimal control. An 
additional and more suitable control would be the conditioned medium from healthy, 
unstressed BL2 cells which could help clarify whether the chemoattractant was 
specifically derived from stressed cells or was simply a concentrated effect from 























































































 Chemotaxis assays were performed to assess the chemoattractive 
ability of supernatants from stressed BL2/bcl-2 cells. To examine the 
contribution of nucleotides to the chemoattractive responses of 
THP-1 cells, stress supernatant was treated with apyrase (A) or the 
THP-1 cells were treated with suramin (B). Controls in (A) and (B) 
were the migration ofTHP-1 cells to assay medium. Data presented 
are the means of the fold increase compared to the control and error 



























































In high density stress






























 A) ATP concentrations in stressed BL2 and BL2/bcl-2 cell supernatants 
were assessed using ATP bioluminescent assay. The difference 
between the concentrations of ATP in BL2 and BL2/bcl-2 was not 
significant by the Mann-Whitney test. B) Apoptotic cell number 
(AxV+PI- cells) and ATP released from 1 ml of 100×106 cells were 
compared between stressed BL2 and BL2/bcl-2 cells. Error bars are 
SEM, n=3.  The difference between the apoptotic cell numbers in BL2 























































 A) Analysis of the purity of separated human blood 
polymorphonuclear cells by cytospin and H&E staining. B) Neutrophil 
chemotaxis assays were performed and the chemoattractive ability of 
ATP and stressed BL2, BL2/bcl-2 supernatants were assessed. fMLP 
(100nM), positive control; control, assay medium. The data presented 
are the mean of migrated neutrophil number/hpf of duplicate samples. 
One representative of three experiments is shown.  
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4.7 ATP was not released from microparticles (MPs) of 
stress supernatant 
In recent years, the occurrence of controlled ATP release from intact mammalian cells 
under different conditions has been gradually accepted, however, the mechanisms of 
ATP release from these cells is not well understood. The two most studied and widely 
accepted modes of ATP release are exocytosis of secretory vesicles that contain ATP 
and ATP release through specialized channels (Junger 2008; Praetorius and Leipziger 
2009). Besides, hypoxia could stimulate vesicular ATP release from rat osteoblasts 
(Orriss, Knight et al. 2009). Thus, pilot experiments were performed to identify the 
possible ATP releasing mechanism in the stress model, including secretory vesicles 
and ion channels. Given that ATP functioned as a chemoattractant for mononuclear 
phagocytes, and the release of fractalkine, a chemokine known to attract mononuclear 
phagocytes in BL, was microparticle-associated (Truman et al., 2008), it was first 
speculated that the release of ATP is microparticle-associated. Hence, microparticles 
from stressed BL2 supernatant were separated and cultured for up to 24 hours to 
observe ATP release. ATP levels were measured at different time points (Figure 4.8). 
The data demonstrated that around 200nM ATP was present in soluble form in 
microparticle-free stress supernatant, and there was no ATP release from cultured 
microparticles at 37ºC within 24 hours. 
 
However, there were limitations for this experiment. First, the identity of 
microparticles after ultracentrifugation should be examined. Although the same 
ultracentrifugation protocol has been used to generate microparticles from apoptotic 
BL cells whose identity has been confirmed by Annexin V staining using flow 
cytometry (Truman, Ford et al. 2008), the identity of microparticles in this study 
(generated from stressed BL cells) should be either by similar Annexin V staining or 
by Western blotting for microparticle markers, such as lipid raft protein flotillin (Lee, 
D’Asti et al. 2011). Second, given that the size of microparticles was unknown and the 
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requirement for sterility, the resuspended microparticles were passed through a 0.22 
µm filter. Since there might be larger microparticles filtered out, the conclusion can 
only be applied to microparticles with diameters smaller than 0.22µm and smaller 

















































 MPs were isolated from stressed BL2 supernatant and incubated for 
different periods of time. ATP levels were measured at each time point. 
MPs-free supe: MPs-free stress supernatant from which MPs were 
isolated. 0h: fresh serum-free RPMI 1640. Data presented are the mean 
of ATP concentration of duplicate samples. Data from one 




4.8 Effect of ATP channel antagonists on ATP release 
during stress 
Since the released ATP in stress supernatant was mostly in soluble form, further  
experiments were carried out to identify whether anion channels were responsible for 
ATP release. Various anion channels are responsible for ATP release in response to 
different stimuli. These channels include connexin and pannexin hemichannels, 
maxi-anion channels, voltage-dependent anion channels (VDAC), and P2X7 receptors 
(Praetorius and Leipziger 2009).  Some channels have already been identified to be 
responsible for the ATP release in different stress conditions. Pannexin 1 is a large pore 
plasma membrane channel and has been found to be involved in ATP release in various 
systems (MacVicar and Thompson 2010). Oxygen and glucose-deprivation can induce 
ATP release from pannexin 1 (Thompson, Zhou et al. 2006). Connexins have several 
similar biophysical and biochemical properties to pannexins and they can also conduct 
ATP across the plasma membrane (Harris 2007; Scemes, Spray et al. 2009). There are 
also reports on the induction of ATP release via a maxi-anion channel upon oxygen 
and glucose- deprivation (Liu, Sabirov et al. 2008). These channel proteins were also 
expressed by BL2 cells according to the gene profiling database previously established 
in our group. Considering the glucose level dropped rapidly in the stress model (Figure 
3.7), the effect of all three channels on ATP release was examined using channel 
antagonists (Figure 4.9). Gd3+and arachidonic acid are maxi-anion channel antagonists; 
carbenoxolone is a connexin and pannexin channel antagonist; and probenecid is a 
pannexin channel antagonist. By comparison with cells that had not been treated with 
inhibitor, Gd3+ did not affect ATP release, but arachidonic acid partially inhibited ATP 
release and carbenoxolone and probenecid were able to reduce the amount of released 
ATP. These observations implicate these channels as mediators of ATP release; 



















































































 Before stress, BL2 cells were treated with different ATP channel 
antagonists and stress supernatants were generated to compare the 
amount of released ATP. 1) Gd3+and Aranchidonic acid: maxi-anion 
channel antagonists; 2) Carbenoxolone: connexin and pannexin 
channel antagonist; 3)Probenecid: pannexin channel Antagonist. Ctrl 
and DMSO were cells treated with solvents before stress. Data 
presented are the means of ATP concentration of duplicate samples. 
Data from one experiment is presented. 
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Chapter 5 Results: Stressed BL cells can 
release factors which can promote tumour 
cell proliferation in vitro 
  
5.1 BL2 cell proliferation kinetics in BL culture 
medium and cell cycle properties   
In an attempt to identify whether stressed tumour cells had any direct trophic effect on 
other tumour cells, the effect of stress supernatant on BL2 cell proliferation was 
assessed. To begin with, the kinetics of BL2 cell proliferation in their normal culture 
medium was established to form the basis and a positive control. The optimal 
concentration for seeding density of cells to reflect the exponential phase of 
proliferation was confirmed as being 0.2x106/ml. Cells were then cultured for up to 96 
hours, and their concentration was monitored every 24 hours (Figure 5.1 A). 
Meanwhile, cell cycle analysis was performed at each time point as cells proliferated 
(Figure 5.1B-F). As cells proliferated, they moved from G1 phase into S phase and 
G2/M phase. However by 96 hour the G1 phase was enriched and the S and G2/M 
phases were depleted suggesting the growth of the population of cells was reaching a 
plateau. 
 
5.2 Identification of optimal serum-free culture 
medium with minimal proliferation effect 
Since serum contains immunoglobulins and many unidentified growth factors which 
might mask the effect of exogenous bioactive factors on BL2 cell proliferation, use of 
a serum-free culture medium was adopted. The commercial product X-VIVO was 
examined since its serum-free formulation only contains defined exogenous growth 
factors, including transferrin and insulin. A range of concentrations of X-VIVO 
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medium in RPMI were assessed, from 1% to 50% (v/v), in the BL2 cell proliferation 
assays (Figure 5.2). BL2 cells grown in 1% X-VIVO exhibited minimal proliferation 
while maintaining cell viability. Therefore, this concentration was used as the 
serum-free culture medium in subsequent assays to identify exogenous bioactive 
factors.  
  
5.3 Supernatants from stressed BL2 cells promoted 
BL2 cell proliferation 
Having established the assay system, stressed BL2 supernatant was applied to the cell 
proliferation assay to determine its effect on the proliferation of BL2 cells thus 
exploring the ability of stressed tumour cells to have a direct trophic effect on other 
tumour cells. Considering the limited availability of stress supernatant, the effect of 
different dilutions was assessed in the assay, including 1 in 4, 1 in 8 and 1 in 16 (Figure 
5.3). Compared with the control which was 1%X-VIVO in RPMI, stress supernatant 
was able to stimulate BL2 cell proliferation in a dose-related fashion. Among the 
dilutions examined, 1 in 4 dilution of stressed BL2 supernatant had the strongest effect, 
therefore, stress supernatants were all diluted 1 in 4 in future experiments. Further 
experiments using stressed BL2 supernatant confirmed that it could significantly 
promote BL2 cell proliferation (Figure 5.4). 
 
The mitogenic effect of stress supernatants was further confirmed by examining Akt 
phosphorylation using Western blotting (Figure 5.5). Akt is constitutively 
phosphorylated on Ser473, but not on Thr308, without which Akt cannot perform its 
kinase function (Alessi, James et al. 1997; Stokoe, Stephens et al. 1997). When treated 
with stressed BL2 supernatant, Akt was phosphorylated on Thr308 and active within 
30 minutes, which is consistent with the proliferation assay where stressed BL2 
supernatants could support proliferation of BL2 cells. However, two batches of 
samples exhibited distinct patterns of phosphorylation. In Figure 5.5, samples in left 
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panels showed around an equal amount of pT308-Akt at 30 and 60 min, and the right 
ones showed peaked expression at 30 min which was partially lost at 60 min. The 
difference might be owing to subtle difference between experiments. Despite the fact 
that Akt was phosphorylated upon stress supernatant treatment, it was nonetheless 
difficult to determine the nature of initial activation: survival or proliferation 
stimulation, since phosphorylated Akt has been found to both promote cell survival 
and stimulate cell proliferation (Vivanco and Sawyers 2002). The resulting cell 
proliferation might either be induced by a mitogen, or be induced by a survival factor 
which inhibited apoptosis leading to further cell growth and proliferation. 
Nevertheless, the presence of activated Akt confirmed the observation from cell 
proliferation assay that the stressed BL2 supernatant promoted cell proliferation 
despite the fact that the nature of the bioactive factors in the stress supernatant was 
unknown.   
 
5.4 Mitogenic effect of stress supernatants is not 
apoptosis-dependent 
The 1 hour high density stress did not induce apoptosis in BL2 cells (Figure 3.2), 
therefore the mitogenic effect of stressed supernatant was unlikely to be due to 
bioactive factors released from apoptotic cells. However, in order to confirm this, 
supernatant generated from stressed BL2/bcl-2 cells was assessed in the proliferation 
assay (Figure 5.6). Supernatant from stressed BL2/bcl-2 cells promoted proliferation 
of BL2 cells indicating the mitogenic effects of stressed supernatant were not 
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A) BL2 cell proliferation kinetics in BL culture medium. Seeding density: 
0.2x106/ml. Viable and total cell concentrations every 24 hours were 
determined using Trypan Blue exclusion. Data presented are means of 
triplicate samples and are representative of three independent 






























































  Figure 5.2 Identification of the optimal concentration of X-VIVO as  






 Various concentrations of X-VIVO were added to BL2 cells cultured in 
serum-free RPMI to establish the minimum concentration that could 
support cell viability without promoting proliferation. Viable (A) and 
total (B) cell concentrations were determined using Trypan Blue 
exclusion every 24 hours. Data are the means of triplicate samples 







































































 Various dilutions of supernatant from stressed BL2 cells were added to 
BL2 cells cultured in serum-free RPMI containing 1% X-VIVO (1%). 
Viable (A) and total (B) cell concentrations were determined using 
Trypan Blue exclusion every 24 hours. 1:4S+1%: stress supernatant 
was diluted1 in 4 in 1%X-VIVO; 1:8S+1%: stress supernatant was 
diluted1 in 8 in 1%X-VIVO; 1:16S+1%: stress supernatant was diluted1 
in 16 in 1%X-VIVO. Data presented are means of triplicate samples 
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viable BL2 cells
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 BL2 cells were cultured in serum-free RPMI containing 1% X-VIVO with 
or without (control) supernatant from stressed BL2 cells that was diluted 
1 in 4. Viable (A) and total (B) cell concentrations were determined 
using Trypan Blue exclusion every 24 hours. Data are means±SEM 
(n=3) *, P<0.05; **, P<0.01; ***, P<0.001, compared with control at the 









































 BL2 cells were incubated in serum-free RPMI containing 1% X-VIVO 
and supernatant from stressed BL2 cells that was diluted 1 in 4.  After 
30 and 60 min. respectively, a cell lysate was prepared. Time 0 was 
lysate from BL2 cells incubated without stress supernatant. Samples 
from two independent preparations were immunoblotted with rabbit 
anti-human phospho-Akt (Ser473), phospho-Akt (Thr308) and 
total-Akt. Akt and phospho-Akt were controls from cell extracts 
































































 BL2 cells were cultured in serum-free RPMI containing 1% X-VIVO 
with or without (control) supernatant from stressed BL2/ bcl-2 cells that 
was diluted 1 in 4. Viable (A) and total (B) cell concentrations were 
determined using Trypan Blue exclusion every 24 hours. Data are 
means±SEM (n=3). *, P<0.05; **, P<0.01, compared with control at  
the corresponding time point (Mann-Whitney test).  
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5.5 Mitogenic effect was not cell line specific 
In order to determine whether the stress supernatants were able to induce proliferation 
in cell types other than the BL2 line, their effects on THP-1 cells were studied (Figure 
5.7). Compared with the control (1%X-VIVO), stressed BL2 supernatant significantly 
promoted THP-1 cell proliferation. Thus, the mitogenic effect was not cell line 
specific.  
 
5.6 Identification of bioactive factors responsible for 
stress-induced proliferation 
 
5.6.1 ATP and lactoferrin were not the bioactive factors in 
stress supernatants  
As demonstrated in chapter 4, there was sufficient ATP in stress supernatants to 
contribute to conditioning of the tumour microenvironment by recruiting mononuclear 
phagocytes. To determine whether ATP could also condition the tumour 
microenviroment by performing direct trophic effects on the tumour cells, exogenous 
ATP was added to BL2 cells and the growth of the cells was observed over 96 hours 
(Figure 5.8). The addition of ATP at various concentrations to BL2 cells in 1% 
X-VIVO in RPMI did not have any effect on the proliferation of the lymphoma cells, 
suggesting that ATP was not the growth-promoting bioactive factor of stress 
supernatant. 
 
Another candidate for the mitogenic effect of stress supernatant was lactoferrin (LFN) 
which is a member of the transferrin family and iron-saturated transferrin has been 
found to promote cell growth (Kovar and Franek 1989).  Moreover, it can be released 
from apoptotic BL cells and has been found to promote BL cell proliferation 
(Bournazou 2010). It was thus speculated that stressed BL cells could also release LFN 
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and that this was responsible for the mitogenic effect of stress supernatant. Based on 
the concentration of LFN used by Bournazou, two concentrations were examined in 
the cell proliferation assay (Figure 5.9). However, neither concentration of LFN could 
promote BL2 cell proliferation, suggesting that lactoferrin was not the bioactive factor.  
   
5.6.2 Heat-stable bioactive factor(s)   
In an attempt to further characterise the stress-derived factor that was responsible for 
promoting proliferation of BL2 cells, stressed BL2 supernatant was boiled for 10 min 
before being applied to the proliferation assay thus determining the heat stability of the 
bioactive factor (Figure 5.10). Heat-inactivation did not affect the proliferation 
stimulating effect compared with the untreated stress supernatant, indicating that the 
bioactive factor(s) was heat stable which might be either lipid or small peptides.  
 
Sphingosine-1-phosphate (S1P) has been found to promote macrophage survival 
(Weigert, Johann et al. 2006) and stimulate glioma cell proliferation (Van Brocklyn, 
Letterle et al. 2002). S1P is also a key factor skewing macrophages towards an M2 
phenotype (Weigert, Weis et al. 2009). Therefore, it might be a vital factor regulating 
the tumour microenvironment. Given that it was also a small lipid, S1P was considered 
to be another candidate for the bioactive factor in stress supernatant. Thus, different 
concentrations of S1P were applied to the proliferation assay and S1P was found to 
significantly promote BL2 cell proliferation, compared with its carrier protein control 
(bovine serum albumin, BSA) (Figure 5.11). It seemed that S1P might be the factor 
causing the proliferation stimulating effect. 
 
To confirm the role of S1P, S1P level in stress supernatants was measured using a S1P 
ELISA. It was a competitive ELISA therefore the less S1P in the sample, the higher the 
final absorbance, as demonstrated by its standard curve (See Appendix 3). Since S1P 
has been found at high concentrations in the circulation and is capable of binding to 
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serum proteins (Scherer, Schmitz et al. 2009) and low-endotoxin BSA has been 
observed to stimulate proliferation of BL2 cells grown in minimal culture media, the 
level of S1P in 4 mg/ml BSA (low-endotoxin, and lipid-free BSA as a control) was also 
examined. 1 μM reconstituted S1P (commercially purchased) was assessed to validate 
the concentration of S1P used in the proliferation assay (Figure 5.12). The result for 1 
μM reconstituted S1P was consistent with its concentration which also confirmed the 
validity and accuracy of the ELISA assay. There was no S1P in low-endotoxin BSA, 
and there seemed to be a tiny amount of S1P in the lipid-free BSA. However, the 
absorbance of stress supernatants (BL2 and BL2/bcl2) was as high as 0 μM S1P, 
suggesting that there was no S1P in the stress supernatants. The result indicated that 
S1P was not the proliferation stimulating factor of stress supernatant.  
 
However, another possible explanation is that S1P was enclosed in microparticles 
released by BL2 cells, since substantial numbers of microparticles are known to be 
released from dying BL cells (Segundo, Medina et al. 1999; Truman, Ford et al. 2008) 
and microparticles released by tumour cells (human hepatocarcinoma and human 
breast carcinoma) are known to be a site for S1P production (Rigogliuso, Donati et al. 
2010). In order to examine whether the proliferation stimulating effect was 
microparticle-related, microparticles were separated from stressed BL2 supernatant by 
ultracentrifugation and applied to the cell proliferation assay (Figure 5.13). 
Microparticle-free and the original stress supernatant were used as controls. The 
majority of the proliferation-stimulating effect of the stress supernatant was found to 
be in the microparticle-free stress supernatant suggesting microparticles from the 
stress supernatant did not have any proliferation-stimulating effect. However, since it 
was necessary to sterilise the microparticles by filtration therefore it was not possible 
to assess the effect of microparticles larger than 0.2 µm. Larger microparticles (larger 
than 0.2 µm) thus may contain the growth-promoting factors of stress supernatant, 


























































  Figure 5.7 Mitogenic effect of supernatant from stressed BL2 cells 






 THP-1 cells were cultured in serum-free RPMI containing 1% 
 X-VIVO with or without (control) supernatant from stressed BL2 cells 
that was diluted 1 in 4. Viable (A) and total (B) cell concentrations were 
determined using Trypan Blue exclusion every 24 hours. 
 Data presented are means±SEM (n=3) *, P<0.05; **, P<0.01, compared 













































































BL2 cells were cultured in serum-free RPMI containing 1% 
X-VIVO with or without (control) the shown concentrations of ATP.   
The mitogenic effect of stressed BL2 supernatant diluted ¼ is also 










































































BL2 cells were cultured in serum-free RPMI containing 1% 
X-VIVO with or without (control) the shown concentrations of lactoferrin 
(LFN). The mitogenic effect of stressed BL2 supernatant diluted ¼ is 




























































 Figure 5.10 Heat stability of mitogenic factor(s) in supernatants      








 BL2 cells were cultured in serum-free RPMI containing 1% 
X-VIVO with or without (control) supernatant from stressed BL2 cells 
that was boiled for 10 min. The mitogenic effect of stressed BL2 
supernatant diluted ¼ is also shown. Data are means of triplicate 
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    BL2 cells were cultured in serum-free RPMI containing 1% 
X-VIVO with or without (control) the shown concentrations of S1P. 
BSA was the carrier protein for S1P. Data presented are mean±SEM 
(n=3). *, p<0.05, compared with BSA control at the corresponding time 










0.06324 mg/ml lipid-free BSA



























 S1P level in stress supernatant was measured using S1P ELISA. 
Calculated S1P concentrations according to the standard curve are 
shown. Purified S1P was used as a control. 4 mg/ml low-endotoxin and 
lipid-free BSA were examined for the existence of S1P. The standard 
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 BL2 cells were cultured in serum-free RPMI containing 1% 
X-VIVO with or without (control) microparticles isolated from 
supernatant from stressed BL2 cells or supernatant depleted of 
microparticles. The mitogenic effect of stressed BL2 supernatant diluted 




Chapter 6 Results: Generation and 
phenotypical characterisation of ESDM 
 
6.1 Directed differentiation of murine embryonic stem 
cells into macrophages 
The most common way of generating differentiated cell types from ES cells is to 
induce them to form three-dimensional multicellular aggregates, which are named 
embryoid bodies (EBs). There are three basic methods for EBs formation, including 
suspension culture in bacterial-grade dishes, hanging drops culture, and 
methylcellulose culture.  
 
When this project was initiated, all published protocols for differentiating murine 
embryonic stem cells into macrophages adopted the differentiation systems in 
methylcellulose semisolid media (Moore, Fabunmi et al. 1998; Chawla, Barak et al. 
2001; Odegaard, Vats et al. 2007). Although methylcellulose allows seeded ES cells to 
generate clonal and reproducible cell aggregates (EBs), it disturbs the unrestricted 
transfer of growth factors added and the handling of the medium by pipettes is difficult 
(Wiles 1993). The cost of the media is another limiting factor for the scale of 
experiments. Efficiency of hematopoietic differentiation has been compared between 
three basic EBs formation methods (Dang, Kyba et al. 2002). Therefore, based on the 
findings of my previous work (Zhuang 2007), all three methods were assessed to 
identify the most effective way to generate macrophages from ES cells. The results 
consistently indicated that compared with hanging drops and methylcellulose culture, 
suspension culture could yield the highest number of macrophage-like cells with the 
most straightforward cell culture procedures, although there was a disadvantage that 
EBs generated in suspension culture were heterogeneous. Thus, work was carried out 
to further define the optimal protocol using the suspension culture system.  
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The media for ES cell differentiation (GMEMDiff, see Appendix 1) was similar to ES 
cell culture media GMEMFCS (see Appendix 1) except that FCS was batch-tested for 
differentiation. Interleukin 3 (IL-3) plays a key role in the lineage commitment from 
pluripotent stem cell to myeloid-restricted progenitor and can act on myeloid 
progenitors to promote their proliferation (Dorshkind 1990). As IL-3 responsive 
progenitor cells differentiate, they become responsive to colony stimulating factor-1 
(CSF-1), which is required for the maintenance of the monocyte phenotype and 
capable of supporting the differentiation and the long-term survival of the 
macrophage-like cells (Young, Lowe et al. 1990). Therefore, both CSF-1 (15%) and 
IL-3 (1ng/ml) were supplemented in ES cell differentiating and EBs culture media (the 
medium was named ESDMDiff, see Appendix 1) and only CSF-1 (15%) was added to 
supernatant cell-derived progenitor cell culture media (the medium was named 
ESDMcult, see Appendix 1). In-house generated L929 cell conditioned media (L929 
CM) was used as the source of CSF-1 and recombinant mouse IL-3 was purchased 
commercially. The main ES cell line used for differentiation was E14. 
 
Firstly, 6×105 trypsin-dissociated E14 cells were seeded in 20 ml ESDMDiff, and 
plated onto one 95 mm diameter bacteriological Petri dish. This time point was defined 
as day 0. Under the culture condition without leukaemia inhibitory factor (LIF), ES 
cells started to differentiate and formed three dimensional structures of various sizes 
which were named embryoid bodies (EBs). As EBs grew bigger, they tended to stick 
to the Petri dish. To avoid their adherence, EBs were dislodged and transferred to a 
new Petri dish on day 4 and day 6, and supplemented with ESDMDiff. After 8 days of 
culture, the EBs were transferred to one gelatine-coated tissue culture dish (95 mm), 
supplemented with 20 ml fresh ESDMDiff. EBs became adherent on the dish, and they 
started to release progenitor cells into the supernatant. Two days later (day 10) their 
supernatant was harvested and progenitor cells in the supernatant were isolated by 
centrifugation and re-suspended in 20 ml ESDMcult (GMEMDiff with L929, penicillin 
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and streptomycin, see Appendix 1) and cultured on one 95 mm diameter 
bacteriological Petri dish. Adherent EBs were replenished with 20 ml fresh ESDMDiff 
for prolonged culture of up to 20 days, and supernatants were harvested every 2 days 
(Figure 6.1A). Adherent cells started to appear on Petri dishes after around 3 to 5 days, 
and the cell number gradually increased with time and formed a confluent monolayer. 
On day 7, adherent cells were harvested by using cold detachment buffer and a cell 
lifter. Around 2 to 4 million macrophages could be harvested from one Petri dish and 
the viability after detachment was >90% according to trypan blue exclusion.  
 
From one dish of ES cells over long term differentiation, 12 to 24 million macrophages 
could be produced in total. More macrophages could be generated when required, 
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 Figure 6.1 Differentiation of murine embryonic stem cells into 










 A) 6x105 ES cells were cultured in suspension for 8 days with CSF-1 
and IL-3 in one Petri dish to form embryoid bodies (EBs) and were 
then plated onto gelatinized tissue culture dishes, also with CSF-1 and 
IL-3. EBs became adherent after 2 days. From day 10, supernatant of 
adherent EBs which contained macrophage progenitor cells was 
collected every 2 days and put onto 95mm Petri dishes, with CSF-1. 
The supernatant was cultured for 7 days before ESDMs were 
harvested. B) Since supernatant can be collected every two days from 
day 10 EBs to day 20 EBs, and 1 dish of ES cells can yield up to 2-4 
x106 ESDMs, after full term of culture, up to 12-24 million ESDMs can 
be harvested from 1 dish of 6x105 ES cells. Higher numbers of ESDMs 
can be obtained by multiplying the starting number of ES cell dishes. 
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6.2 Characterisation of putative embryonic stem cell 
derived macrophages (ESDM) by morphology 
To confirm that the cells which adhered to bacteriological Petri dishes were 
macrophages, cells were first characterised by morphology both in culture and in 
stained cytocentrifuged preparations.  In culture, the cells were strongly adhesive to 
plastic and extended long plasma membrane projections with varied morphology, 
including bipolar and multipolar forms (Figure 6.2C). The morphology indicated that 
these cells might be macrophages or dendritic cells. However, the cells were so 
strongly adherent that detachment directly with a cell lifter yielded a high ratio of dead 
cells, around 50% according to trypan blue exclusion. Pre-treating the cells with cold 
detachment buffer before scraping with a cell lifter can increase the viability to ~ 90%. 
Previous work has shown that mouse spleen dendritic cells are semi-adherent, and 
despite initially adhering to plastic surfaces, they become nonadherent after overnight 
culture (Steinman and Cohn 1973). Therefore, given the strong adhesive nature of the 
ES-derived cells, these cells are unlikely to be dendritic cells. 
 
After detachment, the cells were prepared as single cell suspension for 
cytocentrifugation, followed by Diff Quick staining. Although the cells were 
heterogeneous in morphology, all of them were mononuclear cells which excluded the 
possibility of granulocyte contamination.  
 
Most of them showed mature macrophage morphology, including large cells with low 
nucleocytoplasmic ratio; eccentrically placed, round or kidney-shaped nucleus and a 
cytoplasm containing numerous vacuoles, reflecting active pinocytosis (Figure 6.2 B, 
D). There were also cells which had immature macrophage morphology, including 
high nucleocytoplasmic ratio and dense cytoplasm (Figure 6.2B). Among the mature 
cells, some either bound to cell debris or had an apoptotic cell engulfed inside the 
cytoplasm (Figure 6.2D) which indicated active phagocytosis. The morphology of 
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adherent cells in cytocentrifuged preparations was distinct from that of embryonic 
stem cells (Figure 6.2A).  
 
Together, the adhesive nature, morphology, pinocytosis and phagocytosis activity 
suggested that these adherent cells on Petri dishes were macrophages.  
 
6.3 Characterisation of putative ESDM by 
macrophage-specific markers  
6.3.1 Immunoperoxidase staining 
6.3.1.1 Cytocentrifuge preparations 
In order to confirm the identity of these adherent cells, antibodies against 
macrophage-specific markers were used for immunostaining. Purified F4/80, CD11b 
and CD68 antibodies were used to stain cytocentrifuged preparations of cells. CD68, 
also named macrosialin, is a heavily glycosylated transmembrane protein, expressed 
by tissue macrophages, Langerhans cells and at low levels by dendritic cells. It is the 
murine homologue of the human macrophage glycoprotein CD68, and a member of 
the lysosomal-associated membrane protein family which are located predominantly 
within the cells. Minute but significant amounts of CD68 have also been detected on 
macrophage surfaces (Ramprasad, Terpstra et al. 1996). Cytocentrifuge preparation 
and fixation with acetone made the intracellular antigen accessible to the antibody. 
CD11b, known as the integrin alpha M chain, is implicated in different adhesive 
interactions of monocytes, macrophages and granulocytes. F4/80 is a cell surface 
glycoprotein which is a member of the EGF-TM7 protein family and it has been found 
that the expression of F4/80 is heterogenous and can vary during macrophage 
maturation and activation. Unlike other macrophage markers, F4/80 is not expressed 
on other types of blood cells (Nussenzweig, Steinman et al. 1981).   
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Most cells showed very strong staining of CD68, CD11b and F4/80 (Figure 6.3A), 
suggesting high level expression of these antigens, while a minority were weakly 
stained, which suggested low level or negative expression of antigens. More than 80% 
of cells were positively stained by F4/80 and CD11b antibodies, and more than 90% of 
cells were CD68 positive. The staining profile strongly suggested that the adherent 
cells were macrophages (Figure 6.3B). The stem cell line, E14, was also stained as 
control and it was negative for all the three markers (Figure 6.4). 
 
6.3.1.2 Staining of cells in chamber slides  
In order to determine the expression of the above antigens without the interference of 
the detachment procedure, non-adherent cells from EBs cultures were transferred to 
chamber slides and the cells were stained directly on these. The seeding density was 
adjusted in order to achieve sub-confluence after 7 days culture. Almost all the cells 
were positively stained by CD68, F4/80 and CD11b antibodies, although some cells 
were only weakly stained (Figure 6.5). Furthermore, the staining on chamber slides 
more clearly revealed the bipolar and multipolar stellate morphology of these cells in 
culture.  
 
6.3.2 Analysis by flow cytometry  
Staining of ES cells-derived cells with fluorescence-conjugated antibodies against 
F4/80, CD11b and CD11c was analyzed by flow cytometry. Staining with CD11c 
antibody was used to detect dendritic cells, since the latter are also slightly adherent 
and have some morphological similarity to macrophages. Mouse bone 
marrow-derived macrophages (BMDM) and resident peritoneal cells were analyzed 
by the same criteria for comparison with bona fide macrophages. 
 
Macrophages from each of the three sources had a wide range of forward and side light 
scatter, therefore, a log scale was used for analysis. For both BMDM and peritoneal 
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macrophages, three subpopulations could be identified by light scatter, named gate 1, 2, 
and 3 (Figure 6.6A and B). For BMDM, gate 1 cells were positive for F4/80, CD11b 
and CD11c and gate 2 cells had a lower expression level of F4/80, CD11b and CD11c. 
For peritoneal macrophages, gate 1 and gate 2 cells were positive for F4/80 and CD11b, 
but negative for CD11c. Notably, there was a subpopulation in gate 2 that was negative 
for F4/80 and negative for CD11b. For both BMDM and peritoneal macrophages, gate 
3 cells were negative for all three markers. These data indicated that 1) in addition to 
macrophages, both BMDM and peritoneal cells also contained F4/80 and CD11b 
negative cells which were presumably not macrophages; 2) BMDM gate 1 and 2 cells 
were contaminated by classical dendritic cells as defined by CD11c.  
  
For ESDM, three subpopulations, two major and one minor, could be defined by light 
scatter, named gate 1, 2 and 3 (Figure 6.6 C and D). Unlike BMDM and peritoneal 
cells, ESDM in all three gates were positive for F4/80 and CD11b, but negative for 
CD11c. Similar to resident peritoneal macrophages, there was also a small population 
in gate 2 that was negative for F4/80 and CD11b.   
 
Every time after supernatant was collected, EB cultures were supplemented with fresh 
media, so the culture of embryoid bodies could be maintained to continually generate 
macrophage progenitor cells. ESDM from day 10 embryoid bodies and ESDM from 
day 20 embryoid bodies were analysed to see whether they had the same phenotype. 
Both of them were cultured for 7 days. ESDM from these two sources showed similar 
pattern, positive for F4/80 and CD11b, but negative for CD11c. But ESDM day 20 had 
slightly weaker fluorescence intensity, compared with ESDM day 10 and the 
unspecific binding of F4/80 increased, which might be caused by increased expression 
of Fc receptors (Jungi and Hafner 1986; Clarkson and Ory 1988) (Figure 6.6 D). There 
was also a small population in gate 2 negative for F4/80 and CD11b. 
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In Figure 6.6, gate 2 cells of ESDM were always less strongly stained than gate 1 cells, 
and there was always a small population in gate 2 that was negative for F4/80 and 
CD11b. Since the above fluorescence analysis was performed on the whole cell 
population, bearing in mind that dead cells might lose some cell surface molecules, the 
viability of gate 2 cells was assessed using propidium iodide (PI) to see whether gate 2 
cells were simply dead macrophages. Backgating showed that PI-positive cells were 
not exclusively in gate 2 but were present in all the three gates (Figure 6.7), although 
the majority of dead cells were in that gate. The presence of around 20% dead cells 
within ESDM population offered one explanation of the identify of the 10%-20% 
unstained cells in immunoperoxidase staining and the small negatively stained 
population of gate 2 cells in immunofluorescence staining. However, in order to 
confirm this directly, fluorescence-conjugated antibody staining combined with PI 
binding should be performed. Nevertheless, it did not exclude other possibilities. 
Because only single staining was performed, it did not distinguish whether it was the 
same contaminating population that was negative for all three markers or they were 
indeed macrophages at various stages of maturation which temporarily lack of certain 
































 A: Morphology of ES cells revealed by Quick-Diff staining of 
cytocentrifuge preparation. B: ESDM differentiated from macrophage 
progenitor cells by adherent culture for 7 days. Cytocentrifuge 
preparation of detached ESDM revealed by Quick-Diff staining. 
C: Phase contrast micrograph of ESDM in culture showing bipolar 
(arrow, B) and multipolar (arrow, M) morphologies. D: ESDM bind and 
engulf apoptotic cells and cell debris. Cytocentrifuge preparation of 
detached ESDM revealed by Quick-Diff staining. Inset: higher 































 Figure 6.3 Immunocytochemical demonstration of macrophage 







 Cytocentrifuge preparations of ESDM stained with 
peroxidase-conjugated rat anti-mouse macrophage specific antibodies 
against F4/80, CD68 and CD11b (upper panel) or isotype control 
reagents (lower panel).  Binding was detected using DAB substrate 






























Cytocentrifuged preparations of E14 cells were stained with rat 
anti-mouse macrophage markers, CD68, CD11b and F4/80 or isotype 
control antibody. Other details of immunoperoxidase staining were as 






























Non-adherent cells from EB cultures were transferred to chamber 
slides and stained with rat anti-mouse macrophage-specific markers, 
CD68, CD11b and F4/80 or isotype controls. Other details of 
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 Figure 6.6 Flow cytometric analyses of macrophage and dendritic 
cell markers on ESDM, BMDM and resident peritoneal 










































































Figure 6.7 The second major ESDM subpopulation defined by 






 7 day-matured ESDM derived from supernatants of day 10 EBs and 
day 20 EBs, BMDM and peritoneal macrophages were stained with 
antibodies to F4/80, CD11b and CD11c or isotype controls. Cell 
sub-populations were defined by forward and side light scatter and 
staining of these was analysed by electronic gating on a flow 
cytometer. The histograms for fluorescent staining are shown for 
different gates. A). BMDM, B) Resident peritoneal macrophages, C) 
ESDM from day 10 adherent EBs, D) ESDM from day 20 adherent 
EBs. Green: unstained cells, red: isotype control; blue, antibody as 
indicated. BMDM and resident peritoneal macrophages were from 
Balb/c mice. The data are representative of those from three 
independent experiments.  
 
 
 ESDM were stained with PI to identify dead cells. 26% of cells were 
stained, shown by blue line in histogram, A); red indicates 
fluorescence of unstained cells. B) Backgating of PI positive staining 
on ungated scatter plots: blue, PI positive; red, ungated cells. Data 
representative of those from three independent experiments are 
shown. 
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6.4 Self-renewal assay to exclude the possibility of 
undifferentiated embryonic stem cell contamination 
Since undifferentiated embryonic stem (ES) cells can form teratomas in vivo 
(Nussbaum, Minami et al. 2007), the possibility that ESDM might be contaminated by 
undifferentiated ES cells could hinder the future in vivo application of ESDM. Given 
the FACs data showed a small subpopulation in gate 2 of ESDM to be negative for 
both F4/80 and CD11b and the staining of cytocentrifuge preparation indicated 
approximately 10% of cells were negative for F4/80 and CD11b, it was necessary to 
exclude the possibility of ES cell contamination in ESDM. A self-renewal assay, 
which is based on the principle that the undifferentiated state of ES cells can be 
characterised by high level expression of alkaline phosphatase (Pease, Braghetta et al. 
1990), was therefore performed. ESDM were seeded at different densities, 103, 104, 
105, and 106 per well, with the ES cell line E14 included as a positive control. Two 
different culture conditions were used: GMEMFCS with and without LIF. LIF is the key 
factor for ES cell renewal. For E14 cells, three kinds of colonies were formed at 103 
per well. At higher densities, E14 cell colonies merged (104, 105, and 106 per well), and 
it was impossible to identify and quantify individual colonies. Therefore only cultures 
seeded at 103 per well were analysed. 
 
The colonies formed by ES cells were categorised based on their morphology and the 
intensity of alkaline phosphatase staining (Figure 6.8 A-C). Stem cell colonies are 
small, tightly packed and strongly-stained colonies and consist of only pink-stained, 
alkaline phosphatase positive cells. Mixed colonies have a central core of 
undifferentiated strongly stained ES cells surrounded by differentiated, unstained cells. 
Differentiated colonies are translucent, loosely packed colonies with little or no stain. 
The number of each type of colonies at 103 was quantified (Figure 6.8 G). In 
GMEMFCS with LIF, the majority were stem cell colonies, while without LIF, the 
majority were differentiated colonies with no stem cell colonies at all.  
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ESDM were growing well in ESDMcult but not in GMEMFCS either with or without LIF 
(Figure 6.8 D-F). However, there were no colonies formed in ESDM at all seeding 
densities and there was absolutely no pink staining with each condition. The results 
indicated that in up to 1 million ESDM there was no contamination by undifferentiated 
ES cells.  
 
6.5 Endotoxin control of ESDM culture condition 
LPS can modulate macrophage functions and profoundly affect macrophage 
physiology. Before performing further functional studies, it was therefore critical to 
test whether ESDM were grown in an endotoxin-free environment. All the cell culture 
media, serum and other additive reagents employed were designated to be 
nonpyrogenic by their commercial suppliers and were not assessed. However, the 
L929 CM which was produced in-house was tested for endotoxin using an endpoint 
chromogenic limulus amebocyte lysate (LAL) assay. Four batches of L929 CM were 
generated and stored at -20°C for future use. They were analyzed, and their endotoxin 
level were all less than 0.1 endotoxin units (EU)/ml, which is below the endotoxin 
limit for sterile water for injection set by the FDA, which was 0.25 EU/ml (Figure 6.9). 
It was also much lower than the lowest endotoxin level that has been found to activate 
macrophages (5 EU/ml) (Morris, Crowe et al. 1992).  
 
Furthermore, to confirm ESDM were not activated by endotoxin over long term 
culture, ESDM matured for 7 days were tested for TNF-alpha in their conditioned 
media by TNF-alpha ELISA, since macrophages activated by endotoxin can release 
TNF-alpha. ESDMDiff was used as a negative control and the supernatant of LPS and 
recombinant mouse IFN-gamma treated ESDM was used as a positive control. 16 
samples of ESDM conditioned media were examined (Figure 6.10). Compared with 
the negative control, TNF-alpha levels of all the samples were similar to background 
(dot pointed by red arrow) and much lower than that of classically activated ESDM 
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(dot pointed by blue arrow). These data suggested that during long term culture, 
ESDM were grown in an endotoxin-free environment or in other words, the endotoxin 
level in ESDM culture was not sufficient to classically activate these macrophages. 
Furthermore, the data demonstrated that ESDM had the machinery to be classically 

































 Figure 6.8 Self-renewal assays to exclude the possibility of 





















 Alkaline phosphatase was used as the marker for undifferentiated ES 
cells under early conditions of LIF removal. Cells expressing alkaline 
phosphatase stained pink. In this assay, ES cells were cultured in the 
presence of LIF for one day to keep cell renewal before being changed 
to fresh media with or without LIF. After 5 days, medium was removed 
and colonies were fixed and stained for alkaline phosphatase. ES cells 
formed 3 kinds of colonies, including stem cell colony (A: tight, strongly 
stained, pink colony), mixed colony (B: pink stem cells and 
differentiated unstained cells), and differentiated colony (C: translucent 
dispersed colony with little or no stain). E, F: The same procedure was 
applied to ESDM and no colonies were derived from ESDM, with or 
without LIF, and there was no pink stain at all. D: ESDM were cultured 
in their growth medium as a control. G. Quantification of colonies 
formed by E14 cells and ESDM. Results are representative of two 






















 Figure 6.9 Endotoxin level of the in-house L929 conditioned 





Sample ID 1 2 3 4 5 6 
TNFα (pg/ml) <1 <1 <1 <1 <1 <1 
Sample ID 7 8 9 10 11 12 
TNFα (pg/ml) <1 <1 <1 <1 <1 <1 
Sample ID 13 14 15 16 17 18 
TNFα (pg/ml) <1 <1 <1 <1 <1 1964 
 
 Figure 6.10 Confirmation of long term endotoxin free environment 






 LAL assay was performed according to the manufacturer’s instruction. 
LAL assay standard curve is in Appendix 3. Four batches of L929 CM 
were analyzed. 
 Standard curve of TNF alpha ELISA is in Appendix 3. Samples of 
ESDM culture supernatant (Sample ID 1-16) were tested for the 
presence of TNF alpha. Sample 17: fresh ESDM culture medium alone 
as the negative control. Sample 18: The supernatant from ESDM 
treated with IFN-gamma and LPS for 24 hours as the positive control. 
The data shown are one representative of three independent 
experiments. 
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Chapter 7 Results: Functions of ESDM: 
phagocytosis and chemotaxis 
 
7.1 Phagocytic ability of ESDM to engulf apoptotic 
tumour cells 
An important functional feature of macrophages is their phagocytic ability and it was 
intended that ESDM generated in this study would be primarily applied in the future to 
examine the interaction between apoptotic tumour cells and macrophages in Burkitt’s 
lymphoma (BL), therefore it was essential to evaluate the ability of ESDM to 
phagocytose apoptotic BL cells.  
 
Flow cytometry-based phagocytosis was performed using the published method 
(Jersmann, Ross et al. 2003) due to its advantage of 1) distinguishing bound from 
internalized apoptotic cells 2) eliminating vigorous washings which might skew the 
magnitude of the overall phagocytic response.  
 
BL2 cells were used as phagocytic targets. BL2 cells were labelled with far-red 
fluorescent dye DDAO-SE and induced to undergo apoptosis following UV-irradiation. 
Apoptosis was assessed by Annexin V/ PI staining (Figure 7.1A). Meanwhile, their 
red fluorescent labelling (detected using the FL4 channel) was confirmed in Figure 
6.11 C (UV-BL2 cells).  
 
ESDM constitutively expressing eGFP (GFP7a-ESDM) were used as phagocytic cells. 
They were derived from an ES cell line, GFP#7a, which constitutively expresses eGFP 
(Gilchrist, Ure et al. 2003). The macrophage identity of these cells was confirmed by 
F4/80 and CD11b staining (Figure 7.1 B), and their green fluorescence (FL1 channel) 
was demonstrated in Figure 7.1 C.  
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After apoptotic BL cells and ESDM were co-cultured, aside from the two single 
fluorescence-labelled populations, a third population that was positive for both FL1 
and FL4 was observed. According to the published method, trypsin/EDTA can 
successfully release bound cells from the surface of phagocytes, and therefore the 
double positive cells are predicted to be the macrophages that have engulfed apoptotic 
cells.  
 
7.2 Optimization of ESDM chemotaxis assay 
7.2.1 Inconsistency of ESDM migratory response to C5a  
The results presented in chapter 4 demonstrated that stressed BL cell supernatants 
could release nucleotide to attract THP-1 cells in vitro. However, in order to validate 
the finding, in vitro chemotaxis assay with primary macrophages and in vivo 
experiments have to be performed. ESDM stood out as a primary candidate 
considering their similarity to primary macrophages and feasibility for genetic 
manipulation. After the identification and phagocytic ability of ESDM had been 
appraised, it was important to evaluate their migratory ability using a chemotaxis assay. 
The classical macrophage chemoattractant C5a (Snyderman, Pike et al. 1975) was 
used as a positive control, and chemotaxis assay medium (see Appendix 1) was used as 
a negative control. The same experiment was repeated seven times. However, the 
results were inconsistent, and the ratio of migrated cell number towards positive 
control and towards negative control varied from <1 to 7 (Figure 7.2), indicating that 
ESDM have migratory machinery to respond to C5a. Nevertheless, at least under these 
experimental conditions, the response was very variable. Therefore, measures were 
taken to optimize the chemotaxis assay protocol in an attempt to achieve consistent 




7.2.2 Effect of different pore size on ESDM migration 
responses to C5a 
Published macrophage chemotaxis assays vary widely for the same type of 
macrophages in the choice of membrane pore size between 5μm and 8μm. Thus, in 
order to identify whether pore size was the reason for the above inconsistency, the 
effect of pore size on ESDM migration to C5a was examined. Both 5μm and 8μm pore 
size were assessed (Figure 7.3). However, regardless of the pore size used, the 
migration of ESDM to C5a was not significantly different from the background 
control. The data demonstrated that migration of ESDM to C5a cannot be optimized 
by adjusting membrane pore size. 
  
7.2.3 Effect of CSF-1 starvation on ESDM migration to C5a 
 CSF-1 has been found to be able to mobilize the macrophage cytoskeleton and induce 
rapid behavioural responses (Boocock, Jones et al. 1989). Macrophages stimulated 
with CSF-1 demonstrated migration without directional preferences (which was 
named chemokinesis) in response to linear CSF-1 gradients, however, CSF-1-deprived 
cells can orientate towards the CSF-1 gradient (Webb, Pollard et al. 1996). Given that 
ESDM were derived in an environment rich in CSF-1 (serum and supplemented L929 
CM) for long term, in response to the stimulus of C5a, they might have lost their 
chemotactic ability. Hence, in an attempt to starve them of CSF-1 and enhance their 
sensitivity towards migration signals, ESDM were prepared in assay medium and 
cultured in upper chambers of the transwells for 24 hours. 5μm and 8μm pore sizes 
were assessed. Freshly detached, non-starved ESDM were used for comparison 
(Figure 7.4). The data showed that starved ESDM did not possess better migratory 
ability towards C5a, suggesting CSF-1 was not a significant factor in modulating 
ESDM in this chemotaxis model.  
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7.2.4 Effect of different assay media on ESDM migration 
In most experiments, compared with the response to C5a, ESDM displayed high levels 
of migration to assay medium (control). This can be viewed as lack of a response to 
C5a, or from another perspective, as certain components of the assay medium may 
induce high levels of migration. Considering that the above optimization process did 
not strengthen the response to C5a, assay media were assessed for their ability to 
induce nonspecific chemotaxis responses which potentially masked the response to 
C5a. In order to address this question, another commercial protein-free medium, 
chemically defined hybridoma medium (CD Hybridoma Medium, Invitrogen), was 
assessed in the assay. Meanwhile, given that no protein was present in the assay 
medium and macrophages might be inclined to bind to the membrane nonspecifically, 
causing false high background migration, low endotoxin BSA (0.1% w/v) was added 
to assay medium to see whether BSA can reduce the background migration. Both 5μm 
and 8μm pore size were assessed (Figure 7.5). Compared with assay medium, CD 
Hybridoma Medium induced a higher chemotaxis response, and BSA supplementation 
did not reduce the background, suggesting that of the media tested, the protein-free 































































































  Flow cytometry- based phagocytosis assay was performed to 
examine the phagocytic ability of ESDM.  A) BL2 cells were labeled 
with far-red fluorescent dye DDAO-SE before being treated with UV 
and incubated at 37°C for three hours to induce apoptosis. The 
apoptosis was assessed by AxV/PI staining. The red bar represents 
the early apoptotic population (Annexin V positive and PI negative). B) 
ESDM used in this phagocytosis assay were derived from the 
GFP-expressing mouse embryonic stem cell line, GFP#7a, using the 
same differentiation protocol and their expression of F4/80 and CD11b 
was assessed. C) DDAO-SE labeled apoptotic BL2 cells (UV-BL2) 
were co-cultured with ESDM derived from GFP#7a (GFP 7a-ESDM) 
for 30 mins before being washed and trypsinized for analysis by flow 








































 Chemotaxis assay was performed with 8μm pore size membrane 
transwells. C5a was loaded into lower chambers and incubated at 
37ºC for two hour equilibrium before loading ESDM. C5a (10 ng/ml) 
was positive control; assay media was negative control. Samples were 
analysed in duplicate. The data presented are the mean ratios of 
migrated cell number towards positive control to that of negative 




























 Figure 7.3 Effect of different pore size on ESDM migration in 













 Both 5 μm and 8 μm pore size membranes were assessed in  
chemotaxis assays. The data presented are the mean numbers of 
migrated ESDM per high power field. Error bars indicate SEM. 8 μm 
pore size: n=4; 5μm pore size: n=3; ns: P>0.05 (Mann-Whitney 
test). 
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  Figure 7.4 Effect of CSF-1 starvation on ESDM migration to C5a. 
 
 
 7 day-matured ESDM were detached and seeded into upper 
chambers in assay medium for 24 hour (37ºC, 5%CO2) to starve the 
cells from serum factors before loading C5a in the lower chamber. 
Both 5μm (B) and 8 μm (A) pore size membranes were assessed in 
the chemotaxis assay. Non-starved ESDM were used as a 
comparison. The data presented are the mean numbers of migrated 























































































































 Both 5μm (B) and 8 μm (A) pore size membranes were assessed in 
the chemotaxis assay. CD: Chemically Defined Hybridoma Medium 
(Invitrogen); Control: assay medium; Control +BSA: assay medium 
supplemented with 0.1% low endotoxin BSA. Data are the mean  




7.2.5 Effect of chemoattractant equilibrium on ESDM 
migration  
Conventionally in chemotaxis assays, C5a is added to the lower chambers and cultured 
at 37 C (in a humidified 5% CO2 atmosphere) for an extended period (eg. 2 hours see 
2.21.1) before macrophages are loaded in upper chambers to allow equilibrium 
conditions to be established. However, this allows the possibility that C5a lost some 
activity during the incubation, leading to reduced chemotaxis responses. In order to 
see whether ESDM can migrate to C5a without equilibrium, ESDM were loaded in 
upper chambers immediately after C5a was added. Both 5μm and 8μm pore size were 
assessed (Figure 7.6). In 8μm membrane pore size group, the response to C5a was 
around three times more than the background control, and the trend was reproducible 
in three independent experiments. However, the responses showed wide variation 
between experiments which might be caused by ESDM differences. The results in 
5μm membrane pore size were still inconsistent between three experiments. The data 
suggest that under non-equilibrium conditions and with an 8μm membrane pore size, 
ESDM can display greater migratory responses to C5a. 
 
The optimal conditions for ESDM to migrate towards C5a were selected as follows: 1) 
8μm membrane pore size; 2) serum-free RPMI as assay medium; 3) no starvation 
before the assay; 4) no chemoattractant equilibrium. Therefore, another chemotaxis 
assay was performed using these conditions to validate the protocol and also to 
identify the most potent concentration of C5a to attract ESDM (Figure 7.7). 
Surprisingly, the response to C5a was only slightly higher than the background control, 
and the four different concentrations of C5a showed similar chemoattractant ability. 
This indicated that under certain circumstances, the optimized protocol still generated 




















































































 ESDM were loaded in upper chambers immediately after C5a was 
added in lower chambers. Both 5μm (B) and 8 μm (A) pore size 
membranes were assessed in the chemotaxis assay. The data are 
presented as the mean numbers of migrated ESDM/hpf. The data 




































 The following conditions were used: 1) 8μm pore size membrane 2) 
serum free RPMI as assay medium; 3) ESDM were not starved before 
the assay; 4) no equilibrium was performed before the assay. Four 
different concentrations of C5a were examined. The data presented 
are means of migrated ESDM/hpf. The data are from one 
experiment. 
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7.2.6 Culture detached ESDM in suspension in Teflon pots 
for 24 hours 
The fact that the optimized protocol generated inconsistent results raised doubts about 
its validity. However, although all the above adjustments were made to the protocol, 
the status of the ESDM activation was not assessed. Given that only one out of four 
experiments showed aberrant results, and, on top of that, within the three experiments 
the magnitude of the response was quite different, hence, the variation in ESDM 
activation status might be responsible for the variable chemotaxis results, especially 
the effect of the harsh detachment procedure on the cells. Thus, 24 hours before the 
chemotaxis assay, ESDM were detached from Petri dishes and cultured in suspension 
in Teflon-coated pots with ESDMcult medium. Afterwards, ESDM were harvested from 
suspension culture and used in chemotaxis assays. All the other procedures and 
settings were the same as the optimized protocol described above. A range of classical 
macrophage chemoattractants, including CCL5, VEGF and C5a, were assessed with 
the new method (Figure 7.8). The data demonstrated that ESDM had strong migratory 
responses to C5a and CCL5 in a dose dependent manner and only weak response to 
high concentrations of VEGF. The results were reproducible, suggesting that factors 
associated with detachment of the ESDM had led to the irregular chemotaxis response 
and this effect can be prevented or reversed by 24 hours suspension culture. 
Furthermore, the data confirmed that ESDM had migratory machinery and both C5a 
and CCL5 were their potent chemoattractants. 
 
In order to confirm the response of ESDM to C5a was indeed chemotaxis instead of 
chemokinesis, C5a was placed in the upper chambers (Figure 7.9). The migration 
induced by C5a in upper wells was similar to the background control, demonstrating 
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 Figure 7.8 Chemotaxis assay with ESDM recovered in Teflon 










 One day before the assay, ESDM were detached from Petri dishes on 
day 6 and cultured in fresh ESDMcult in Teflon pots. ESDM harvested 
from suspension culture were used in the chemotaxis assay. A range 
of macrophage chemoattractants (CCL5, VEGF, and C5a) were 
assessed. The data are means of fold increase compared to negative 























































C5a (50ng/ml) was loaded into upper wells to see the chemokinesis 
response. Control: assay medium; C5a in lower wells: positive control. 
Data are the mean numbers of migrated ESDM/hpf±SEM. n=3; 
P<0.05, compared with control (Mann-Whitney test). 
. 
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7.3 Migration of ESDM to stressed BL2 supernatant 
Since stressed BL supernatant has been identified to be chemoattractive for THP-1 
cells, and the chemoattractant was found to be ATP, in order to be able to apply ESDM 
in future macrophage infiltration studies in BL both in vitro and in vivo, it was 
important to assess in the chemotaxis assay the migratory ability of ESDM towards 
stressed BL supernatant. Four different batches of stressed BL2 supernatant were 
examined with C5a as a positive control and assay medium as a negative control 
(Figure 7.10). However ESDM migrated to C5a, but not to any of the four samples.  
 
7.4 Cells from earlier stages of ESDM maturation 
Although the origin of tumour-associated macrophages has not been clearly identified, 
it has been proposed that they were derived from both monocyte extravasation and 
proliferation of in situ macrophages (Gordon and Taylor 2005). Based on the fact that 
ESDM did not migrate to supernatants from stressed BL2 cells, it was hypothesized 
that the ESDM used were matured to a state that they had lost the ability to respond to 
the chemoattractants present in the stress supernatants. During the course of these 
studies, a paper was published describing a similar differentiation system from human 
ES cells, and they identified the progenitor cells in supernatant from adherent 
embryonic bodies as monocytes (Karlsson, Cowley et al. 2008). Therefore, cells were 
harvested and examined from earlier stages of ESDM maturation (Figure 7.11 A). 
ESDM used for previous chemotaxis assay were matured on Petri dishes for 6 days 
and in Teflon pots for one day, hence they were designated ESDM d7. Earlier ESDM, 
which were matured on Petri dishes for 2 days and in Teflon Pots for one day, were 
designated ESDM d3. Non-adherent cells in the supernatant from adherent EBs were 
nominated ESDM d0.  
 
To identify these cells, ESDM d0 and d3 were labeled with the same 
fluorescence-conjugated antibodies used for d7 ESDM (Figure 7.11 B, C). ESDM d0 
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and d3 displayed similar light scatter and antibody staining pattern to that of ESDM d7, 
although with minor variations in fluorescence intensity. The data in one way 
confirmed the myeloid lineage identity of ESDM d0 and d3, considering that both of 
them express F4/80 and CD11b. The similarity in F4/80 antibody staining pattern 
suggested that ESDM d0 are unlikely to be monocytes, since it has been demonstrated 
before that the level of F4/80 expression on monocytes is much lower than that of 
macrophages (Austyn and Gordon 1981; Geissmann, Jung et al. 2003; Gordon and 
Taylor 2005). Thus, the difference in the phenotypes and maturation stages of these 
cells should be characterized further.    
 
7.5 Progressively matured ESDM showed increasing 
phagocytic ability to eat apoptotic BL cells 
It has been shown that freshly isolated human blood monocytes did not phagocytose 
apoptotic cells (Newman, Henson et al. 1982), however, cells gradually acquired this 
capacity as they differentiated and matured into macrophages (Callahan, Halleck et al. 
2003). Thus, phagocytosis assays were performed in order to identify whether ESDM, 
as they gradually matured on Petri dishes, can acquire the capacity to phagocytose 
apoptotic cells. ESDM d0, d3 and d7 were assessed, and cold-shock induced apoptotic 
BL2 cells were used (Figure 7.12). Only one pilot experiment was carried out due to 
time limitations. However, the results demonstrated evidently that ESDM d0 had weak 
phagocytic response, but as ESDM matured, they gradually acquired enhanced 
phagocytic ability to phagocytose apoptotic BL cells, suggesting that ESDM d0, d3 




























































 C5a (50ng/ml) was used as a positive control. Four different batches of 
supernatants from stressed BL2 cells (BL2-1 to BL2-4) were assessed 
for their ability to attract ESDM. C5a: positive control; Control: assay 










Non-adherent cells in supernatant:  ESDM d0
2 days on Petri dish and 1 day in Teflon Pot: ESDM d3




















 A) Schematic demonstrating ESDM d0, ESDM d3 and ESDM d7. 
B)-C) (See the following two pages) Cell scatter and phenotype of 
ESDM d0 and d3 by flow cytometry. Staining of sub-populations 
defined by light scatter was compared.  F4/80-PE, CD11b-PE and 
CD11c-FITC antibodies were used to label the cells. The histograms 
of fluorescent staining were displayed by different gates. Green line: 
unstained cells; red line: Isotype control; blue line: stained with Abs.  
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 Figure 7.12 Progressively matured ESDM showed increasing 










Flow cytometry was used to determine the uptake of apoptotic BL2 
cells by ESDM d0, d3 and d7. The phagocytic co-culture with 
apoptotic BL2 cells was for one hour. The data presented are the 
mean percentages of phagocytosed ESDM in the total ESDM. Alone: 





7.6 Migration of ESDM d0 and d3 to stressed BL2 
supernatants 
Having obtained evidence that ESDM d0 and d3 were from earlier stages of ESDM 
maturation, their migratory ability towards stressed BL2 supernatant was assessed by 
using the same supernatant in the previous ESDM d7 chemotaxis assay (Figure 7.10). 
Both ESDM d0 and d3 migrated consistently to four different batches of stress 
supernatant, and ESDM d0 showed much stronger responses to both C5a and 
supernatants (Figure 7.13). Considering the lack of responsiveness of ESDM d7, the 
results together indicated that ESDM d0 and d3 had greater migratory ability towards 
chemoattractants, especially the ones in stress supernatant, and as they matured, they 
gradually lost this ability. This observation accorded well with previous findings that 
stress supernatants could attract THP-1 cells, which is a human monocytic cell line and 
suggested that the chemoattractants in stress supernatants had cross-species reactivity. 
 
7.7 Migration of ESDM to stressed BL2/bcl-2 
supernatant 
Since stressed BL2/bcl-2 supernatant could attract THP-1 cells, its activity on ESDM 
was also assessed. Stressed BL2 supernatant was used as a comparison (Figure 7.14). 
Similar to the result shown in Figure 7.10 and 7.13, ESDM d0 had the strongest ability 
migrating to C5a and stressed BL2/bcl-2 supernatant, and as cells became more 
mature, they gradually lost the ability. The response to BL2/bcl-2 was similar to BL2, 
further supporting the conclusion that the chemoattractive ability in stress supernatants 





7.8 Migration of day 2 human monocyte-derived 
macrophages (HMDM) to ATP 
In order to confirm in primary cells from a different species that stress supernatant can 
differentially attract macrophages of various maturation stages, responses of human 
monocyte-derived macrophages were studied.  Only one pilot experiment was carried 
out using HMDM matured on Petri dishes for two days with various concentrations of 
ATP as chemoattractants (Figure 7.15). Day 2 HMDM exhibited dose dependent 
migratory response to ATP, even though the response was weak. Further experiments 























































































 Figure 7.13 Migration of ESDM d0 and d3 to supernatants from 






 The same batches of stress supernatants as used in ESDM d7 
chemotaxis assay (Figure 7.10) were applied in this experiment and 
ESDM d0 (A) and d3 (B) were assessed. C5a (50ng/ml): positive 
control; Control: assay medium. The data presented are the mean 



































































































 Supernatants from stressed BL2/bcl-2 cells were used as 
chemoattractants, and supernatans from stressed BL2 cells were used 
as its comparison. ESDM d0 (A), d3 (B) and d7 (C) were assessed. 
C5a (50 ng/ml): positive control; Control: assay medium. The data are 










































 Two days differentiated HMDM on Petri dishes were used in 
chemotaxis assay, and four concentrations of ATP were 
examined. C5a (50ng/ml): positive control; Control: assay 
medium. Data presented are the mean numbers of migrated 
ESDM/hpf. Data from one experiment are presented. 
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Chapter 8 Discussion 
 
8.1 Summary of results 
Although mostly obtained using an in vitro model, results from this study suggest that 
stressed, pre-apoptotic Burkitt’s lymphoma cells could contribute to tumour 
micro-environmental conditioning by regulating immune cell infiltration as well as 
direct trophic effect on other viable tumour cells and possibly stromal cells. High 
density stress in which glucose was rapidly consumed could trigger BL2 cells to 
undergo apoptosis. Cell-free stress supernatants harvested from high density stressed, 
pre-apoptotic BL2 cells could selectively regulate immune cell infiltration, 
specifically, recruit mononuclear phagocytes but inhibit neutrophil infiltration, 
suggesting that under stress, pre-apoptotic cells may have already started to generate 
signals that prelude their imminent demise. Analysis of the chemoattractive ability of 
stress supernatants for THP-1 cells by enzyme digestion and antagonist blockade 
suggested a role of nucleotides in the recruitment process of THP-1 cells. Since ATP 
and UTP have been identified as mononuclear phagocyte chemoattractants released 
from apoptotic cells (Elliott, Chekeni et al. 2009), and ATP is one of the nucleotides 
most studied in its role in immune cell migration, the possible role of ATP in stress 
supernatants as a chemoattractant was investigated further. This study indicated that 
ATP could be one of the chemoattractants for mononuclear phagocytes released from 
stressed cells; however, the mechanisms of ATP release under stress have not been 
identified. Furthermore, ATP was shown to activate neutrophil migration and the fact 
that stress supernatants which contained ATP, paradoxically, inhibited neutrophil 
chemotaxis, demonstrating the possible presence of potent ‘keep-out’ signals.  These 
signals were not identified.  
 
The stress supernatants could also promote the survival and proliferation of both 
tumour cells and mononuclear phagocytes, demonstrated that stressed BL2 cells may 
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have direct trophic effects on other cells in the environment. This effect was not 
contact-dependent. The identity of the bioactive factor(s) in stress supernatants was 
sought and several candidate factors were examined, including ATP, lactoferrin and 
S1P, however none of these had the appropriate properties. The identification of the 
heat-stable bioactive factor requires further investigation.  
 
The possible association of the above micro-environmental conditioning effects with 
the spontaneous apoptosis in BL2 cells was excluded by studying responses of BL2 
cells which over-expressed bcl-2 and therefore had inherent resistance to spontaneous 
apoptosis. Supernatant harvested from stressed BL2/bcl-2 cells demonstrated similar 
micro-environmental conditioning effects as unmodified BL2 cells, including 
regulating immune cell infiltration as well as a direct trophic effect. However, the 
question as to how the release of nucleotides and the unidentified bioactive factor(s) 
from pre-apoptotic BL2 cells was coupled with the intracellular pre-apoptosis program 
has not been answered.  
 
On the other hand, an optimal protocol which can effectively generate relatively pure 
macrophages from murine embryonic stem cells was established. The purity of ESDM 
was assessed by morphology and macrophage markers as well as self-renewal assay 
which excluded the possible contamination by undifferentiated ES cells. ESDM 
exhibited the ability to migrate to pre-apoptotic cells and to phagocytise apoptotic cells; 
therefore, they and their genetically manipulated forms can be applied to studies of 
migration to apoptotic cells and clearance of apoptotic cells and their molecular 
mechanisms. Furthermore, gradual changes in the chemotaxis and phagocytosis ability 
of ESDM as they matured were observed. Mature ESDM were better at phagocytosing 




8.2 Roles of ATP in the tumour microenvironment 
8.2.1 Effect of ATP on immune cell migration 
8.2.1.1 ATP as an extracellular signalling molecule 
ATP is well known for its function as a fundamental intracellular component which 
serves not only as energy currency to sustain the cell’s viability and functions but also 
as basic building blocks for the synthesis of DNA and RNA. However, ATP also 
functions as an extracellular signalling molecule in purinergic signalling, in both an 
autocrine and paracrine manner thereby playing an important role in modulating 
cellular functions in both the immune system and cancers (Burnstock, Fredholm et al. 
2010).  
 
Released ATP can be rapidly hydrolysed to AMP, ADP and adenosine by four 
categories of ectonucleotidases involved in purinergic signalling (Yegutkin 2008) 
(Table 8.1). However, the expression pattern of the ectonucleotidases varies between 
cell types thereby defines the different ATP metabolism and signalling mechanisms of 
each cell type.  
 
Extracellular ATP and its metabolites exert a wide range of cellular effect through 
different receptors.  Two types of purinergic receptors have been cloned and 
characterised: 1) P1 receptors are G protein-coupled receptors (GPCRs) and selective 
for adenosine binding with four subtypes (A1, A2A, A2B and A3); 2) P2 receptors are 
selective for ATP and ADP and some of them also bind to UTP or UDP. Two types of 
P2 receptors are distinguished: P2X receptors are ATP-gated ion channels with seven 
subtypes (P2X1-7) and P2Y receptors are GPCRs with eight subtypes (P2Y1, P2Y2, 
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8.2.1.2 Effects of ATP on macrophage migration 
Monocytes/macrophages have machinery for both autocrine and paracrine purinergic 
signalling. Multiple P2 receptor subtypes are expressed on monocytes and 
macrophages, including P2Y1,2,4,6,11,12 and P2X1,4,5,7. P2Y13 is only expressed on 
monocytes. The expression and activity of ectonucleotidases, including CD39 and 
CD73 are also detected on monocytes and macrophages (Koziak, Sevigny et al. 1999; 
Beigi and Dubyak 2000). The role of ATP as a chemoattractant has been studied 
widely (Bours, Swennen et al. 2006), but this remains controversial. In this study, ATP 
was demonstrated to induce the chemotaxis not chemokinesis of THP-1 cells and the 
optimal concentration to induce migration was 0.9 μM. A higher concentration of ATP, 
such as 90 μM, did not induce a chemoattractive response (Figure 4.1). The result is 
consistent with the findings of Elliott et al. (Elliott, Chekeni et al. 2009). They 
demonstrated that ATP is a chemoattractant released from apoptotic cells for 
mononuclear phagocytes in a dose-dependent manner in vitro and the optimal 
concentration was 0.1μM. Checkerboard experiments in which equal concentrations 
of ATP are added to both sides of the chamber induced no migration therefore 
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excluded the possibility of random migration without direction, namely chemokinesis. 
The effect of ATP as a chemoattractant for mononuclear phagocytes released from 
apoptotic cells was also proved in an in vivo air punch model. The involvement of ATP 
receptor P2Y2 was demonstrated both in vitro knock-down by shRNA and in vivo by 
using P2Y2-/- mice.   
 
However, one study (Kaufmann, Musset et al. 2005) concluded differently. These 
authors showed that ATP only induced human monocyte migration within the 
concentration range of 10-100μM, which was found to induce little or no response of 
migration in the present studies and those of Elliott et al (2009). Kaufmann et al also 
performed a checkerboad analysis and a similar migratory effect was observed, 
suggesting a chemokinesis effect. Kaufmann et al also analysed the intracellular 
signalling of the migratory response by measuring the level of phosphorylated Akt.  
Unlike the increased level of phosphorylated Akt in fMLP-induced monocytes which 
showed a chemotaxis response, there was no increase in the level of phosphorylated 
Akt in samples treated with ATP. Phosphoinositide 3-kinase γ (PI-3Kγ) is well known 
to be essential for neutrophil and macrophage migration and deficiency of PI-3Kγ 
leads to a reduced migratory ability (Hirsch, Katanaev et al. 2000; Li, Jiang et al. 2000; 
Sasaki, Irie-Sasaki et al. 2000).  Further studies revealed that G-protein coupled 
PI-3Kγ, which activates Akt by generating phosphatidylinositol 3,4,5-triphosphate, is 
essential for the directional orientation of neutrophils rather than the rate of migration, 
during their response to fMLP (Hannigan, Zhan et al. 2002). This led to the conclusion 
that ATP only induced non-directional migration of human monocytes. However, 
although PI-3K played an essential role in neutrophil chemotaxis, no studies have 
directly shown that PI-3K is important for the directionality of macrophage 




Another level of complexity of the relationship between ATP and macrophage 
migration was added by the discovery that macrophage chemotaxis required a 
navigational system depending on the autocrine ‘purinergic feedback loops’ of 
macrophages both in vitro and in vivo (Kronlage, Song et al. 2010). In response to the 
chemoattractant C5a, macrophages released ATP, and this, together with its 
metabolites activated subsequent multiple components of purinergic signalling, 
including P2Y2 (receptor for ATP), P2Y12 (receptor for adenosine diphosphate, ADP) 
and A2a, A2a, and A3 (receptors for adenosine) which were all required for effective 
chemotactic navigation. Pannexin 1 which was the channel responsible for ATP 
release from neutrophils in their autocrine navigational system was not responsible for 
autocrine ATP release in macrophages (Chen, Corriden et al. 2006). This finding is 
consistent with the previous observation that macrophage migration in vivo and in 
vitro was impaired in CD39-null mice which disrupted the metabolism of ATP, an 
essential component in ‘purinergic feedback loops’ required by the chemotaxis process 
(Goepfert, Sundberg et al. 2001).  The study was consistent with data from the present 
work which showed the treatment of CCL2 with apyrase, which potentially interrupted 
the autocrine purinergic signalling, could cause some reduction in macrophage 
chemotaxis, although a substantial chemotaxis response could still be observed 
(Figure 4.3).  
 
ATP might therefore still be a chemoattractant for mononuclear phagocytes despite all 
the complexity and controversy. However, since the in vitro data was generated using a 
Boyden chamber, considering the complexity of the interpretation, a direct 
microscopy-based chemotaxis assay in which macrophage directional migration and 
velocity could be recorded in real-time, as has already been applied to studies of 
neutrophil chemotaxis, could be adopted for further macrophage chemotaxis studies 
(Chen, Corriden et al. 2006). The data generated would help distinguish chemotaxis 
from chemokinesis more directly. In addition, since macrophage chemotaxis requires 
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autocrine ATP signalling for navigation, data from experiments using apyrase 
treatment or ATP receptor gene knock-out cells must be carefully examined before the 
role of ATP as a chemoattractant can be confirmed.  
 
Another question remained to be answered is whether ATP is a short-range or 
long-range chemoattractant in vivo. ATP receptors and ectonucleotidases are widely 
distributed on almost all cells, despite of the different combinations of expression. As 
ATP is released, it can be rapidly hydrolysed by ectonucleotidases nearby in a stepwise 
manner, from ADP, AMP to adenosine. The instability of ATP indicates that it might 
not be functional over long-range. However, ATP can still function as a long-range 
chemoattractant if the released ATP is enclosed in exocytosis vehicles. Enclosed ATP 
can be carried over long distance and gradually release ATP, consequently forming an 
ATP gradient. Although the data presented in this study suggested that the release of 
ATP was independent of microparticles with sizes smaller than 0.22 μm in diameter, 
recent investigations have indicated that the diameter of the microparticles released 
from apoptotic BL cells can be up to 1 μm (Pasikowska 2010). Therefore, improved 
methods to isolate the whole population of microparticles in sterile condition should 
be adopted in order to examine the possibility of ATP release through microparticles. 
Another point to bear in mind is that ATP is present in blood. Although different 
methods vary widely in their estimates of blood ATP concentration: values from 28 
nM to 11,000 nM have been reported (Gorman, Feigl et al. 2007), it remains unknown 
whether the concentrations of ATP released from stressed cells could successfully 
establish a chemoattractant gradient.  
 
Another possibility is that since fractalkine can be released from apoptotic BL cells 
and its release is microparticle-associated, fractalkine can be the long-range 
chemoattractant while ATP functions as a short-range chemoattractant in BL 
microenvironment. Although ATP has been identified as a chemoattractant for 
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mononuclear phagocytes, another possibility should not be overlooked. It has been 
shown that activation of P2Y6 on human promonocytic cell line U937 could induce 
the release of MCP-1, which is a well-established mononuclear phagocyte 
chemoattractant, suggesting that it is likely that ATP could also be an inducer for a 
chemoattractant for mononuclear phagocytes to be released (Cox, Gomes et al. 2005). 
 
8.2.1.3 Effects of ATP on other immune cell migration 
The data presented also suggested ATP, especially at relatively high concentrations 
(9-90μM) - which exceed the amount of ATP contained in stress supernatants, could 
induce neutrophil migration in vitro (see Figure 4.7). ATP is known to be a ‘danger 
signal’ to recruit immune cells, such as neutrophils, when large amount of ATP, around 
5mM to 10 mM, was suddenly released from damaged cells, thus inducing 
pro-inflammatory cell infiltration. The regulation of cell migration by ATP has been 
observed in various immune cells, such as mast cells (McCloskey, Fan et al. 1999), 
dendritic cells (Liu, Bohlen et al. 1999; Schnurr, Toy et al. 2003), eosinophils (Muller, 
Robaye et al. 2010) and natural killer cells (Gorini, Callegari et al. 2010). However, 
the role of ATP in neutrophil migration will be focused on here. 
 
The ATP receptors expressed on neutrophils include P2Y1,2,4,6,11,14 and P2X1,4,5,7. They 
also express CD39 and CD73. Thus, neutrophils can respond to and hydrolyse ATP. 
On the other hand, neutrophils can release ATP during inflammation (Bours, Swennen 
et al. 2006). Therefore, the functions of neutrophils can be regulated by ATP in both 
paracrine and autocrine manner. Evidence from in vitro studies suggested that ATP can 
stimulate neutrophil adherence to endothelial cells (Rounds, Likar et al. 1999). In vivo 
study confirmed that ATP could enhance the adherence of neutrophils to blood vessels 
in the initial stage of inflammatory response and increase the number of recruited 
neutrophils (McDonald, Pittman et al. 2010). However, the question whether 
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extracellular ATP functions as a neutrophil chemoattractant has not yet been answered 
unequivocally. Different observations have been described in different models. For 
example, instead of affecting migration, 0.3 μM ATP induces only the aggregation of 
rat neutrophils (Ford-Hutchinson 1982). Micromolar concentrations of ATP were  
found to inhibit rabbit neutrophil chemotaxis induced by fMLP (Elferink, de Koster et 
al. 1992). ATP analogue, ATPγS, induced human neutrophils chemotaxis and actin 
polymerization (Verghese, Kneisler et al. 1996). However, recent studies indicated that 
ATP could induce neutrophil chemokinesis and autocrine signalling of ATP induced by 
chemotactic stimulus (such as fMLP) was essential in facilitating the migratory 
response of human neutrophils (Chen, Corriden et al. 2006). The function of ATP as a 
neutrophil chemoattactant has not yet been established, however, the mechanism of 
ATP autocrine signalling in promoting chemotaxis has been characterised. ATP can be 
released near the activated chemoattractant receptors and either activate its receptor 
P2Y2, or be hydrolyzed by membrane CD39 and alkaline phosphatases (AP) into 
adenosine which further activates A3 receptors at the leading edge. These activated 
P2Y2 and A3 receptors can enhance the mobilization of cellular skeleton in the 
migratory response and therefore facilitate the chemotaxis response towards the 
chemotactic source (Corriden, Chen et al. 2008). The common requirement of 
autocrine purinergic signalling for the navigation of macrophage and neutrophil 
chemotaxis suggests that there might be a common mechanism of navigational 
mechanism present for immune cell migration.  
 
8.2.1.4 Chemoattractants released during different stages of 
apoptosis 
Multiple chemoattractants have been reported to be released from apoptotic cells 
before loss of cellular integrity, but little is known about the stage of apoptosis. 
However, several studies have revealed the association between chemoattractant 
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release and apoptosis program. LPC is released as a ‘find-me’ signal for mononuclear 
phagocytes from apoptotic MCF-7 breast cancer cells (from other apoptotic cells as 
well but with less characterisation) and the release of this soluble lipid mediator is 
dependent on capase-3 cleaved calcium-independent phospholipase A2 (Lauber, Bohn 
et al. 2003). ATP as a mononuclear phagocyte chemoattractant can be released from 
apoptotic cells through pannexin 1 channels, and the opening of these channels is 
dependent on caspase-3, and caspase-7 cleavage (Elliott, Chekeni et al. 2009; Chekeni, 
Elliott et al. 2010). However, the release of other chemoattractive molecules, such as 
S1P, S19, EMAPII, fractalkine, is only described as release from apoptotic cells 
(Shalak, Kaminska et al. 2001; Yamamoto 2007; Gude, Alvarez et al. 2008; Truman, 
Ford et al. 2008). In this study, it has been demonstrated that the release of ATP is from 
pre-apoptotic cells and independent of apoptosis, therefore, clearly defined the stage of 
‘find-me’ signal release, although the releasing mechanism of ATP under stress has not 
been confirmed. But the question whether and how ATP release from pre-apoptotic 
cells under stress is coupled to any components in apoptosis program is intriguing.  
 
8.2.2 Multiple roles of ATP in the tumour 
microenvironment 
8.2.2.1 Direct effects of ATP on tumour cells 
It has been shown in human glioma cells that 100μM ATP could significantly promote 
their proliferation (Rathbone, Middlemiss et al. 1992; Morrone, Jacques-Silva et al. 
2003). However, in my study, different concentrations of ATP (from 0.09 μM to 90μM) 
were examined to see their proliferative effects on BL2 cells; however, ATP did not 
show any direct effect on BL2 cell proliferation, indicating the direct tumour growth 
promoting effect of ATP does not apply to all the tumour models. However, the 
possible roles of ATP on tumour cells should not be ignored. The extracellular 
concentration of ATP can be highly elevated in tumours compared with normal tissues, 
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whose near to plasma membrane concentrations of extracellular ATP under resting 
condition are only within a 1 to 10 nanomolar range. ATP concentrations in the 
interstitium of various tumours have been reported to be in the hundreds of 
micromolar range using a chimeric plasma membrane-luciferase assay (Pellegatti, 
Raffaghello et al. 2008). Thus, elevated extracellular ATP in tumours may be 
associated with tumourigenesis. For example, human fibrosarcoma cells could release 
ATP to induce the upregulation of intracellular calcium level in endothelium cells 
which is an important intracellular regulator in the endothelial cells invasion and 
metastasis (Nejime, Tanaka et al. 2008).  
 
Another indirect mechanism of tumour promotion involving ATP signalling was 
relevant to one of ATP receptors, P2X7. It is known that very high concentrations of 
extracellular ATP, for example, more than 1mM, have cytotoxic effect both in normal 
tissues and malignancies, involving the activation of P2X7 receptor (Wang, Wang et al. 
2004; Zhang, Meng et al. 2009). However, the level of P2X7 is found significantly 
lowered in different types of cancer cells compared to their normal counterparts (Li, 
Zhou et al. 2006), suggesting a tumour protective mechanism.   
8.2.2.2 Effects of ATP on tumour-associated macrophages 
As a ‘find-me’ signal released from pre-apoptotic cells, ATP has a broader potential to 
regulate TAM than simply being a chemoattractant. The qualitative effect of ATP on 
macrophages is concentration dependent. High concentrations of ATP (ATP at 
millimolar concentration) stimulate monocytes/macrophages to release 
proinflammatory cytokines, such as IL-1α, IL-18 and TNF-α and the effect is 
suggested to be mediated by P2X7 receptor (Bours, Swennen et al. 2006). Low to 
medium concentrations of ATP has immunomodulatory or immunosuppressive effects 
on macrophages. It has been reported that pre-treatment of peritoneal macrophages 
with 100 μM ATP could significantly reduce the amount of IL-12 and TNF-α released 
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upon LPS stimulation (Hasko, Kuhel et al. 2000), while 0.1 to 1 mM ATP significantly 
reduced the production of IL-12p40 and TNF-α in LPS-primed human alveolar 
macrophages (Myrtek, Muller et al. 2008).  Also, Kaufmann et al., (2005) have 
reported that 10 -100μM ATPγS, which is a P2Y2 antagonist, profoundly inhibited 
secretion of proinflammatory cytokines (TNF-α and MCP-1) from classically 
activated human monocytes, but increased production of IL-10, an anti-inflammatory 
cytokine (Kaufmann, Musset et al. 2005). In LPS stimulated human whole blood, 100 
μM and 300 μM ATP inhibited the release of TNF-α but increased IL-10 release, and 
thereby had an  anti-inflammatory effect (Swennen, Bast et al. 2005). The 
anti-inflammatory effect was not affected by treatment with adenosine deaminase, 
suggesting the effect was not due to adenosine derived from ATP degradation. 
Although the concentration of ATP in the tumour microenvironment has not been 
measured directly in BL, in other tumours concentrations in the hundreds of 
micromolar range have been reported.  This suggests ATP is capable of driving 
recruited mononuclear phagocytes into an M2, ‘anti-inflammatory’ phenotype.  
 
ATP has been reported to enhance the phagocytosis of latex beads by macrophages 
(Ichinose 1995). Recent studies indicate that exogenous ATP could enhance the 
binding of macrophages to apoptotic cells (Marques-da-Silva, Burnstock et al. 2011). 
Thus it has been speculated that ATP could also enhance the phagocytosis of apoptotic 
cells by recruited macrophages in BL microenvironment. Either purified ATP or 
supernatants from stressed BL cells could be examined for their ability to change the 
functional capacities of macrophages. Finally, adenosine, a metabolite of ATP whose 
functions are beyond the scope of this study, could as well enhance the macrophage 
phagocytosis ability and tune macrophage into M2 phenotype (Hask, Pacher et al. 
2007). Therefore, the early release of ATP from stressed tumour cells could contribute 
to the macrophage polarization for subsequently clearance of apoptotic cells and 
pro-tumour functions which thereby conditions the tumour microenvironment.  
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8.2.2.3 Identified roles of ATP in regulating immune responses 
Large amount of ATP released from damaged cells is well recognized as a ‘danger 
signal’ which can activate NOD-like receptor family, pyrin domain containing 3 
(NLRP3) inflammasomes in immune cells to induce inflammatory responses, 
including neutrophils, macrophages and dendritic cells (Di Virgilio 2005; Schroder 
and Tschopp 2010). Nevertheless, the immune regulatory effect of ATP is complicated, 
and it has been suggested that the effect can be immuno-stimulatory or 
immune-suppressive depending on the concentration of ATP and the components of 
purinergic signalling in the environment (Boeynaems and Communi 2006). One 
theory was proposed that ATP played distinct roles at three stages of the inflammatory 
response (Bours, Swennen et al. 2006). In the first stage, large amount of ATP is 
released from damaged cells, which recruits leukocytes to damaged sites and initiate 
immune response, including inducing inflammatory activation of neutrophils and 
macrophages, maturation and Th1 cell-stimulatory ability of DCs, and proliferation 
and activation of lymphocytes. In the second stage, ATP is partially hydrolyzed by 
ectonucleotidases; therefore only low concentrations of ATP and accumulating 
adenosine are present in the environment. Low concentrations of ATP - by activating 
P2Y receptors - plays an immunomodulatory role by inhibiting TNFα release and 
stimulating IL-10 release. On the other hand, adenosine which activates P2 receptor 
contributes to down-regulating the inflammatory response stimulated in the first stage. 
At the final stage, extracellular adenosine becomes the key factor in the process of 
immunosuppression and tissue healing. The expression of P1 receptors is up-regulated 
during the inflammatory response which subsequently enhances the 
immunosuppressive effect of adenosine. This hypothesis was supported by 
accumulated evidence (Di Virgilio, Boeynaems et al. 2009) and is consistent with the 
observations of macrophage responses to ATP. Considering the concentrations of ATP 
likely to be found in many tumours, the major influence of ATP on the tumour 
microenvironment would be predicted to be one of immunosuppression.  
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8.3 Trophic effects of stressed tumour cells   
8.3.1 Further characterization of the bioactive factor 
Although S1P appeared promising as a candidate for the bioactive factor in stress 
supernatants, it could not be detected by ELISA. However this indicates that S1P was 
not present in soluble form. It is possible that S1P occurs in association with 
microparticles which, depending on their size were not retained in supernatants under 
the conditions studied. This requires investigation. 
 
Although displaying mitogenic effect, stress supernatants did enhance the viability of 
BL2 cells within the first 24 hours. Since group I BL cells tend to undergo apoptosis in 
sub-optimal conditions, such as in reduced concentrations of FCS (Gregory, Dive et al. 
1991), the bioactive factor in the supernatant could possibly function as a survival 
factor as well as a mitogen (Collins, Perkins et al. 1994). The nature of the stimulation 
could be determined by analysing various relevant parameters of apoptosis in cells 
triggered by an inducer of apoptosis such as staurosporine, compared with cells 
pre-treated with supernatants from stressed BL cells. Several parameters could be 
measured, including caspase-3 activity, the level of bcl-2 and phophorylated-Bad.  
 
The identification of bioactive factor with mitogenic effect should be performed 
further. Knowing that the factor is heat-stable, further investigation into its identify can 
be performed using proteinase K, DNase, or RNase to characterise it as being protein, 
DNA or RNA respectively. Extraction of stress supernatant with an organic solvent 
such as chloroform, could be informative as to the possible lipid nature of the factor. In 
addition, the molecules in stress supernatant could be analyzed by high-performance 
liquid chromatography or mass spectrometry in order to create a short-list of candidate 




8.3.2 Direct trophic effects of stressed tumour cells 
Data presented here demonstrated direct trophic effects of stressed, pre-apoptotic 
tumour cells on other viable tumour cells, as well as mononuclear phagocytes. Similar 
direct trophic effects were demonstrated in vivo in 1956 when it was shown that 
lethally damaged tumour cells by X-ray irradiation could promote tumourigenesis and 
progression in a mouse model (Revesz 1956). However, no mechanism has been 
reported to account for this observation. Nevertheless, as mentioned in the 
introduction, a similar phenomenon was observed in Drosophila (Fan and Bergmann 
2008). Stress or damage induced apoptosis could trigger the proliferation of remaining 
cells which was termed ‘apoptosis-induced compensatory proliferation’. Drosophila’s 
initiator caspase, Dronc and effector caspases DrlCE and Dcp-1 were found related to 
this compensatory effect but the mechanism was not completely understood. 
Interestingly, one study into the mechanism of compensatory proliferation indicated 
that under the circumstances of loss of one copy of dronc gene, effector caspases can 
still be activated, but the compensatory proliferation effect was significantly 
suppressed (Wells, Yoshida et al. 2006), suggesting that initiator caspase Dronc was 
more important than executing apoptosis program for the effect.  
 
This finding is to some extent similar to the finding in the high density stress model 
reported here. The fact that supernatants from stressed, pre-apoptotic BL2 cells which 
were shown induced to undergo apoptosis when subsequently returned to low cell 
density culture (Figure 3.3) could promote growth indicated that the release of the 
bioactive factor(s) was independent of the complete execution of apoptosis program. 
Furthermore, supernatants from stressed BL2/bcl-2 cells, which were shown not to be 
induced to undergo apoptosis when subsequently returned to low density culture 
(Figure 3.4), exhibited similar growth promoting effects as stressed BL2 cells (Figures 
5.4 and 5.6). This indicates that the release of the bioactive factor(s) was a process 
which functioned independently of bcl-2 protein. The release might be coupled to the 
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events upstream of bcl-2 protein in mitochondria-dependent apoptotic pathway or 
coupled to other mitochondria-independent apoptotic pathway if the release is 
apoptosis-related. Nevertheless, this direct trophic effect of stressed tumour cells 
might be a compensatory growth regulatory mechanism for stress- or damage-induced 
cell loss in normal tissue development which stressed tumour cells can harness to 
promote tumour growth.  
 
8.3.3 Multiple signals act in concert to condition the 
tumour microenvironment in BL 
This study demonstrated a selective recruitment of immune cells by stressed, 
pre-apoptotic Burkitt’s lymphoma cells, in which mononuclear phagocytes were 
attracted but the migration of neutrophils was inhibited. ATP, which is present in stress 
supernatants, is likely to be the chemoattractant responsible for the mononuclear 
phagocyte recruitment, ‘find-me’ signal. Although it has not been determined whether 
ATP induces chemotaxis or chemokinesis, it has been shown to activate the migration 
of the neutrophils as discussed above. The presence of a neutrophil migration 
inhibitory factor or factors was demonstrated in stress supernatants but was not 
identified. It might be one of the identified neutrophil migration inhibitory factors, 
such as lactoferrin (Bournazou, Pound et al. 2009) and netrin-1 (Ly, Komatsuzaki et al. 
2005).  
 
The fine balance of ‘find-me’ and ‘keep-out’ signals released from pre-apoptotic cells 
is reminiscent of similar mechanism of apoptotic cells, since it has been demonstrated 
that apoptotic BL cells can also release ‘find-me’ and ‘keep-out’ signals, fractalkine 
and lactoferrin, respectively (Truman, Ford et al. 2008; Bournazou, Mackenzie et al. 
2009; Bournazou, Pound et al. 2009). The release of molecules with similar effects at 
an earlier stage emphasized the importance of timing in selectively recruiting immune 
cells and further microenvironmental conditioning.  
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Since ATP can drive macrophages towards an anti-inflammatory, M2 phenotype and 
enhance their phagocytic ability, the early release of the ATP-dependent ‘find-me’ 
signal(s) can begin the polarization of macrophages during their migration and ensure 
the prompt clearance of apoptotic cell debris and the subsequent immune-suppressive, 
pro-tumour functions. Furthermore, macrophages have been shown with the capability 
to influence cell fate of survival or death. Classically activated macrophages, primed 
by IFN-γ and LPS exhibited ability to induce apoptosis and inhibit mitosis in 
mesangial cells (Duffield, Erwig et al. 2000). In the nematode Caenorhabditis elegans, 
engulfing cells were found essential in triggering apoptosis (Hoeppner, Hengartner et 
al. 2001; Reddien, Cameron et al. 2001). Previous work has demonstrated that IL-10 
activated macrophages could secrete tumour cell growth/survival factor BAFF (B 
cell-activating factor of the TNF family) (Ogden, Pound et al. 2005). Since ATP was 
released from pre-apoptotic cells whose fate has not yet been decided, recruited 
macrophages might play an important role in affecting the fate of stressed, 
pre-apoptotic cells therefore regulating the balance of cell birth and death in the 
tumour microenvironment. However, further experiments are required to validate this 
speculation. Nevertheless, these effects, together with the direct trophic effect of 
stressed tumour cells demonstrated that pre-apoptotic BL cells can contribute to 
conditioning the tumour microenvironment in favour of tumour growth.   
 
It is possible that the death of some tumour cells may benefit the tumour as a whole 
(Gregory and Pound 2010; Gregory and Pound 2011). Signals from pre-apoptotic and 
apoptotic BL cells may work in concert to create a pro-tumour microenvironment. 
Understanding the microenvironmental conditioning signals in tumours, has value in 
targetting therapy but also has broader implications for medicine. Considering the 
important tumour-promoting functions of TAM, ‘find-me’ signals for TAM provide 
promising targets for the development of antagonists to disrupt their recruitment and to 
weaken environmental support for tumour growth. Similarly, bringing in neutrophils 
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and eosinophils into tumour sites by neutralising ‘keep-out’ signals, such as lactoferrin, 
might induce inflammatory immune response leading to tumour distruction. 
Furthermore, failed clearance of apoptotic cells has been shown to elicit inflammatory 
immune responses which are responsible for some autoimmune diseases, such as 
systemic lupus erythematosus (SLE) (Gaipl, Munoz et al. 2007; Nagata, Hanayama et 
al. 2010). Therefore, blockade of the phagocytosis process in an attempt to invoke 
anti-tumour immune responses provides a therapeutic target which can be achieved by 
masking ‘eat-me’ signals on apoptotic cells using specific antibodies. One example is 
the blockade of PS which has already been demonstrated to induce tumour regression 
(Bondanza, Zimmermann et al. 2004). It is possible that this approach might be 
valuable in treatment of some autoimmune diseases. Since decreased phagocytic 
ability of macrophages as well as reduced levels of macrophage attraction signals were 
found associated with SLE, agonists that can enhance the engulfing ability of 
macrophages or agonists that can attract macrophages are also promising valuable 
therapeutic targets for treatment of SLE.  
 
8.4 The nature of high density stress 
8.4.1 Mechanism of high density stress  
8.4.1.1 Main stressors in high density stress 
Having excluded hypoxia as a stressor in the high density model, glucose level was 
measured to investigate whether glucose deprivation could be the stressor. The glucose 
level dropped rapidly during the first hour, and it was almost completely depleted by 4 
hours, suggesting limitation of glucose supply to large numbers of cells. On the other 
hand, glucose deprivation could explain well the non-apoptotic cell death during 
longer stress, since apoptosis is an ATP-dependent process and lack of ATP could 
switch apoptosis to necrosis (Leist, Single et al. 1997). The induction of apoptosis after 
stressed cells were cultured at lower density in fresh media with sufficient glucose 
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therefore adequate energy supply was consistent with this interpretation. However, 
glucose-free media or glucose metabolism inhibitors, such as 2-deoxyglucose, could 
be applied in this model in order to confirm the inducing effect of glucose deprivation 
on BL2 cell apoptosis. Alternatively, the presence of glucose deprivation could be 
examined by measuring AMP-activated protein kinase (AMPK), whose activation can 
be induced by glucose-deprivation for temporal protection (Kato, Ogura et al. 2002; 
Priebe, Tan et al. 2011). 
 
Another possible contributor in the high density stress model is oxidative stress. 
During high density stress, while glucose is rapidly consumed, toxic metabolites, such 
as reactive oxygen species (ROS), are generated. Glucose deprivation is a trigger to 
induce oxidative stress and transformed human cell types have been found to be more 
sensitive to glucose deprivation induced oxidative stress than are healthy cells (Spitz, 
Sim et al. 2000). ROS can damage most of the biological macromolecules, including 
proteins, nucleic acids and lipids (Ott, Gogvadze et al. 2007). When ROS-induced 
damage reaches a critical point various modes of cell death, including apoptosis, 
autophagic cell death, might be induced depending on the intensity of the stress (Chen, 
McMillan-Ward et al. 2007; Orrenius, Gogvadze et al. 2007). However, the presence 
of oxidative stress has to be proved and can be achieved by either measuring the 
damage to the macromolecules or measuring the intracellular antioxidant level.    
8.4.1.2 Cellular stress responses 
In order to investigate the mechanisms of the stress response after high density culture, 
protein levels of molecular chaperones Hsp27, Hsp70 and Hsp90 were examined by 
western blot. There was no change in the protein levels of Hsp70 and Hsp90, 
indicating that these two molecular chaperones were not induced by high density stress 
therefore no protective effect from them. But the protein level of Hsp27 decreased as 
stress continued. Interestingly, Hsp27 has been found to translocate into the nucleus 
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from the cytoplasm in response to stress and thereby become detergent insoluble 
(Arrigo, Suhan et al. 1988), which might explain the reduction in the expression level 
of Hsp27 since whole cell lysates were applied in the assay . However, in order to 
examine this interpretation, separate extraction and analysis of nuclear and 
cytoplasmic proteins must be performed.   
 
Another molecule that should be examined in order to understand the cellular stress 
response in the high density model is p53, which is a key factor regulating cellular 
response to glucose deprivation and oxidative stress (Vousden and Ryan 2009). 
Glucose deprivation induces the activation of AMPK which subsequently activates 
p53. Activated p53 then performs multiple functions to sustain cell survival under 
stress, including cell cycle arrest at G1/S boundary by activating p21, proliferation 
inhibition by inhibiting Akt, growth inhibition but autophagy promotion by inhibiting 
mTOR. Under low level of oxidative stress, p53 can create an anti-oxidant 
environment by activating Sestrins, TP53-induced glycolysis and apoptosis regulator 
(TIGAR) and tumour protein p53-inducible nuclear protein 1 (TP53INPI), therefore 
lead to cellular protection and survival.    
 
Another response that might occur in the system is the unfolded protein response 
(UPR) which results from the accumulation of unfolded proteins in the endoplasmic 
reticulum (ER stress) (Schroder and Kaufman 2005; Ron and Walter 2007). UPR can 
subsequently activate ER resident proteins, such as inositol-requiring protein-1 (IRE1), 
protein kinase RNA-like ER kinase (PERK) and activate transcription factor 6 (ATF6) 
to transmit the stress signal. Since glucose starvation can induce UPR and UPR has 
been found to promote cell survival by secreting trophic factors (Tamatani, 
Matsuyama et al. 2001), UPR might be the key mediator of signal pathways induced 
by high density stress. However, further experiments measuring the activation of UPR 
targets, such as sXBP1 mRNA (a key marker for IRE activation)  and the 
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translocation of ATF6a from the ER to the nucleus, are required in order to examine 
the contribution of UPR in high density stress (Cawley, Deegan et al. 2011).  
 
8.4.2 High density stress and BL2 cell apoptosis 
Cellular stress responses are a self-defence mechanism, however, when the stress 
stimulus is beyond a certain threshold, stress signalling pathways will eventually 
activate the cell death pathway. The molecular events of the activation pathway 
leading to apoptosis after high density stress have not been identified.  Some cellular 
stress could trigger apoptosis by the intrinsic apoptotic pathway which activates 
caspase-9 by way of outer mitochondrial membrane permeabilization. Other cellular 
stress, including heat shock and metabolic stress might directly activate caspase-2 to 
initiate the apoptosis programme, although in some cell types this pathway would also 
involve mitochondria (Green 2011). In the present studies, after 1 hour of high density 
stress, there was no change in mitochondrial membrane potential (Figure 3.2), 
therefore model is more likely to induce apoptosis by way of caspase-2 and 
independent of mitochondria (Bouchier-Hayes 2010). Since the role of caspase-2 in 
driving apoptosis was postulated to depend on the extent of its activation, it might as 
well explain the induction of apoptosis in only a fraction of cells by high density stress 
(Bouchier-Hayes and Green 2012). Furthermore, over-expression of Myc protein 
could induce the expression of p53 (Speidel 2009). Under acute or long-lasting 
unresolved stress, p53 could adopt an apoptosis induction strategy. P53 could either 
promote apoptosis by activating transcription of BH-3 only protein of Bcl-2 family or 
by acting as a BH-3 only protein (Vousden and Lane 2007). Therefore, p53 might be 
both a sensor and an initiator of apoptosis in response to high density stress.  
 
Another form of cell death, autophagy, could also be induced by over-expression of 
Myc (Reef, Zalckvar et al. 2006), and it is reported that when the nutrients are limiting, 
Myc-induced lymphoma cells adopted autophagy for short-term survival before 
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‘eating themselves to death’ (Amaravadi, Yu et al. 2007; Maclean, Dorsey et al. 2008). 
Thus, it was also possible that during long term high density stress, cells sustained 
their survival by autophagy before dying by necrosis. 
 
A group I BL cell line was employed in the present work because it retains features of 
cells in the original tumour. This line, BL2, possesses an intrinsically high tendency to 
undergo apoptosis, which could partly be attributed to the de-regulated 
over-expression of Myc protein and very low or no expression of anti-apoptotic 
protein Bcl-2 (Henderson, Rowe et al. 1991). It might also reflect a germinal centre 
origin of the cells, since germinal centre B cells undergo apoptosis unless they receive 
survival signals. In order to better understand the mechanism driving apoptosis in BL, 
several studies have been undertaken in B lymphoma cells. Growth factor deprivation 
was found to induce apoptosis in group I BL cell lines (Gregory, Dive et al. 1991). 
Heat shock at 42°C was found to induce apoptosis in B lymphoma cells (WEHI-231 B 
cells) which can be partially prevented by bcl-2 over-expression (Cuende, 
Ales-Martinez et al. 1993). Likewise, cold shock could potently induce group-I BL 
cell apoptosis when the cells were brought back to culture at 37°C (Gregory and 
Milner 1994). Despite the fact that these stimulators are artificial which can not be 
present in the natural BL tumour microenvironment, they demonstrated that these cells 
could undergo apoptosis in response to cellular stress of various natures. Considering 
the rapid proliferation of BL cells and the limitation of oxygen and nutrients which is 
aggravated by the de-regulated over-expression of Myc protein, a combinatiion of 
high density stress with limited nutrients is more likely to be a physiological stressor 
that drives apoptosis and conditions the microenvironment in the tumour. 
 
8.4.3 Implications for tumour microenvironment  
Although the mechanism of high density stress has not been clarified, the finding that 
stressed tumour cells could affect other cells in the microenvironment to promote 
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tumour growth provides another perspective to look at cellular stress response and the 
subsequent biological effects. Most studies of the cellular stress response focus on the 
effect on stressed cells themselves. For example, the blocking of cell cycle and the 
inhibition of cell proliferation by p53 in stressed cells were believed to contribute to 
tumour suppression (Vousden and Prives 2009). The cellular protective effect 
provided by the unfolded protein response was believed to contribute to 
tumourigenesis (Fels and Koumenis 2006). However, it is also important to remember 
the interaction and communication between different cells within tumours. Apart from 
this study, there are several very good examples of the effect of stressed cells on their 
neighbours. One is the compensatory proliferation in Drosophila as discussed above. 
Another one is in Caenorhabditis elegans. Cells under hypoxic stress could secrete a 
neutral tyrosinase to remotely promote cell survival (Sendoel, Kohler et al. 2010). The 
last one is the bystander effect induced by radiation which describes a phenomenon 
that cells not directly exposed to ionizing radiation die or exhibit chromosomal 
mutation or instability as though they have been exposed (Seymour and Mothersill 
2004). Interestingly, macrophages are an important player in mediating this effect 
(Lorimore, Chrystal et al. 2008).  
 
The microenvironmental effect of metabolic stressed cells might partially explain the 
resistance of some tumours to anti-VEGF treatment, which aims to reduce 
angiogenesis (Bagri, Kouros-Mehr et al. 2010; Keunen, Johansson et al. 2011).The 
concept of restoring the balance between pro- and anti-angiogenic factors to achieve 
normal vasculature in tumours has been referred to as ‘vascular normalization’. This 
approach, combined with traditional chemotherapy, has been shown to promote 
patient survival, such as patients with primary glioblastoma and prostate carcinoma 
and patients with breast cancer brain metastases (Goel, Duda et al. 2011). 
 
All together, the microenvironmental conditioning effects of stressed BL cells to 
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promote tumour growth support the notion that in order to conquer tumours, including 
lymphomas, the paradigm of treatment should shift from the malignant cell-centered 
therapy to combining treatment targeting the interplay between malignant cells and the 
environment (Mantovani, Allavena et al. 2008; Burger, Ghia et al. 2009; Coupland 
2011). In NHL, conventional treatments are mostly targeting the proliferating tumour 
cells, such as chemotherapy or rituximab, but not the microenvironment, which might 
explain why some malignancies are still not curable despite the advances in 
therapeutics. One of the new drugs targeting the microenvironment in lymphoma is an 
antibody against CD137 which targets T cells in the tumour microenvironment and it 
has shown potent anti-lymphoma effect in NHL (Houot, Goldstein et al. 2009). Thus, 
better understanding the tumour microenvironment may provide more targets for 
effective tumour treatment.  
 
8.5 Embryonic stem cell derived macrophages (ESDM)  
8.5.1 Macrophage characteristics of ESDM  
The collective evidence presented from studies of their morphology, expression of 
macrophage markers, their phagocytic and migratory ability, argues strongly that the 
cells generated from murine ES cells under the conditions described were 
macrophages. Although 10%-20% of the cells did not stain for classical macrophage 
markers it is possible that this could be accounted for by reduced marker expression by 
dead macrophages considering the around 90% viability after detachment. However, 
the use of cell type-specific markers detected by monoclonal antibodies cannot be used 
in isolation to identify a cell type (Hume, Ross et al. 2002). It is possible that the cells 
which did not stain for the macrophage markers were a macrophage subset which does 
not express classical markers. As monocytes differentiate into macrophages, there are 
many phenotypic changes, including a reduction in the nucleocytoplasmic ratio (Sokol, 
Hudson et al. 1987), increased numbers of lysosomes and mitochondria (Cohn and 
Benson 1965; Kradin, McCarthy et al. 1986), and decreased levels of ER-MP12, 
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ER-MP20, ER-MP54, ER-MP58 expression (Leenen, de Bruijn et al. 1994). Such 
phenotypic features could be used to assess the macrophage characteristics of ESDM 
for further maturity analysis of ESDM.  
 
A further possibility is that the cells which differentiated from ES cells included some 
dendritic cells. Although CD11c was long considered to be the surface marker that 
could distinguish dendritic cells (DC) from macrophages, it is now known to be 
expressed by most tissue macrophages (Hume 2008). The defining characteristic of 
DC is their functional ability to prime the T cell responses but this has been challenged 
by the finding that macrophages can also activate T cell response (Pozzi, Maciaszek et 
al. 2005). There are even reports suggesting that following phagocytic activation, 
macrophages could acquire the archetypal DC phenotype, including the specialized 
antigen-presenting function (Steinman and Inaba 1999; Mellman and Steinman 2001). 
Transcriptome analysis indicated that antigen-presenting dendritic cells were a 
specialized activation state of macrophages rather than a separate cell type (Hume 
2006). However, in order to resolve the relationship between macrophages and DC, a 
closer investigation into the cells is required, by analysing cell origin, anatomical 
location, function and phenotype, in a systems biology approach. While recognizing 
the indistinct boundary between these two cell types, the properties of the 
macrophage-like cells generated from ES cells fit the classical definition of 
macrophages and the presence of classical dendritic cells was excluded by CD11c 
staining. This favours the notion that they are macrophages.  
 
When analysing the light scatter characteristics of ESDM by flow cytometry, two 
major subpopulations were identified on the basis of size and granularity (Figure 6.6). 
The two major subsets were reminiscent of the classification of two subsets in blood 
monocytes (Geissmann, Jung et al. 2003). It would be interesting to separate these two 
subpopulations using a flow cytometry-based cell sorter and see whether these cells 
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have any difference in phenotype and migratory ability that might enable them to be 
defined as different subsets of monocytes. Furthermore, in the light of the report that 
subpopulations of mouse blood monocytes, defined by the different expression levels 
of Ly6C, differ in their maturation stage (Sunderkotter, Nikolic et al. 2004), the 
possibility exists that the two subpopulations of ESDM, which had different 
expression levels of F4/80 and CD11b, might represent differences in maturity.  
 
The observation that as ESDM matured, they gradually lost the ability to migrate 
towards stress supernatants and had enhanced capability to ingest apoptotic cells fits 
well with the classical description of monocyte recruitment into tissues, their 
differentiation into macrophages and their development of macrophage functions, 
including clearance of cell debris. However, the molecular mechanisms of this 
differentiation and maturation process responsible for the capability switch are 
unknown, and in vivo it is likely to be further complicated by stressed tumour cells 
releasing factors (soluble or microparticle-associated) in addition to monocyte 
chemoattractants that can condition monocytes and influence the differentiation 
process towards the production of macrophages that have acquired the ability to ingest 
apoptotic cells. Thus, ESDM provide a convenient in vitro model to identify the 
molecular mechanism of this maturation process with respect to both phenotype and 
functions.   
 
8.5.2 ESDM in biology and medicine 
There have been significant recent developments in studies of macrophage 
differentiation from stem cells. Macrophages have been generated not only from 
murine and human embryonic stem cells, but also from murine and human induced 
pluripotent stem cells which are induced pluripotent stem cells from differentiated 
somatic cells and exhibit the morphology, growth and differentiation properties of ES 
cells (Moore, Fabunmi et al. 1998; Anderson, Bandi et al. 2006; Karlsson, Cowley et 
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al. 2008; Senju, Haruta et al. 2009; Senju, Haruta et al. 2011). The Hox gene has 
already been transfected into murine ES cells to produce an immortalized myeloid 
progenitor cell line in an attempt to generate an endless production of macrophages 
when required, instead of starting new ES cell culture each time (Wang, Calvo et al. 
2006; Odegaard, Vats et al. 2007). Human ES cell differentiation has successfully 
progressed from a co-culture system to a co-culture-free system which greatly 
simplifies the culture procedures. Inducible pluripotent stem cells may prove valuable 
in providing new therapies.    
 
It is important to bear in mind the plasticity and adaptability of macrophages. Despite 
the fact that the haematopoiesis during ES cells/EB differentiation is considered to be 
similar, if not identical to that of the early embryo (Keller 2005), ESDM are a model 
generated in vitro in an artificial environment which provides broad  differentiation 
requirements. Considering the heterogeneity of in vivo macrophages as well as the 
complicated interaction between cytokines and microenvironment during macrophage 
development, it cannot recapitulate the in vivo generation of specific subsets of 
macrophages. The in vitro differentiation system is highly restricted in its scope. 
Given the heterogeneity and plasticity of macrophages, the differentiation protocol 
would have to be more specific according to target organs and functions to replicate 
the complex interactions occurring in vivo. However, it provides a prototype for the 
development of future differentiation systems that can take into consideration the in 
situ phenotype and the microenvironment of the target organ. Therefore, before future 
application of ESDM in vitro and in vivo, it would be preferable to precondition 
ESDM in an environment that mimics the target in vivo microenvironment.    
 
8.5.3 ESDM as a novel model for macrophages 
Commonly used macrophage models have their intrinsic disadvantages. For example, 
tumour-derived cell lines, such as RAW 267.4, J774, and THP-1 cells, have the 
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potential for their tumour origin and possible tumour-specific mutations to interfere 
with the interpretation of experimental results. Indeed, primary tumour cells have been 
found to be deficient in the IFN-γ pathway (Xu, Grander et al. 1994; Wong, Krauer et 
al. 1997; Sun, Pabon et al. 1998) which is vital for classical macrophage activation. 
Gene profiling has also revealed that J774A.1 and RAW264.7 differed significantly 
from mouse peritoneal macrophages at the level of gene expression (Lindmark, 
Rosengren et al. 2004). Primary cells are also frequently used to obtain macrophages 
for in vitro studies (e.g. bone marrow-derived macrophages (BMDM) and elicited 
peritoneal macrophages); these are more like ‘normal’ macrophages, but they are 
always limited in cell numbers and have inherent resistance to genetic modifications. 
The acquisition of these primary cells always requires the access to living organisms. 
It is also demonstrated in this study that BMDM are very easily contaminated by other 
cell types.  
 
The in vitro haematopoiesis that occurs in ES cells/EB differentiation in vitro has been 
confirmed to recapitulate the early processes of in vivo embryogenesis (Keller 2005; 
Wobus and Boheler 2005). Gene profiling has already demonstrated similar gene 
expression pattern between ESDM and peritoneal macrophages (Lindmark, 
Rosengren et al. 2004). Furthermore, ES cells can be genetically manipulated, 
including gain-of-function, loss-of-function and temporal and spatial restricted control, 
and relevant protocols have already been successfully established. Manipulated ES 
cells can be differentiated into macrophages which would be a valuable model for both 
in vitro and in vivo studies of macrophage gene functions. Thus, ESDM have the 
potential to provide an improved cellular model considering their unlimited cell 
number, similarity to primary macrophages and feasibility for genetic manipulation.  
 
Despite all the advantages, this differentiation system has crucial flaws. The 
fundamental problem is the use of foetal bovine serum, which is a non-physiological, 
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undefined supplement with regards to murine ES cells. The variation in serum batches 
influences the reproducibility of ES cell differentiation. Therefore, in order to generate 
a protocol that can be employed widely, a serum-free and chemically-defined culture 
system must be established. Nevertheless, the demonstrated abilities of ESDM to 
migrate to and engulf apoptotic cells, together the genetic feasibility, provides a 
valuable model to study the molecular mechanisms underlying the interaction between 
apoptotic cells and macrophages. 
 
8.6 Concluding remarks and future perspectives 
In summary, the studies presented in this thesis indicate that in Burkitt’s lymphoma, 
stressed, pre-apoptotic tumour cells can condition the tumour microenvironment by 
selectively recruiting mononuclear phagocytes and inhibiting the infiltration of 
neutrophils as well as secreting survival/mitogenic factors. ATP is likely to be the 
mononuclear phagocyte chemoattractant released from pre-apoptotic cells and other 
possible roles of ATP in conditioning the tumour microenvironment, such as 
regulating the functions of tumour-associated macrophages, direct pro-tumour effects 
as well as influencing immune responses, have been proposed. The possible 
mechanisms of cellular stress responses, including temporary cellular protection and 
induction of apoptosis, in high density stress have been discussed. Although the 
survival/mitogenic factors and neutrophil infiltration inhibitory factors have not been 
identified, the studies provide novel perspectives in understanding the tumour 
microenvironment and identifying new therapeutic targets. Targeting the ‘find-me’ 
‘keep-out’ and ‘eat-me’ signals in the tumour microenvironment may regulate the 
infiltration and functions of immune cells therefore either suppress pro-tumour 
functions or induce anti-tumour immune responses.  The discovery that stressed 
tumour cells have direct trophic effects on other tumour cells supports the combination 
treatment of cancer which targets both malignant cells and the microenvironment and 




Furthermore, a scheme for generation of ESDM has been developed and optimized 
and their phenotypes and functions have been assessed. The purity, availability and 
genetic tractability make them a valuable model to study the molecular mechanisms of 
macrophage functions and role of the cells in tumour development.  ESDM from 
murine and human ES cells as well as inducible pluripotent stem cells also provide 
























Aldinucci, D., A. Gloghini, et al. (2010). "The classical Hodgkin's lymphoma 
microenvironment and its role in promoting tumour growth and immune escape." J 
Pathol 221(3): 248-263. 
Alessi, D. R., S. R. James, et al. (1997). "Characterization of a 
3-phosphoinositide-dependent protein kinase which phosphorylates and activates 
protein kinase Bα." Curr Biol 7(4): 261-269. 
Allavena, P., C. Garlanda, et al. (2008). "Pathways connecting inflammation and 
cancer." Curr Opin Genetics Dev 18(1): 3-10. 
Allday, M. J. (2009). "How does Epstein-Barr virus (EBV) complement the activation 
of Myc in the pathogenesis of Burkitt's lymphoma?" Semin Cancer Biol 19(6): 
366-376. 
Amaravadi, R. K., D. Yu, et al. (2007). "Autophagy inhibition enhances 
therapy-induced apoptosis in a Myc-induced model of lymphoma." J Clin Invest 
117(2): 326-336. 
Anderson, J. S., S. Bandi, et al. (2006). "Derivation of normal macrophages from 
human embryonic stem (hES) cells for applications in HIV gene therapy." 
Retrovirology 3: 24. 
Armitage, J. and D. Weisenburger (1998). "New approach to classifying 
non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. 
non-Hodgkin's Lymphoma Classification Project." J Clin Oncol 16(8): 2780-2795. 
Arrigo, A. P., J. P. Suhan, et al. (1988). "Dynamic changes in the structure and 
intracellular locale of the mammalian low-molecular-weight heat shock protein." Mol 
Cell Biol 8(12): 5059-5071. 
Austyn, J. M. and S. Gordon (1981). "F4/80, a monoclonal antibody directed 
specifically against the mouse macrophage." Eur J Immunol 11(10): 805-815. 
Bagri, A., H. Kouros-Mehr, et al. (2010). "Use of anti-VEGF adjuvant therapy in 
cancer: challenges and rationale." Trends Molec Med 16(3): 122-132. 
Balkwill, F. (2004). "Cancer and the chemokine network." Nat Rev Cancer 4(7): 
540-550. 
Balkwill, F. and A. Mantovani (2001). "Inflammation and cancer: back to Virchow?" 
Lancet 357(9255): 539-545. 
 205
Barnhart, B. C., E. C. Alappat, et al. (2003). "The CD95 type I/type II model." Semin 
Immunol 15(3): 185-193. 
Beere, H. M., B. B. Wolf, et al. (2000). "Heat-shock protein 70 inhibits apoptosis by 
preventing recruitment of procaspase-9 to the Apaf-1 apoptosome." Nat Cell Biol 2(8): 
469-475. 
Beigi, R. D. and G. R. Dubyak (2000). "Endotoxin activation of macrophages does not 
induce ATP release and autocrine stimulation of P2 nucleotide receptors." J Immunol 
165(12): 7189-7198. 
Berard, C. (1969). "Histopathological definition of Burkitt's tumour." Bull World 
Health Organ 40(4): 601-607. 
Bialik, S. and A. Kimchi (2006). "The death-associated protein kinases: structure, 
function, and beyond." Annu Rev Biochem 75: 189-210. 
Bingle, L., N. J. Brown, et al. (2002). "The role of tumour-associated macrophages in 
tumour progression: implications for new anticancer therapies." J Pathol 196(3): 
254-265. 
Biswas, S. K., L. Gangi, et al. (2006). "A distinct and unique transcriptional program 
expressed by tumor-associated macrophages (defective NF-kappaB and enhanced 
IRF-3/STAT1 activation)." Blood 107(5): 2112-2122. 
Boeynaems, J.-M. and D. Communi (2006). "Modulation of inflammation by 
extracellular nucleotides." J Invest Dermatol 126(5): 943-944. 
Bondanza, A., V. S. Zimmermann, et al. (2004). "Inhibition of phosphatidylserine 
recognition heightens the immunogenicity of irradiated lymphoma cells in vivo." J 
Exp Med 200(9): 1157-1165. 
Boocock, C. A., G. E. Jones, et al. (1989). "Colony-stimulating factor-1 induces rapid 
behavioural responses in the mouse macrophage cell line, BAC1.2F5." J Cell Sci 93 
( Pt 3): 447-456. 
Bouchier-Hayes, L. (2010). "The role of caspase-2 in stress-induced apoptosis." J Cell 
Mol Med 14(6a): 1212-1224. 
Bouchier-Hayes, L. and D. R. Green (2012). "Caspase-2: the orphan caspase." Cell 
Death Differ 19(1): 51-57. 
Boudreault, F. and R. Grygorczyk (2002). "Cell swelling-induced ATP release and 
gadolinium-sensitive channels." Am J Physiol-Cell Physiol 282(1): C219-C226. 
Bournazou, I. (2010) "Lactoferrin: an anti-inflammatory molecule released by 
 206
apoptotic cells to inhibit granulocyte migration." The University of Edinburgh. PhD 
Bournazou, I., K. J. Mackenzie, et al. (2009). "Inhibition of eosinophil migration by 
lactoferrin." Immunol Cell Biol 88(2): 220-223. 
Bournazou, I., J. D. Pound, et al. (2009). "Apoptotic human cells inhibit migration of 
granulocytes via release of lactoferrin." J Clin Invest 119(1): 20-32. 
Bours, M. J., E. L. Swennen, et al. (2006). "Adenosine 5'-triphosphate and adenosine 
as endogenous signaling molecules in immunity and inflammation." Pharmacol Ther 
112(2): 358-404. 
Brahimi-Horn, M. C., J. Chiche, et al. (2007). "Hypoxia signalling controls metabolic 
demand." Curr Opin Cell Biol 19(2): 223-229. 
Brennan, M. A. and B. T. Cookson (2000). "Salmonella induces macrophage death by 
caspase-1-dependent necrosis." Mol Microbiol  38(1): 31-40. 
Brown, S., I. Heinisch, et al. (2002). "Apoptosis disables CD31-mediated cell 
detachment from phagocytes promoting binding and engulfment." Nature 418(6894): 
200-203. 
Bruey, J. M., C. Ducasse, et al. (2000). "Hsp27 negatively regulates cell death by 
interacting with cytochrome c." Nat Cell Biol 2(9): 645-652. 
Burger, J. A., P. Ghia, et al. (2009). "The microenvironment in mature B-cell 
malignancies: a target for new treatment strategies." Blood 114(16): 3367-3375. 
Burgess, A. W., D. Metcalf, et al. (1985). "Purification of two forms of 
colony-stimulating factor from mouse L-cell-conditioned medium." J Biol Chem 
260(29): 16004-16011. 
Burkitt, D. (1958). "A sarcoma involving the jaws in African children." Br J Surg 
46(197): 218-223. 
Burnstock, G., B. B. Fredholm, et al. (2010). "The birth and postnatal development of 
purinergic signalling." Acta Physiol (Oxf) 199(2): 93-147. 
Buttner, S., T. Eisenberg, et al. (2007). "Endonuclease G regulates budding yeast life 
and death." Mol Cell 25(2): 233-246. 
Calderwood, S. K., M. A. Khaleque, et al. (2006). "Heat shock proteins in cancer: 
chaperones of tumorigenesis." TIBS 31(3): 164-172. 
Callahan, M. K., M. S. Halleck, et al. (2003). "Phosphatidylserine expression and 
phagocytosis of apoptotic thymocytes during differentiation of monocytic cells." J 
 207
Leukoc Biol 74(5): 846-856. 
Cardona, A. E., E. P. Pioro, et al. (2006). "Control of microglial neurotoxicity by the 
fractalkine receptor." Nat Neurosci 9(7): 917-924. 
Cario, G., U. Z. Stadt, et al. (2000). "Variant translocations in sporadic Burkitt's 
lymphoma detected in fresh tumour material: analysis of three cases." Br J Haematol 
110(3): 537-546. 
Castedo, M., T. Hirsch, et al. (1996). "Sequential acquisition of mitochondrial and 
plasma membrane alterations during early lymphocyte apoptosis." J Immunol 157(2): 
512-521. 
Cawley, K., S. Deegan, et al. (2011). "Assays for detecting the unfolded protein 
response." Methods Enzymol 490: 31-51. 
Chambers, I., D. Colby, et al. (2003). "Functional expression cloning of Nanog, a 
pluripotency sustaining factor in embryonic stem cells." Cell 113(5): 643-655. 
Charette, S. J. and J. Landry (2000). "The interaction of HSP27 with Daxx identifies a 
potential regulatory role of HSP27 in Fas-induced apoptosis." Ann N Y Acad Sci 926: 
126-131. 
Chauhan, D., G. Li, et al. (2003). "Hsp27 inhibits release of mitochondrial protein 
Smac in multiple myeloma cells and confers dexamethasone resistance." Blood 102(9): 
3379-3386. 
Chawla, A., Y. Barak, et al. (2001). "PPAR-[gamma] dependent and independent 
effects on macrophage-gene expression in lipid metabolism and inflammation." Nat 
Med 7(1): 48-52. 
Chekeni, F. B., M. R. Elliott, et al. (2010). "Pannexin 1 channels mediate `find-me' 
signal release and membrane permeability during apoptosis." Nature 467(7317): 
863-867. 
Chen, W., M. E. Frank, et al. (2001). "TGF-beta released by apoptotic T cells 
contributes to an immunosuppressive milieu." Immunity 14(6): 715-725. 
Chen, Y., R. Corriden, et al. (2006). "ATP release guides neutrophil chemotaxis via 
P2Y2 and A3 receptors." Science 314(5806): 1792-1795. 
Chen, Y., E. McMillan-Ward, et al. (2007). "Oxidative stress induces autophagic cell 
death independent of apoptosis in transformed and cancer cells." Cell Death Differ 
15(1): 171-182. 
Cho, Y. S., S. Challa, et al. (2009). "Phosphorylation-driven assembly of the 
 208
RIP1-RIP3 complex regulates programmed necrosis and virus-induced 
inflammation." Cell 137(6): 1112-1123. 
Clarkson, S. B. and P. A. Ory (1988). "CD16. Developmentally regulated IgG Fc 
receptors on cultured human monocytes." J Exp Med 167(2): 408-420. 
Cohn, Z. A. and B. Benson (1965). "The differentiation of mononuclear phagocytes. 
morphology, cytochemistry, and biochemistry." J Exp Med 121: 153-170. 
Collins, M. K., G. R. Perkins, et al. (1994). "Growth factors as survival factors: 
regulation of apoptosis." BioEssays 16(2): 133-138. 
Colotta, F., P. Allavena, et al. (2009). "Cancer-related inflammation, the seventh 
hallmark of cancer: links to genetic instability." Carcinogenesis 30(7): 1073-1081. 
Concannon, C. G., S. Orrenius, et al. (2001). "Hsp27 inhibits cytochrome c-mediated 
caspase activation by sequestering both pro-caspase-3 and cytochrome c." Gene Expr 
9(4-5): 195-201. 
Condeelis, J. and J. W. Pollard (2006). "Macrophages: obligate partners for tumor cell 
migration, invasion, and metastasis." Cell 124(2): 263-266. 
Cooper, E. H., G. L. Frank, et al. (1966). "Cell proliferation in Burkitt tumours." Eur J 
Cancer 2(4): 377-384. 
Corriden, R., Y. Chen, et al. (2008). "Ecto-nucleoside triphosphate 
diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by 
hydrolyzing released ATP to adenosine." J Biol Chem 283(42): 28480-28486. 
Coupland, S. E. (2011). "The challenge of the microenvironment in B-cell 
lymphomas." Histopathology 58(1): 69-80. 
Cox, M. A., B. Gomes, et al. (2005). "The pyrimidinergic P2Y6 receptor mediates a 
novel release of proinflammatory cytokines and chemokines in monocytic cells 
stimulated with UDP." Biochem Biophys Res Commun 330(2): 467-473. 
Cuende, E., J. E. Ales-Martinez, et al. (1993). "Programmed cell death by 
bcl-2-dependent and independent mechanisms in B lymphoma cells." EMBO J 12(4): 
1555-1560. 
Curiel, T. J., G. Coukos, et al. (2004). "Specific recruitment of regulatory T cells in 
ovarian carcinoma fosters immune privilege and predicts reduced survival." Nat Med 
10(9): 942-949. 
Cvetanovic, M., J. E. Mitchell, et al. (2006). "Specific recognition of apoptotic cells 
reveals a ubiquitous and unconventional innate immunity." J Biol Chem 281(29): 
 209
20055-20067. 
Cvetanovic, M. and D. S. Ucker (2004). "Innate Immune discrimination of apoptotic 
cells: repression of proinflammatory macrophage transcription is coupled directly to 
specific recognition." J Immunol 172(2): 880-889. 
Dang, C. V., K. A. O'Donnell, et al. (2006). "The c-Myc target gene network." Semin 
Cancer Biol 16(4): 253-264. 
Dang, S. M., M. Kyba, et al. (2002). "Efficiency of embryoid body formation and 
hematopoietic development from embryonic stem cells in different culture systems." 
Biotechnol Bioeng  78(4): 442-453. 
Dave, S. S., G. Wright, et al. (2004). "Prediction of survival in follicular lymphoma 
based on molecular features of tumor-infiltrating immune cells." N Eng J Med 351(21): 
2159-2169. 
de Visser, K. E., A. Eichten, et al. (2006). "Paradoxical roles of the immune system 
during cancer development." Nat Rev Cancer 6(1): 24-37. 
Degenhardt, K., R. Mathew, et al. (2006). "Autophagy promotes tumor cell survival 
and restricts necrosis, inflammation, and tumorigenesis." Cancer cell 10(1): 51-64. 
Degterev, A., Z. Huang, et al. (2005). "Chemical inhibitor of nonapoptotic cell death 
with therapeutic potential for ischemic brain injury." Nat Chem Biol 1(2): 112-119. 
DeNardo, D. G., J. B. Barreto, et al. (2009). "CD4+ T cells regulate pulmonary 
metastasis of mammary carcinomas by enhancing protumor properties of 
macrophages." Cancer cell 16(2): 91-102. 
Devitt, A., O. D. Moffatt, et al. (1998). "Human CD14 mediates recognition and 
phagocytosis of apoptotic cells." Nature 392(6675): 505-509. 
Di Virgilio, F. (2005). "Purinergic mechanism in the immune system: a signal of 
danger for dendritic cells." Purinergic Signal 1(3): 205-209. 
Di Virgilio, F., J.-M. Boeynaems, et al. (2009). "Extracellular nucleotides as negative 
modulators of immunity." Curr Opin Pharmacol  9(4): 507-513. 
Dorshkind, K. (1990). "Regulation of hemopoiesis by bone marrow stromal cells and 
their products." Annu Rev Immunol 8: 111-137. 
Duffield, J. S., L. P. Erwig, et al. (2000). "Activated macrophages direct apoptosis and 
suppress mitosis of mesangial cells." J Immunol 164(4): 2110-2119. 
Elferink, J. G., B. M. de Koster, et al. (1992). "Inhibition of neutrophil chemotaxis by 
 210
purinoceptor agonists." Arch Int Pharmacodyn Ther 317: 93-106. 
Elliott, M. R., F. B. Chekeni, et al. (2009). "Nucleotides released by apoptotic cells act 
as a find-me signal to promote phagocytic clearance." Nature 461(7261): 282-286. 
Elliott, M. R. and K. S. Ravichandran (2010). "Clearance of apoptotic cells: 
implications in health and disease." J Cell Biol 189(7): 1059-1070. 
Evan, G. I., A. H. Wyllie, et al. (1992). "Induction of apoptosis in fibroblasts by c-myc 
protein." Cell 69(1): 119-128. 
Fadok, V., D. Voelker, et al. (1992). "Exposure of phosphatidylserine on the surface of 
apoptotic lymphocytes triggers specific recognition and removal by macrophages." J 
Immunol 148(7): 2207-2216. 
Fadok, V. A., D. L. Bratton, et al. (2001). "Phagocyte receptors for apoptotic cells: 
recognition, uptake, and consequences." J Clin Invest 108(7): 957-962. 
Fadok, V. A., D. L. Bratton, et al. (1998). "Macrophages that have ingested apoptotic 
cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine 
mechanisms involving TGF-beta, PGE2, and PAF." J Clin Invest 101(4): 890-898. 
Fan, Y. and A. Bergmann (2008). "Apoptosis-induced compensatory proliferation. The 
cell is dead. Long live the cell!" Trends Cell Biol 18(10): 467-473. 
Fan, Y. and A. Bergmann (2008). "Distinct mechanisms of apoptosis-induced 
compensatory proliferation in proliferating and differentiating tissues in the 
Drosophila eye." Dev Cell 14(3): 399-410. 
Fels, D. R. and C. Koumenis (2006). "The PERK/eIF2α/ATF4 module of the UPR in 
hypoxia resistance and tumor growth." Cancer Biol Ther  5(7): 723-728. 
Fernandes-Alnemri, T., J. Wu, et al. (2007). "The pyroptosome: a supramolecular 
assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation." 
Cell Death Differ 14(9): 1590-1604. 
Ferry, J. A. (2006). "Burkitt's lymphoma: clinicopathologic features and differential 
diagnosis." Oncologist 11(4): 375-383. 
Flavell, R. A., S. Sanjabi, et al. (2010). "The polarization of immune cells in the 
tumour environment by TGFβ." Nat Rev Immunol 10(8): 554-567. 
Folkman, J. (2006). "Angiogenesis." Annu Rev Med 57: 1-18. 
Ford-Hutchinson, A. W. (1982). "Aggregation of rat neutrophils by nucleotide 
triphosphates." Br J Pharmacol 76(3): 367-371. 
 211
Franchi, L., T. Eigenbrod, et al. (2009). "The inflammasome: a caspase-1-activation 
platform that regulates immune responses and disease pathogenesis." Nat Immunol 
10(3): 241-247. 
Friel, R., D. Fisher, et al. (2006). "Embryonic stem cell technology: applications and 
uses in functional genomic studies." Stem Cell Rev 2(1): 31-35. 
Gaipl, U. S., T. D. Beyer, et al. (2003). "Exposure of anionic phospholipids serves as 
anti-inflammatory and immunosuppressive signal--implications for antiphospholipid 
syndrome and systemic lupus erythematosus." Immunobiology 207(1): 73-81. 
Gaipl, U. S., L. E. Munoz, et al. (2007). "Clearance deficiency and systemic lupus 
erythematosus (SLE)." J Autoimmun 28(2-3): 114-121. 
Galluzzi, L., I. Vitale, et al. (2012). "Molecular definitions of cell death subroutines: 
recommendations of the Nomenclature Committee on Cell Death 2012." Cell Death 
Differ 19(1): 107-120. 
Gao, Y., J. M. Herndon, et al. (1998). "Antiinflammatory effects of CD95 ligand 
(FasL)-induced apoptosis." J Exp Med  188(5): 887-896. 
Gardai, S. J., K. A. McPhillips, et al. (2005). "Cell-surface calreticulin initiates 
clearance of viable or apoptotic cells through trans-activation of LRP on the 
phagocyte." Cell 123(2): 321-334. 
Gazzaniga, S., A. I. Bravo, et al. (2007). "Targeting tumor-associated macrophages 
and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma 
xenograft." J Invest Dermatol 127(8): 2031-2041. 
Geissmann, F., S. Jung, et al. (2003). "Blood monocytes consist of two principal 
subsets with distinct migratory properties." Immunity 19(1): 71-82. 
George, K. (1983). "Specific chromosomal translocations and the genesis of 
B-cell-derived tumors in mice and men." Cell 32(2): 311-315. 
Gilchrist, D. S., J. Ure, et al. (2003). "Labeling of hematopoietic stem and progenitor 
cells in novel activatable EGFP reporter mice." genesis 36(3): 168-176. 
Goel, S., D. G. Duda, et al. (2011). "Normalization of the vasculature for treatment of 
cancer and other diseases." Physiol Rev  91(3): 1071-1121. 
Goepfert, C., C. Sundberg, et al. (2001). "Disordered cellular migration and 
angiogenesis in CD39-null mice." Circulation 104(25): 3109-3115. 
Golpon, H. A., V. A. Fadok, et al. (2004). "Life after corpse engulfment: phagocytosis 
of apoptotic cells leads to VEGF secretion and cell growth." The FASEB Journal. 
 212
Gordon, J., K. Knox, et al. (1993). "Regulation of survival in normal and neoplastic B 
lymphocytes." Leukemia 7 Suppl 2: S5-9. 
Gordon, S. and P. R. Taylor (2005). "Monocyte and macrophage heterogeneity." Nat 
Rev Immunol 5(12): 953-964. 
Gorini, S., G. Callegari, et al. (2010). "ATP secreted by endothelial cells blocks 
CX3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y11 receptor 
activation." Blood 116(22): 4492-4500. 
Gorman, M. W., E. O. Feigl, et al. (2007). "Human plasma ATP concentration." Clin 
Chem 53(2): 318-325. 
Green, D. (2011). "The end and after: how dying cells impact the living organism." 
Immunity 35(4): 441-444. 
Gregory, C. and J. Pound (2010). "Microenvironmental influences of apoptosis in vivo 
and in vitro." Apoptosis 15(9): 1029-1049. 
Gregory, C. D., C. Dive, et al. (1991). "Activation of Epstein-Barr virus latent genes 
protects human B cells from death by apoptosis." Nature 349(6310): 612-614. 
Gregory, C. D. and A. E. Milner (1994). "Regulation of cell survival in Burkitt 
lymphoma: Implications from studies of apoptosis following cold-shock treatment." 
Int J Cancer 57(3): 419-426. 
Gregory, C. D. and J. D. Pound (2011). "Cell death in the neighbourhood: direct 
microenvironmental effects of apoptosis in normal and neoplastic tissues." J Pathol 
223(2): 178-195. 
Gregory, C. D., T. Tursz, et al. (1987). "Identification of a subset of normal B cells 
with a Burkitt's lymphoma (BL)-like phenotype." J Immunol 139(1): 313-318. 
Greten, F. R., L. Eckmann, et al. (2004). "IKKβ links inflammation and tumorigenesis 
in a mouse model of colitis-associated cancer." Cell 118(3): 285-296. 
Grimsley, C. and K. S. Ravichandran (2003). "Cues for apoptotic cell engulfment: 
eat-me, don't eat-me and come-get-me signals." Trends Cell Biol  13(12): 648-656. 
Grivennikov, S. I., F. R. Greten, et al. (2010). "Immunity, inflammation, and cancer." 
Cell 140(6): 883-899. 
Gross, A., J. M. McDonnell, et al. (1999). "BCL-2 family members and the 
mitochondria in apoptosis." Genes Dev 13(15): 1899-1911. 
Gude, D. R., S. E. Alvarez, et al. (2008). "Apoptosis induces expression of 
 213
sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" 
signal." FASEB J 22(8): 2629-2638. 
Guenebeaud, C., D. Goldschneider, et al. (2010). "The dependence receptor 
UNC5H2/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase." 
Mol Cell 40(6): 863-876. 
Hagemann, T., J. Wilson, et al. (2006). "Ovarian cancer cells polarize macrophages 
toward a tumor-associated phenotype." J Immunol 176(8): 5023-5032. 
Hamaguchi, I., N. B. Woods, et al. (2000). "Lentivirus vector gene expression during 
ES cell-derived hematopoietic development in vitro." J Virol 74(22): 10778-10784. 
Hamilton, J. A. (2008). "Colony-stimulating factors in inflammation and 
autoimmunity." Nat Rev Immunol 8(7): 533-544. 
Hanada, T., M. Nakagawa, et al. (2000). "Prognostic value of tumor-associated 
macrophage count in human bladder cancer." Int J Urol  7(7): 263-269. 
Hanahan, D. and R. Weinberg (2011). "Hallmarks of cancer: the next generation." Cell 
144(5): 646-674. 
Handyside, A. H., G. T. O'Neill, et al. (1989). "Use of BRL-conditioned medium in 
combination with feeder layers to isolate a diploid embryonal stem cell line." Dev 
Genes Evol  198(1): 48-56. 
Hannigan, M., L. Zhan, et al. (2002). "Neutrophils lacking phosphoinositide 3-kinase γ 
show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis." Proc 
Natl Acad Sci U S A  99(6): 3603-3608. 
Harris, A. L. (2007). "Connexin channel permeability to cytoplasmic molecules." Prog 
Biophys Mol Biol 94(1-2): 120-143. 
Hask, G., P. Pacher, et al. (2007). "Shaping of monocyte and macrophage function by 
adenosine receptors." Pharmacol Ther  113(2): 264-275. 
Hasko, G., D. G. Kuhel, et al. (2000). "ATP suppression of interleukin-12 and tumour 
necrosis factor-alpha release from macrophages." Br J Pharmacol 129(5): 909-914. 
Haynie, J. L. and P. J. Bryant (1977). "The effects of X-rays on the proliferation 
dynamics of cells in the imaginal wing disc of Drosophila melanogaster " Dev Genes 
Evol  183(2): 85-100. 
He, S., L. Wang, et al. (2009). "Receptor interacting protein kinase-3 determines 
cellular necrotic response to TNF-alpha." Cell 137(6): 1100-1111. 
 214
Hegde, R., S. M. Srinivasula, et al. (2002). "Identification of Omi/HtrA2 as a 
mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis 
protein-caspase interaction." J Biol Chem 277(1): 432-438. 
Henderson, S., M. Rowe, et al. (1991). "Induction of bcl-2 expression by Epstein-Barr 
virus latent membrane protein 1 protects infected B cells from programmed cell 
death." Cell 65(7): 1107-1115. 
Henson, P. M. and D. A. Hume (2006). "Apoptotic cell removal in development and 
tissue homeostasis." Trends Immunol 27(5): 244-250. 
Heuff, G., H. S. Oldenburg, et al. (1993). "Enhanced tumour growth in the rat liver 
after selective elimination of Kupffer cells." Cancer Immunol Immunother 37(2): 
125-130. 
Hirsch, E., V. L. Katanaev, et al. (2000). "Central Role for G Protein-Coupled 
Phosphoinositide 3-Kinase γ in Inflammation." Science 287(5455): 1049-1053. 
Hitomi, J., D. E. Christofferson, et al. (2008). "Identification of a molecular signaling 
network that regulates a cellular necrotic cell death pathway." Cell 135(7): 1311-1323. 
Hoeppner, D. J., M. O. Hengartner, et al. (2001). "Engulfment genes cooperate with 
ced-3 to promote cell death in Caenorhabditis elegans." Nature 412(6843): 202-206. 
Holder, M. J., N. M. Barnes, et al. (2006). "Lymphoma cells protected from apoptosis 
by dysregulated bcl-2 continue to bind Annexin V in response to B-cell receptor 
engagement: A cautionary tale." Leukemia Res 30(1): 77-80. 
Holmgren, L., M. S. O'Reilly, et al. (1995). "Dormancy of micrometastases: balanced 
proliferation and apoptosis in the presence of angiogenesis suppression." Nat Med 1(2): 
149-153. 
Hori, M., S. Xiang, et al. (2001). "Non-Hodgkin lymphomas of mice." Blood Cells, 
Molecules, and Diseases 27(1): 217-222. 
Houot, R., M. J. Goldstein, et al. (2009). "Therapeutic effect of CD137 
immunomodulation in lymphoma and its enhancement by Treg depletion." Blood 
114(16): 3431-3438. 
Hristov, M., W. Erl, et al. (2004). "Apoptotic bodies from endothelial cells enhance the 
number and initiate the differentiation of human endothelial progenitor cells in vitro." 
Blood 104(9): 2761-2766. 
Hume, D. A. (2006). "The mononuclear phagocyte system." Curr Opin Immunol 18(1): 
49-53. 
 215
Hume, D. A. (2008). "Macrophages as APC and the dendritic cell myth." J Immunol 
181(9): 5829-5835. 
Hume, D. A., I. L. Ross, et al. (2002). "The mononuclear phagocyte system revisited." 
J Leukoc Biol 72(4): 621-627. 
Huynh, M. L., V. A. Fadok, et al. (2002). "Phosphatidylserine-dependent ingestion of 
apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation." J 
Clin Invest 109(1): 41-50. 
Ichinose, M. (1995). "Modulation of phagocytosis by P2-purinergic receptors in 
mouse peritoneal macrophages." Jpn J Physiol 45(5): 707-721. 
Iversen, O. H., U. Iversen, et al. (1974). "Cell kinetics in Burkitt lymphoma." Eur J 
Cancer  (1965) 10(3): 155-163. 
Jackson, M., A. H. Taylor, et al. (2010). "The culture of mouse embryonic stem cells 
and formation of embryoid bodies." Methods Mol Biol 633: 1-18. 
Jakob, U., M. Gaestel, et al. (1993). "Small heat shock proteins are molecular 
chaperones." J Biol Chem 268(3): 1517-1520. 
Jeffers, J. R., E. Parganas, et al. (2003). "Puma is an essential mediator of 
p53-dependent and -independent apoptotic pathways." Cancer cell 4(4): 321-328. 
Jersmann, H. P. A., K. A. Ross, et al. (2003). "Phagocytosis of apoptotic cells by 
human macrophages: analysis by multiparameter flow cytometry." Cytometry Part A 
51A(1): 7-15. 
Jones, R. G., D. R. Plas, et al. (2005). "AMP-activated protein kinase induces a 
p53-dependent metabolic checkpoint." Mol Cell 18(3): 283-293. 
Joza, N., S. A. Susin, et al. (2001). "Essential role of the mitochondrial 
apoptosis-inducing factor in programmed cell death." Nature 410(6828): 549-554. 
Judah, F. (2003). "Angiogenesis and apoptosis." Sem Cancer Biol  13(2): 159-167. 
Junger, W. (2008). "Purinergic regulation of neutrophil chemotaxis." Cell Mol Life Sci 
65(16): 2528-2540. 
Junger, W. G. (2011). "Immune cell regulation by autocrine purinergic signalling." Nat 
Rev Immunol 11(3): 201-212. 
Jungi, T. W. and S. Hafner (1986). "Quantitative assessment of Fc receptor expression 
and function during in vitro differentiation of human monocytes to macrophages." 
Immunology 58(1): 131-137. 
 216
Karin, M. (2006). "Nuclear factor-[kappa]B in cancer development and progression." 
Nature 441(7092): 431-436. 
Karin, M. and F. R. Greten (2005). "NF-κB: linking inflammation and immunity to 
cancer development and progression." Nat Rev Immunol 5(10): 749-759. 
Karlsson, K. R., S. Cowley, et al. (2008). "Homogeneous monocytes and macrophages 
from human embryonic stem cells following coculture-free differentiation in M-CSF 
and IL-3." Exp Hematol 36(9): 1167-1175. 
Kato, K., T. Ogura, et al. (2002). "Critical roles of AMP-activated protein kinase in 
constitutive tolerance of cancer cells to nutrient deprivation and tumor formation." 
Oncogene 21(39): 6082-6090. 
Kaufmann, A., B. Musset, et al. (2005). ""Host tissue damage" signal ATP promotes 
non-directional migration and negatively regulates Toll-like receptor signaling in 
human monocytes." J Biol Chem 280(37): 32459-32467 
 
Keller, G. (2005). "Embryonic stem cell differentiation: emergence of a new era in 
biology and medicine." Genes Dev 19(10): 1129-1155. 
Kerr, J. F., A. H. Wyllie, et al. (1972). "Apoptosis: a basic biological phenomenon with 
wide-ranging implications in tissue kinetics." Br J Cancer 26(4): 239-257. 
Keunen, O., M. Johansson, et al. (2011). "Anti-VEGF treatment reduces blood supply 
and increases tumor cell invasion in glioblastoma." Proc Natl Acad Sci U S A 108(9): 
3749-3754. 
Kimura, Y. N., K. Watari, et al. (2007). "Inflammatory stimuli from macrophages and 
cancer cells synergistically promote tumor growth and angiogenesis." Cancer Sci 
98(12): 2009-2018. 
Kinchen, J. (2010). "A model to die for: signaling to apoptotic cell removal in worm, 
fly and mouse." Apoptosis 15(9): 998-1006. 
Kinchen, J. M. and K. S. Ravichandran (2007). "Journey to the grave: signaling events 
regulating removal of apoptotic cells." J Cell Sci 120(Pt 13): 2143-2149. 
Kobara, M., N. Sunagawa, et al. (2008). "Apoptotic myocytes generate monocyte 
chemoattractant protein-1 and mediate macrophage recruitment." J Appl Physiol 
104(3): 601-609. 
Komarova, E. Y., E. A. Afanasyeva, et al. (2004). "Downstream caspases are novel 
targets for the antiapoptotic activity of the molecular chaperone Hsp70." Cell Stress 
 217
Chaperon 9(3): 265-275. 
Kondo, S., N. Senoo-Matsuda, et al. (2006). "DRONC coordinates cell death and 
compensatory proliferation." Mol Cell Biol 26(19): 7258-7268. 
Kovar, J. and F. Franek (1989). "Growth-stimulating effect of transferrin on a 
hybridoma cell line: relation to transferrin iron-transporting function." Exp Cell Res 
182(2): 358-369. 
Koziak, K., J. Sevigny, et al. (1999). "Analysis of CD39/ATP diphosphohydrolase 
(ATPDase) expression in endothelial cells, platelets and leukocytes." Thromb 
Haemost 82(5): 1538-1544. 
Kradin, R. L., K. M. McCarthy, et al. (1986). "Flow-cytometric and ultrastructural 
analysis of alveolar macrophage maturation." J Leukoc Biol 40(4): 407-417. 
Kroemer, G., L. Galluzzi, et al. (2007). "Mitochondrial membrane permeabilization in 
cell death." Physiol Rev  87(1): 99-163. 
Kroemer, G., L. Galluzzi, et al. (2009). "Classification of cell death: recommendations 
of the Nomenclature Committee on Cell Death 2009." Cell Death Differ 16(1): 3-11. 
Kroemer, G. and B. Levine (2008). "Autophagic cell death: the story of a misnomer." 
Nat Rev Mol Cell Biol 9(12): 1004-1010. 
Kronlage, M., J. Song, et al. (2010). "Autocrine purinergic receptor signaling is 
essential for macrophage chemotaxis." Sci. Signal. 3(132): ra55. 
Kuang, D.-M., Q. Zhao, et al. (2009). "Activated monocytes in peritumoral stroma of 
hepatocellular carcinoma foster immune privilege and disease progression through 
PD-L1." J Exp Med  206(6): 1327-1337. 
Kuang, D. M., Y. Wu, et al. (2007). "Tumor-derived hyaluronan induces formation of 
immunosuppressive macrophages through transient early activation of monocytes." 
Blood 110(2): 587-595. 
Kultz, D. (2005). "Molecular and evolutionary basis of the cellular stress response." 
Annu Rev Physiol 67: 225-257. 
Kyba, M., R. C. Perlingeiro, et al. (2002). "HoxB4 confers definitive 
lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac 
hematopoietic progenitors." Cell 109(1): 29-37. 
Lamkanfi, M., T. D. Kanneganti, et al. (2008). "Targeted peptidecentric proteomics 
reveals caspase-7 as a substrate of the caspase-1 inflammasomes." Mol Cell 
Proteomics 7(12): 2350-2363. 
 218
Laptenko, O. and C. Prives (2006). "Transcriptional regulation by p53: one protein, 
many possibilities." Cell Death Differ 13(6): 951-961. 
Lauber, K., E. Bohn, et al. (2003). "Apoptotic cells induce migration of phagocytes via 
caspase-3-mediated release of a lipid attraction signal." Cell 113(6): 717-730. 
Lee, T., E. D’Asti, et al. (2011). "Microvesicles as mediators of intercellular 
communication in cancer—the emerging science of cellular ‘debris’." Semin 
Immunopathol 33(5): 455-467. 
Leek, R. D., C. E. Lewis, et al. (1996). "Association of macrophage infiltration with 
angiogenesis and prognosis in invasive breast carcinoma." Cancer Res 56(20): 
4625-4629. 
Leenen, P. J. M., M. F. T. R. de Bruijn, et al. (1994). "Markers of mouse macrophage 
development detected by monoclonal antibodies." J Immunol Methods  174(1-2): 
5-19. 
Legrand, D., E. Elass, et al. (2005). "Lactoferrin." Cell Mol Life Sci 62(22): 
2549-2559. 
Leist, M., B. Single, et al. (1997). "Intracellular adenosine triphosphate (ATP) 
concentration: a switch in the decision between apoptosis and necrosis." J Exp Med  
185(8): 1481-1486. 
Lenoir, G. M., M. Vuillaume, et al. (1985). "The use of lymphomatous and 
lymphoblastoid cell lines in the study of Burkitt's lymphoma." IARC Sci Publ(60): 
309-318. 
Lenz, G., G. Wright, et al. (2008). "Stromal gene signatures in Large-B-Cell 
lymphomas." N Eng J Med 359(22): 2313-2323. 
Leoncini, L., M. T. Del Vecchio, et al. (1993). "Correlations between apoptotic and 
proliferative indices in malignant non-Hodgkin's lymphomas." Am J Pathol 142(3): 
755-763. 
Levens, J. M., J. Gordon, et al. (2000). "Micro-environmental factors in the survival of 
human B-lymphoma cells." Cell Death Differ 7(1): 59-69. 
Levine, A. J., W. Hu, et al. (2006). "The P53 pathway: what questions remain to be 
explored?" Cell Death Differ 13(6): 1027-1036. 
Levine, A. J., J. Momand, et al. (1991). "The p53 tumour suppressor gene." Nature 
351(6326): 453-456. 
Lewis, C. E. and R. Hughes (2007). "Inflammation and breast cancer. 
 219
Microenvironmental factors regulating macrophage function in breast tumours: 
hypoxia and angiopoietin-2." Breast Cancer Res 9(3): 209. 
Li, L. Y., X. Luo, et al. (2001). "Endonuclease G is an apoptotic DNase when released 
from mitochondria." Nature 412(6842): 95-99. 
Li, P., D. Nijhawan, et al. (1997). "Cytochrome c and dATP-dependent formation of 
Apaf-1/caspase-9 complex initiates an apoptotic protease cascade." Cell 91(4): 
479-489. 
Li, X., L. Zhou, et al. (2006). "The P2X7 receptor: a novel biomarker of uterine 
epithelial cancers." Cancer Epidemiol Biomarkers Prev 15(10): 1906-1913. 
Li, Z., H. Jiang, et al. (2000). "Roles of PLC- β2 and - β3 and PI3Kγ in 
chemoattractant-mediated signal transduction." Science 287(5455): 1046-1049. 
Lin, E. Y., A. V. Nguyen, et al. (2001). "Colony-stimulating factor 1 promotes 
progression of mammary tumors to malignancy." J Exp Med  193(6): 727-740. 
Lin, W.-W. and M. Karin (2007). "A cytokine-mediated link between innate immunity, 
inflammation, and cancer." J Clin Invest 117(5): 1175-1183. 
Lindmark, H., B. Rosengren, et al. (2004). "Gene expression profiling shows that 
macrophages derived from mouse embryonic stem cells is an improved in vitro model 
for studies of vascular disease." Exp Cell Res  300(2): 335-344. 
Lissbrant, I. F., P. Stattin, et al. (2000). "Tumor associated macrophages in human 
prostate cancer: relation to clinicopathological variables and survival." Int J Oncol 
17(3): 445-451. 
Liu, H.-T., R. Sabirov, et al. (2008). "Oxygen-glucose deprivation induces ATP release 
via maxi-anion channels in astrocytes." Purinergic Signal 4(2): 147-154. 
Liu, Q. H., H. Bohlen, et al. (1999). "Expression and a role of functionally coupled 
P2Y receptors in human dendritic cells." FEBS Lett 445(2-3): 402-408. 
Liu, Y. J., G. D. Johnson, et al. (1992). "Germinal centres in T-cell-dependent antibody 
responses." Immunol Today 13(1): 17-21. 
Lorimore, S. A., J. A. Chrystal, et al. (2008). "Chromosomal instability in unirradiated 
hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation." 
Cancer Res 68(19): 8122-8126. 
Lowe, S. W., E. Cepero, et al. (2004). "Intrinsic tumour suppression." Nature 
432(7015): 307-315. 
 220
Lucas, M., L. M. Stuart, et al. (2006). "Requirements for apoptotic cell contact in 
regulation of macrophage responses." J Immunol 177(6): 4047-4054. 
Lum, J. J., D. E. Bauer, et al. (2005). "Growth factor regulation of autophagy and cell 
survival in the absence of apoptosis." Cell 120(2): 237-248. 
Lutzke, B. S. and J. M. Braughler (1990). "An improved method for the identification 
and quantitation of biological lipids by HPLC using laser light-scattering detection." J 
Lipid Res 31(11): 2127-2130. 
Ly, N. P., K. Komatsuzaki, et al. (2005). "Netrin-1 inhibits leukocyte migration in vitro 
and in vivo." Proc Natl Acad Sci U S A 102(41): 14729-14734. 
Ma, Y., A. Ramezani, et al. (2003). "High-level sustained transgene expression in 
human embryonic stem cells using lentiviral vectors." Stem cells 21(1): 111-117. 
Maclean, K. H., F. C. Dorsey, et al. (2008). "Targeting lysosomal degradation induces 
p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis." 
J Clin Invest 118(1): 79-88. 
MacVicar, B. A. and R. J. Thompson (2010). "Non-junction functions of pannexin-1 
channels." Trends Neurosci 33(2): 93-102. 
Mann, R. B., E. S. Jaffe, et al. (1976). "Non-endemic Burkitt's lymphoma." N Eng J 
Med 295(13): 685-691. 
Mantovani, A., P. Allavena, et al. (2008). "Cancer-related inflammation." Nature 
454(7203): 436-444. 
Mantovani, A., P. Allavena, et al. (2004). "Chemokines in the recruitment and shaping 
of the leukocyte infiltrate of tumors." Sem Cancer Biol  14(3): 155-160. 
Mantovani, A., B. Bottazzi, et al. (1992). "The origin and function of tumor-associated 
macrophages." Immunol Today 13(7): 265-270. 
Mantovani, A., B. Savino, et al. (2009). "The chemokine system in cancer biology and 
therapy." Cytokine Growth Factor Rev  21(1): 27-39. 
Mantovani, A. and A. Sica (2010). "Macrophages, innate immunity and cancer: 
balance, tolerance, and diversity." Curr Opin Immunol 22(2): 231-237. 
Mantovani, A., A. Sica, et al. (2005). "Macrophage polarization comes of age." 
Immunity 23(4): 344-346. 
Mantovani, A., S. Sozzani, et al. (2002). "Macrophage polarization: tumor-associated 
macrophages as a paradigm for polarized M2 mononuclear phagocytes." Trends 
 221
Immunol23(11): 549-555. 
Marques-da-Silva, C., G. Burnstock, et al. (2011). "Purinergic receptor agonists 
modulate phagocytosis and clearance of apoptotic cells in macrophages." 
Immunobiology 216(1-2): 1-11. 
Mayer, M. P. and B. Bukau (2005). "Hsp70 chaperones: cellular functions and 
molecular mechanism." Cell Mol Life Sci 62(6): 670-684. 
McCloskey, M. A., Y. Fan, et al. (1999). "Chemotaxis of rat mast cells toward adenine 
nucleotides." J Immunol 163(2): 970-977. 
McDonald, B., K. Pittman, et al. (2010). "Intravascular danger signals guide 
neutrophils to sites of sterile inflammation." Science 330(6002): 362-366. 
McDonald, P. P., V. A. Fadok, et al. (1999). "Transcriptional and translational 
regulation of inflammatory mediator production by endogenous TGF-beta in 
macrophages that have ingested apoptotic cells." J Immunol 163(11): 6164-6172. 
Mehlen, P. and D. E. Bredesen (2011). "Dependence receptors: from basic research to 
drug development." Sci Signal 4(157): mr2. 
Mellman, I. and R. M. Steinman (2001). "Dendritic cells: specialized and regulated 
antigen processing machines." Cell 106(3): 255-258. 
Mille, F., C. Thibert, et al. (2009). "The patched dependence receptor triggers 
apoptosis through a DRAL-caspase-9 complex." Nat Cell Biol 11(6): 739-746. 
Miyanishi, M., K. Tada, et al. (2007). "Identification of Tim4 as a phosphatidylserine 
receptor." Nature 450(7168): 435-439. 
Monks, J., D. Rosner, et al. (2005). "Epithelial cells as phagocytes: apoptotic epithelial 
cells are engulfed by mammary alveolar epithelial cells and repress inflammatory 
mediator release." Cell Death Differ 12(2): 107-114. 
Moore, K. J., R. P. Fabunmi, et al. (1998). "In vitro differentiated embryonic stem cell 
macrophages : a model system for studying atherosclerosis-associated macrophage 
functions." Arterioscler Thromb Vasc Biol 18(10): 1647-1654. 
Morimoto, K., H. Amano, et al. (2001). "Alveolar macrophages that phagocytose 
apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in 
mice." Am J Respir Cell Mol Biol 24(5): 608-615. 
Morris, D. D., N. Crowe, et al. (1992). "Endotoxin-induced production of interleukin 6 
by equine peritoneal macrophages in vitro." Am J Vet Res 53(8): 1298-1301. 
 222
Morrone, F. B., M. C. Jacques-Silva, et al. (2003). "Extracellular nucleotides and 
nucleosides induce proliferation and increase nucleoside transport in human glioma 
cell lines." J Neurooncol 64(3): 211-218. 
Muller, T., B. Robaye, et al. (2010). "The purinergic receptor P2Y2 receptor mediates 
chemotaxis of dendritic cells and eosinophils in allergic lung inflammation." Allergy 
65(12): 1545-1553. 
Murdoch, C., M. Muthana, et al. (2008). "The role of myeloid cells in the promotion of 
tumour angiogenesis." Nat Rev Cancer 8(8): 618-631. 
Myrtek, D., T. Muller, et al. (2008). "Activation of human alveolar macrophages via 
P2 receptors: coupling to intracellular Ca2+ increases and cytokine secretion." J 
Immunol 181(3): 2181-2188. 
Nagata, S., R. Hanayama, et al. (2010). "Autoimmunity and the clearance of dead 
cells." Cell 140(5): 619-630. 
Negus, R. P., G. W. Stamp, et al. (1995). "The detection and localization of monocyte 
chemoattractant protein-1 (MCP-1) in human ovarian cancer." J Clin Invest 95(5): 
2391-2396. 
Nejime, N., N. Tanaka, et al. (2008). "Effect of P2 receptor on the intracellular calcium 
increase by cancer cells in human umbilical vein endothelial cells." Naunyn 
Schmiedebergs Arch Pharmacol 377(4-6): 429-436. 
Nelson, D. A., T. T. Tan, et al. (2004). "Hypoxia and defective apoptosis drive genomic 
instability and tumorigenesis." Genes Dev 18(17): 2095-2107. 
Nevala, W. K., C. M. Vachon, et al. (2009). "Evidence of systemic Th2-driven chronic 
inflammation in patients with metastatic melanoma." Clin Cancer Res 15(6): 
1931-1939. 
Newman, S. L., J. E. Henson, et al. (1982). "Phagocytosis of senescent neutrophils by 
human monocyte-derived macrophages and rabbit inflammatory macrophages." J Exp 
Med  156(2): 430-442. 
Nishie, A., M. Ono, et al. (1999). "Macrophage infiltration and heme oxygenase-1 
expression correlate with angiogenesis in human gliomas." Clin Cancer Res 5(5): 
1107-1113. 
Nowicki, A., J. Szenajch, et al. (1996). "Impaired tumor growth in colony-stimulating 
factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of 
CSF-1-dependent macrophages in formation of tumor stroma." Int J Cancer 65(1): 
112-119. 
 223
Nussbaum, J., E. Minami, et al. (2007). "Transplantation of undifferentiated murine 
embryonic stem cells in the heart: teratoma formation and immune response." The 
FASEB Journal 21(7): 1345-1357. 
Nussenzweig, M., R. Steinman, et al. (1981). "Studies of the cell surface of mouse 
dendritic cells and other leukocytes." J Exp Med  154(1): 168-187. 
Odegaard, J. I., D. Vats, et al. (2007). "Quantitative expansion of ES cell-derived 
myeloid progenitors capable of differentiating into macrophages." J Leukoc Biol 81(3): 
711-719. 
Ogden, C. A., J. D. Pound, et al. (2005). "Enhanced apoptotic cell clearance capacity 
and B cell survival factor production by IL-10-activated macrophages: implications 
for Burkitt's lymphoma." J Immunol 174(5): 3015-3023. 
Ojalvo, L. S., W. King, et al. (2009). "High-density gene expression analysis of 
tumor-associated macrophages from mouse mammary tumors." Am J Pathol 174(3): 
1048-1064. 
Okada, M., M. Saio, et al. (2009). "Tumor-associated macrophage/microglia 
infiltration in human gliomas is correlated with MCP-3, but not MCP-1." Int J Oncol 
34(6): 1621-1627. 
Oliveira, M. A., G. M. Lima, et al. (2003). "Immature macrophages derived from 
mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation." J 
Leukoc Biol 74(5): 857-867. 
Ollivier, V., S. Faure, et al. (2003). "Fractalkine/CX3CL1 production by human aortic 
smooth muscle cells impairs monocyte procoagulant and inflammatory responses." 
Cytokine 21(6): 303-311. 
Orrenius, S., V. Gogvadze, et al. (2007). "Mitochondrial oxidative stress: implications 
for cell death." Annu Rev Pharmacol Toxicol 47: 143-183. 
Orriss, I. R., G. E. Knight, et al. (2009). "Hypoxia stimulates vesicular ATP release 
from rat osteoblasts." J Cell Physiol 220(1): 155-162. 
Ott, M., V. Gogvadze, et al. (2007). "Mitochondria, oxidative stress and cell death." 
Apoptosis 12(5): 913-922. 
Pages, F., J. Galon, et al. (2010). "Immune infiltration in human tumors: a prognostic 
factor that should not be ignored." Oncogene 29(8): 1093-1102. 
Pandey, P., R. Farber, et al. (2000). "Hsp27 functions as a negative regulator of 
cytochrome c-dependent activation of procaspase-3." Oncogene 19(16): 1975-1981. 
 224
Pang, B., X. Zhou, et al. (2007). "Lipid peroxidation dominates the chemistry of DNA 
adduct formation in a mouse model of inflammation." Carcinogenesis 28(8): 
1807-1813. 
Park, D., A. C. Tosello-Trampont, et al. (2007). "BAI1 is an engulfment receptor for 
apoptotic cells upstream of the ELMO/Dock180/Rac module." Nature 450(7168): 
430-434. 
Park, S. S., J. S. Kim, et al. (2005). "Insertion of c-Myc into Igh induces B-cell and 
plasma-cell neoplasms in mice." Cancer Res 65(4): 1306-1315. 
Park, S. Y., M. Y. Jung, et al. (2008). "Rapid cell corpse clearance by stabilin-2, a 
membrane phosphatidylserine receptor." Cell Death Differ 15(1): 192-201. 
Parnaik, R., M. C. Raff, et al. (2000). "Differences between the clearance of apoptotic 
cells by professional and non-professional phagocytes." Curr Biol 10(14): 857-860. 
Pasikowska, M. (2010) "Chemotactic signals released during Burkitt's lymphoma cell 
death." The University of Edinburgh. PhD 
Pease, S., P. Braghetta, et al. (1990). "Isolation of embryonic stem (ES) cells in media 
supplemented with recombinant leukemia inhibitory factor (LIF)." Dev Biol  141(2): 
344-352. 
Pellegatti, P., L. Raffaghello, et al. (2008). "Increased level of extracellular ATP at 
tumor sites: in vivo imaging with plasma membrane luciferase." PLoS One 3(7): 
e2599. 
Pezzella, F., A. G. Tse, et al. (1990). "Expression of the bcl-2 oncogene protein is not 
specific for the 14;18 chromosomal translocation." Am J Pathol 137(2): 225-232. 
Pollard, J. W. (2009). "Trophic macrophages in development and disease." Nat Rev 
Immunol 9(4): 259-270. 
Porta, C., M. Rimoldi, et al. (2009). "Tolerance and M2 (alternative) macrophage 
polarization are related processes orchestrated by p50 nuclear factor-κB." Proc Natl 
Acad Sci U S A  106(35): 14978-14983. 
Pozzi, L.-A. M., J. W. Maciaszek, et al. (2005). "Both dendritic cells and macrophages 
can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and 
differentiate into memory cells." J Immunol 175(4): 2071-2081. 
Praetorius, H. A. and J. Leipziger (2009). "ATP release from non-excitable cells." 
Purinergic Signal 5(4): 433-446. 
Priebe, A., L. Tan, et al. (2011). "Glucose deprivation activates AMPK and induces 
 225
cell death through modulation of Akt in ovarian cancer cells." Gynecol Oncol  122(2): 
389-395. 
Qian, B.-Z. and J. W. Pollard (2010). "Macrophage diversity enhances tumor 
progression and metastasis." Cell 141(1): 39-51. 
Ralevic, V. and G. Burnstock (1998). "Receptors for purines and pyrimidines." 
Pharmacol Rev 50(3): 413-492. 
Ramprasad, M., V. Terpstra, et al. (1996). "Cell surface expression of mouse 
macrosialin and human CD68 and their role as macrophage receptors for oxidized low 
density lipoprotein." Proc Natl Acad Sci U S A  93(25): 14833-14838. 
Rathbone, M. P., P. J. Middlemiss, et al. (1992). "Adenosine and its nucleotides 
stimulate proliferation of chick astrocytes and human astrocytoma cells." Neurosci 
Res 13(1): 1-17. 
Ravichandran, K. (2011). "Beginnings of a good apoptotic meal: the find-me and 
eat-me signaling pathways." Immunity 35(4): 445-455. 
Reddien, P. W., S. Cameron, et al. (2001). "Phagocytosis promotes programmed cell 
death in C. elegans." Nature 412(6843): 198-202. 
Reef, S., E. Zalckvar, et al. (2006). "A short mitochondrial form of p19ARF induces 
autophagy and caspase-independent cell death." Mol Cell 22(4): 463-475. 
Revesz, L. (1956). "Effect of tumour cells killed by x-rays upon the growth of admixed 
viable cells." Nature 178(4547): 1391-1392. 
Rigogliuso, S., C. Donati, et al. (2010). "An active form of sphingosine kinase-1 is 
released in the extracellular medium as component of membrane vesicles shed by two 
human tumor cell lines." J Oncol 2010: 509329. 
Robinson-Smith, T. M., I. Isaacsohn, et al. (2007). "Macrophages mediate 
inflammation-enhanced metastasis of ovarian tumors in mice." Cancer Res 67(12): 
5708-5716. 
Roca, H., Z. S. Varsos, et al. (2009). "CCL2 and interleukin-6 promote survival of 
human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage 
polarization." J Biol Chem 284(49): 34342-34354. 
Ron, D. and P. Walter (2007). "Signal integration in the endoplasmic reticulum 
unfolded protein response." Nat Rev Mol Cell Biol 8(7): 519-529. 
Rounds, S., L. L. Likar, et al. (1999). "Nucleotide-induced PMN adhesion to cultured 
epithelial cells: possible role of MUC1 mucin." Am J Physiol 277(5 Pt 1): L874-880. 
 226
Rowe, M., C. M. Rooney, et al. (1985). "Distinctions between endemic and sporadic 
forms of epstein-barr virus-positive burkitt's lymphoma." Int J Cancer 35(4): 435-441. 
Saccani, A., T. Schioppa, et al. (2006). "p50 nuclear factor-κB overexpression in 
tumor-associated macrophages inhibits M1 inflammatory responses and antitumor 
resistance." Cancer Res 66(23): 11432-11440. 
Salcedo, R., K. Wasserman, et al. (1999). "Vascular endothelial growth factor and 
basic fibroblast growth factor induce expression of CXCR4 on human endothelial 
cells: in vivo neovascularization induced by stromal-derived factor-1alpha." Am J 
Pathol 154(4): 1125-1135. 
Saleh, A., S. M. Srinivasula, et al. (2000). "Negative regulation of the Apaf-1 
apoptosome by Hsp70." Nat Cell Biol 2(8): 476-483. 
Sansonetti, P. J., A. Phalipon, et al. (2000). "Caspase-1 activation of IL-1beta and 
IL-18 are essential for Shigella flexneri-induced inflammation." Immunity 12(5): 
581-590. 
Sasaki, T., J. Irie-Sasaki, et al. (2000). "Function of PI3Kγ in thymocyte development, 
T cell activation, and neutrophil migration." Science 287(5455): 1040-1046. 
Sato, T., M. Terai, et al. (2011). "Interleukin 10 in the tumor microenvironment: a 
target for anticancer immunotherapy." Immunol Res 51(2-3): 170-182. 
Saunders, J. W., Jr. (1966). "Death in embryonic systems." Science 154(3749): 
604-612. 
Savill, J. (1997). "Recognition and phagocytosis of cells undergoing apoptosis." Br 
Med Bull 53(3): 491-508. 
Savill, J., I. Dransfield, et al. (2002). "A blast from the past: clearance of apoptotic 
cells regulates immune responses." Nat Rev Immunol 2(12): 965-975. 
Savill, J., N. Hogg, et al. (1992). "Thrombospondin cooperates with CD36 and the 
vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis." 
J Clin Invest 90(4): 1513-1522. 
Scaffidi, C., S. Fulda, et al. (1998). "Two CD95 (APO-1/Fas) signaling pathways." 
EMBO J 17(6): 1675-1687. 
Scemes, E., D. C. Spray, et al. (2009). "Connexins, pannexins, innexins: novel roles of 
"hemi-channels"." Pflugers Arch 457(6): 1207-1226. 
Scherer, M., G. Schmitz, et al. (2009). "High-throughput analysis of sphingosine 
1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples 
 227
by liquid chromatography-tandem mass spectrometry." Clin Chem 55(6): 1218-1222. 
Schnurr, M., T. Toy, et al. (2003). "ATP gradients inhibit the migratory capacity of 
specific human dendritic cell types: implications for P2Y11 receptor signaling." Blood 
102(2): 613-620. 
Schroder, K. and J. Tschopp (2010). "The Inflammasomes." Cell 140(6): 821-832. 
Schroder, M. and R. J. Kaufman (2005). "The mammalian unfolded protein response." 
Annu Rev Biochem 74: 739-789. 
Segundo, C., F. Medina, et al. (1999). "Surface molecule loss and bleb formation by 
human germinal center B cells undergoing apoptosis: role of apoptotic blebs in 
monocyte chemotaxis." Blood 94(3): 1012-1020. 
Semenza, G. L. (2007). "Hypoxia-inducible factor 1 (HIF-1) pathway." Sci. STKE 
2007(407): cm8-. 
Sendoel, A., I. Kohler, et al. (2010). "HIF-1 antagonizes p53-mediated apoptosis 
through a secreted neuronal tyrosinase." Nature 465(7298): 577-583. 
Senju, S., M. Haruta, et al. (2011). "Generation of dendritic cells and macrophages 
from human induced pluripotent stem cells aiming at cell therapy." Gene Ther 18: 
874-883. 
Senju, S., M. Haruta, et al. (2009). "Characterization of dendritic cells and 
macrophages generated by directed differentiation from mouse induced pluripotent 
stem cells." Stem cells 27(5): 1021-1031. 
Seymour, C. B. and C. Mothersill (2004). "Radiation-induced bystander 
effects-implications for cancer." Nat Rev Cancer 4(2): 158-164. 
Shalak, V., M. Kaminska, et al. (2001). "The EMAPII cytokine is released from the 
mammalian multisynthetase complex after cleavage of its p43/proEMAPII 
component." J Biol Chem 276(26): 23769-23776. 
Smith, A. G. (2001). "Embryo-derived stem cells: of mice and men." Annu Rev Cell 
Dev Biol 17: 435-462. 
Smyth, M. J., G. P. Dunn, et al. (2006). "Cancer immunosurveillance and 
immunoediting: the roles of immunity in suppressing tumor development and shaping 
tumor immunogenicity." Adv Immunol 90: 1-50. 
Snyderman, R., M. C. Pike, et al. (1975). "Quantification of mouse macrophage 
chemotaxis in vitro: role of C5 for the production of chemotactic activity." Infect. 
Immun. 11(3): 488-492. 
 228
Sokol, R. J., G. Hudson, et al. (1987). "Human macrophage development: a 
morphometric study." J Anat 151: 27-35. 
Solinas, G., G. Germano, et al. (2009). "Tumor-associated macrophages (TAM) as 
major players of the cancer-related inflammation." J Leukoc Biol 86(5): 1065-1073. 
Soria, G. and A. Ben-Baruch (2008). "The inflammatory chemokines CCL2 and CCL5 
in breast cancer." Cancer Lett 267(2): 271-285. 
Speidel, D. (2009). "Transcription-independent p53 apoptosis: an alternative route to 
death." Trends Cell Biol  20(1): 14-24. 
Spiess, C., A. S. Meyer, et al. (2004). "Mechanism of the eukaryotic chaperonin: 
protein folding in the chamber of secrets." Trends Cell Biol  14(11): 598-604. 
Spitz, D. R., J. E. Sim, et al. (2000). "Glucose deprivation-induced oxidative stress in 
human tumor cells: a fundamental defect in metabolism?" Ann NY Acad Sci899(1): 
349-362. 
Srinivasula, S. M., M. Ahmad, et al. (1996). "Molecular ordering of the Fas-apoptotic 
pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates 
multiple Ced-3/ICE-like cysteine proteases." Proc Natl Acad Sci U S A 93(25): 
14486-14491. 
Steel, R., J. P. Doherty, et al. (2004). "Hsp72 inhibits apoptosis upstream of the 
mitochondria and not through interactions with Apaf-1." J Biol Chem 279(49): 
51490-51499. 
Steinman, R. M. and Z. A. Cohn (1973). "Identification of a novel cell type in 
peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution." 
J Exp Med 137(5): 1142-1162. 
Steinman, R. M. and K. Inaba (1999). "Myeloid dendritic cells." J Leukoc Biol 66(2): 
205-208. 
Stephen, P. (1889). "The distribution of secondary growths in cancer of the breast  " 
Lancet 133(3421): 571-573. 
Stojdl, D. F., B. Lichty, et al. (2000). "Exploiting tumor-specific defects in the 
interferon pathway with a previously unknown oncolytic virus." Nat Med 6(7): 
821-825. 
Stokoe, D., L. R. Stephens, et al. (1997). "Dual role of 
phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B." 
Science 277(5325): 567-570. 
 229
Sun, W. H., C. Pabon, et al. (1998). "Interferon-α resistance in a cutaneous T-cell 
lymphoma cell line is associated with lack of STAT1 expression." Blood 91(2): 
570-576. 
Sunderkotter, C., T. Nikolic, et al. (2004). "Subpopulations of mouse blood monocytes 
differ in maturation stage and inflammatory response." J Immunol 172(7): 4410-4417. 
Susin, S. A., H. K. Lorenzo, et al. (1999). "Molecular characterization of 
mitochondrial apoptosis-inducing factor." Nature 397(6718): 441-446. 
Swennen, E. L. R., A. Bast, et al. (2005). "Immunoregulatory effects of adenosine 
5′-triphosphate on cytokine release from stimulated whole blood." Eur J Immunol 
35(3): 852-858. 
Symmans, W. F., J. F. Cangiarella, et al. (2000). "Apoptotic index from fine needle 
aspiration cytology as a criterion to predict histologic grade of non-Hodgkin's 
lymphoma." Acta Cytol 44(2): 194-204. 
Szondy, Z., Z. Sarang, et al. (2003). "Transglutaminase 2-/- mice reveal a 
phagocytosis-associated crosstalk between macrophages and apoptotic cells." Proc 
Natl Acad Sci U S A 100(13): 7812-7817. 
Tamatani, M., T. Matsuyama, et al. (2001). "ORP150 protects against 
hypoxia/ischemia-induced neuronal death." Nat Med 7(3): 317-323. 
Tan, T.-T., K. Degenhardt, et al. (2005). "Key roles of BIM-driven apoptosis in 
epithelial tumors and rational chemotherapy." Cancer cell 7(3): 227-238. 
Taylor, R. C., S. P. Cullen, et al. (2008). "Apoptosis: controlled demolition at the 
cellular level." Nat Rev Mol Cell Biol 9(3): 231-241. 
Thompson, R. J., N. Zhou, et al. (2006). "Ischemia opens neuronal gap junction 
hemichannels." Science 312(5775): 924-927. 
Torroella-Kouri, M., R. Silvera, et al. (2009). "Identification of a subpopulation of 
macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less 
differentiated." Cancer Res 69(11): 4800-4809. 
Truman, L. (2005) "Macrophage chemotaxis to apoptotic cells." The University of 
Edinburgh. PhD 
Truman, L. A., C. A. Ford, et al. (2008). "CX3CL1/fractalkine is released from 
apoptotic lymphocytes to stimulate macrophage chemotaxis." Blood 112(13): 
5026-5036. 
Truman, L. A., C. A. Ogden, et al. (2004). "Macrophage chemotaxis to apoptotic 
 230
Burkitt's lymphoma cells in vitro: role of CD14 and CD36." Immunobiology 209(1-2): 
21-30. 
Tsuchiya, S., M. Yamabe, et al. (1980). "Establishment and characterization of a 
human acute monocytic leukemia cell line (THP-1)." Int J Cancer 26(2): 171-176. 
Tsutsui, S., K. Yasuda, et al. (2005). "Macrophage infiltration and its prognostic 
implications in breast cancer: the relationship with VEGF expression and microvessel 
density." Oncol Rep 14(2): 425-431. 
Van Brocklyn, J. R., C. A. Letterle, et al. (2002). "Sphingosine-1-phosphate stimulates 
human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP 
kinase and phosphatidylinositol 3-kinase β." Cancer Lett 181(2): 195-204. 
Van den Eijnde, S. M., L. Boshart, et al. (1997). "Phosphatidylserine plasma 
membrane asymmetry in vivo: a pancellular phenomenon which alters during 
apoptosis." Cell Death Differ 4(4): 311-316. 
Verghese, M. W., T. B. Kneisler, et al. (1996). "P2U agonists induce chemotaxis and 
actin polymerization in human neutrophils and differentiated HL60 cells." J Biol 
Chem 271(26): 15597-15601. 
Vermes, I., C. Haanen, et al. (1995). "A novel assay for apoptosis flow cytometric 
detection of phosphatidylserine expression on early apoptotic cells using fluorescein 
labelled Annexin V." J Immunol Methods  184(1): 39-51. 
Villunger, A., E. M. Michalak, et al. (2003). "p53- and drug-induced apoptotic 
responses mediated by BH3-only proteins puma and noxa." Science 302(5647): 
1036-1038. 
Vivanco, I. and C. L. Sawyers (2002). "The phosphatidylinositol 3-kinase-AKT 
pathway in human cancer." Nat Rev Cancer 2(7): 489-501. 
Voll, R. E., M. Herrmann, et al. (1997). "Immunosuppressive effects of apoptotic 
cells." Nature 390(6658): 350-351. 
Vousden, K. H. (2005). "Apoptosis. p53 and PUMA: a deadly duo." Science 
309(5741): 1685-1686. 
Vousden, K. H. and D. P. Lane (2007). "p53 in health and disease." Nat Rev Mol Cell 
Biol 8(4): 275-283. 
Vousden, K. H. and C. Prives (2009). "Blinded by the light: the growing complexity of 
p53." Cell 137(3): 413-431. 
Vousden, K. H. and K. M. Ryan (2009). "p53 and metabolism." Nat Rev Cancer 9(10): 
 231
691-700. 
Wajant, H. (2002). "The Fas signaling pathway: more than a paradigm." Science 
296(5573): 1635-1636. 
Wang, G. G., K. R. Calvo, et al. (2006). "Quantitative production of macrophages or 
neutrophils ex vivo using conditional Hoxb8." Nat Methods 3(4): 287-293. 
Wang, H., R. J. Grand, et al. (1996). "Repression of apoptosis in human B-lymphoma 
cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the 
retinoblastoma protein." Oncogene 13(2): 373-379. 
Wang, J. and L. M. Boxer (2005). "Regulatory elements in the immunoglobulin heavy 
chain gene 3' enhancers induce c-myc deregulation and lymphomagenesis in murine B 
cells." J Biol Chem 280(13): 12766-12773. 
Wang, Q., L. Wang, et al. (2004). "P2X7 receptor-mediated apoptosis of human 
cervical epithelial cells." Am J Physiol Cell Physiol 287(5): C1349-1358. 
Warburg, O. (1956). "On the origin of cancer cells." Science 123(3191): 309-314. 
Warburg, O., S. W. House, et al. (1956). "On respiratory impairment in cancer cells." 
Science 124(3215): 267-272. 
Warburg, O. H. and F. Dickens (1930). The metabolism of tumours: investigations 
from the Kaiser Wilhelm Institute for Biology, Berlin-Dahlem, Constable. 
Webb, S. E., J. W. Pollard, et al. (1996). "Direct observation and quantification of 
macrophage chemoattraction to the growth factor CSF-1." J Cell Sci  109(4): 
793-803. 
Wegele, H., L. Muller, et al. (2004). "Hsp70 and Hsp90--a relay team for protein 
folding." Rev Physiol Biochem Pharmacol 151: 1-44. 
Weigert, A., A. M. Johann, et al. (2006). "Apoptotic cells promote macrophage 
survival by releasing the antiapoptotic mediator sphingosine-1-phosphate." Blood 
108(5): 1635-1642. 
Weigert, A., N. Weis, et al. (2009). "Regulation of macrophage function by 
sphingosine-1-phosphate." Immunobiology 214(9-10): 748-760. 
Wells, B. S., E. Yoshida, et al. (2006). "Compensatory proliferation in Drosophila 
imaginal discs requires Dronc-dependent p53 activity." Curr Biol 16(16): 1606-1615. 
White, E. (2007). "Role of the metabolic stress responses of apoptosis and autophagy 
in tumor suppression." Ernst Schering Found Symp Proc(4): 23-34. 
 232
White, G. E., T. C. Tan, et al. (2010). "Fractalkine has anti-apoptotic and proliferative 
effects on human vascular smooth muscle cells via epidermal growth factor receptor 
signalling." Cardiovasc Res 85(4): 825-835. 
Wiles, M. V. (1993). "Embryonic stem cell differentiation in vitro." Methods Enzymol 
225: 900-918. 
Wobus, A. M. and K. R. Boheler (2005). "Embryonic stem cells: prospects for 
developmental biology and cell therapy." Physiol Rev  85(2): 635-678. 
Wong, L. H., K. G. Krauer, et al. (1997). "Interferon-resistant human melanoma cells 
are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma." J Biol 
Chem 272(45): 28779-28785. 
Wood, W., M. Turmaine, et al. (2000). "Mesenchymal cells engulf and clear apoptotic 
footplate cells in macrophageless PU.1 null mouse embryos." Development 127(24): 
5245-5252. 
Wyckoff, J., W. Wang, et al. (2004). "A paracrine loop between tumor cells and 
macrophages is required for tumor cell migration in mammary tumors." Cancer Res 
64(19): 7022-7029. 
Wyckoff, J. B., Y. Wang, et al. (2007). "Direct visualization of macrophage-assisted 
tumor cell intravasation in mammary tumors." Cancer Res 67(6): 2649-2656. 
Wyllie, A. H. (1985). "The biology of cell death in tumours." Anticancer Res 5(1): 
131-136. 
Wyllie, A. H., J. F. R. Kerr, et al. (1980). Cell Death: the significance of apoptosis. 
International Review of Cytology, Academic Press. Volume 68: 251-306. 
Xu, B., D. Grander, et al. (1994). "Primary leukemia cells resistant to alpha-interferon 
in vitro are defective in the activation of the DNA-binding factor interferon-stimulated 
gene factor 3." Blood 84(6): 1942-1949. 
Yamamoto, T. (2007). "Roles of the ribosomal protein S19 dimer and the C5a receptor 
in pathophysiological functions of phagocytic leukocytes." Pathol Int 57(1): 1-11. 
Yegutkin, G. G. (2008). "Nucleotide- and nucleoside-converting ectoenzymes: 
important modulators of purinergic signalling cascade." Biochim Biophys Acta 
1783(5): 673-694. 
Yin, X. M., K. Wang, et al. (1999). "Bid-deficient mice are resistant to Fas-induced 
hepatocellular apoptosis." Nature 400(6747): 886-891. 
Young, D. A., L. D. Lowe, et al. (1990). "Comparison of the effects of IL-3, 
 233
granulocyte-macrophage colony-stimulating factor, and macrophage 
colony-stimulating factor in supporting monocyte differentiation in culture. Analysis 
of macrophage antibody-dependent cellular cytotoxicity." J Immunol 145(2): 607-615. 
Young, J. C., V. R. Agashe, et al. (2004). "Pathways of chaperone-mediated protein 
folding in the cytosol." Nat Rev Mol Cell Biol 5(10): 781-791. 
Zeisberger, S. M., B. Odermatt, et al. (2006). "Clodronate-liposome-mediated 
depletion of tumour-associated macrophages: a new and highly effective 
antiangiogenic therapy approach." Br J Cancer 95(3): 272-281. 
Zenger, E., N. W. Abbey, et al. (2002). "Injection of human primary effusion 
lymphoma cells or associated macrophages into severe combined immunodeficient 
mice causes murine lymphomas." Cancer Res 62(19): 5536-5542. 
Zhang, D. W., J. Shao, et al. (2009). "RIP3, an energy metabolism regulator that 
switches TNF-induced cell death from apoptosis to necrosis." Science 325(5938): 
332-336. 
Zhang, X., L. Meng, et al. (2009). "The role of P2X7 receptor in ATP-mediated human 
leukemia cell death: calcium influx-independent." Acta Biochim Biophys Sin 
(Shanghai) 41(5): 362-369. 
Zhuang, L. (2007) "Generation of a new cellular system for the studies of 
tumour-associated macrophages." The University of Edinburgh. MSc 
Ziegler-Heitbrock, H. W., E. Thiel, et al. (1988). "Establishment of a human cell line 
(Mono Mac 6) with characteristics of mature monocytes." Int J Cancer 41(3): 456-461. 
Zou, H., W. J. Henzel, et al. (1997). "Apaf-1, a human protein homologous to C. 
elegans CED-4, participates in cytochrome c-dependent activation of caspase-3." Cell 
90(3): 405-413. 
Zujovic, V., J. Benavides, et al. (2000). "Fractalkine modulates TNF-alpha secretion 








Appendix 1: List of medium 
 
Embryonic stem (ES) cell growth medium (GMEMFCS): 
1× Glasgow Minimal Essential Medium (Gibco) 
10% (v/v) FCS (Globepharm) (batch tested for ES cell self-renewal) 
0.25% (v/v) sodium bicarbonate (Giobo) 
1% (v/v) non-essential amino acids (Gibco) 
4mM L-glutamine (Gibco) 
2mM sodium pyruvate (Gibco) 
0.1mM 2-mercaptoethanol (Sigma) 
 
The above media was supplemented with 100U/mL Leukaemia Inhibitory Factor (LIF) 
as required. 
 
Embryonic stem (ES) cell differentiation medium (GMEMDiff) : 
1× Glasgow Minimal Essential Medium (Gibco) 
10% (v/v) Diff (Globepharm) (batch tested for ES cell differentiation) 
0.25% (v/v) sodium bicarbonate (Giobo) 
1% (v/v) non-essential amino acids (Gibco) 
4mM L-glutamine (Gibco) 
2mM sodium pyruvate (Gibco) 
0.1mM 2-mercaptoethanol (Sigma) 
 
Burkitt’s lymphoma cell culture medium (BL medium): 
1×RPMI 1640 (Gibco) 
10% fetal bovine serum (FBS) (v/v, Biosera) 
2mM L-glutamine (PAA) 
100 IU/ml penicillin (PAA) 
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100 μg/ml streptomycin (PAA) 
 
L929 cell culture medium: 
1×D-MEM: F12 with Glutamax (Gibco)  
10% fetal bovine serum (FBS) (v/v, Biosera) 
100 IU/ml penicillin (PAA) 
100μg/ml streptomycin (PAA) 
 
Bone marrow derived macrophages culture medium (DMEMsupp):  
1×D-MEM: F12 with GLutamax (Gibco) 
2mM L-glutamine (PAA) 
100 IU/ml penicillin (PAA) 
100μg/ml streptomycin (PAA) 
20% (v/v) FBS 
10% (v/v) L929 CM 
 
MonoMac6 cell culture medium: 
1×RPMI 1640 (Gibco) 
10% fetal bovine serum (FBS) (v/v, Biosera) 
2mM L-glutamine (PAA) 
100 IU/ml penicillin (PAA) 
100 μg/ml streptomycin (PAA) 
OPI media supplement, HYBRI-MAX (Sigma) (contains final working concentrations 
of 1 mM oxaloacetate, 0.45 mM pyruvate, 0.2 U/ml insulin) 
1×Amino acids non-essential (PAA) 
 
THP-1 cell culture medium: 
1×RPMI 1640 (Gibco) 
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10% fetal bovine serum (FBS) (v/v, Biosera) 
2mM L-glutamine (PAA) 
100 IU/ml penicillin (PAA) 
100 μg/ml streptomycin (PAA) 
 
 
Embryonic stem cell derived macrophages (ESDM) culture medium (ESDMcult):  
GMEMDiff  
15% (v/v) L929 CM 
100 IU/ml penicillin (PAA) 
100 μg/ml streptomycin (PAA) 
 
 
Embryonic stem cell derived macrophages (ESDM) differentiation medium 
(ESDMDiff ):  
GMEMDiff  
15% (v/v) L929 CM 
1ng/ml IL-3  
 
Chemotaxis assay medium: 
1×RPMI 1640 (Gibco) 
2mM L-glutamine (PAA) 
100 IU/ml penicillin (PAA) 





Appendix 2: List of buffer 
 
Detachment Buffer: 
Hank’s BSS (without Ca2+ /Mg2+/ phenol red, PAA) 
5mM EDTA (Fisher) 
0.2% low-endotoxin BSA (w/v, PAA)) 
 
Substrate solution preparation for self-renewal assay: 
The substrate was prepared freshly as follows: 1ml sodium nitrite solution was gently 
mixed with 1ml Fast Red TR solution and the mixture was added to 50ml deionized 















































 The dotted line and red arrow indicates the non-pyrogenic level of 





























0 1 2 3











         Figure Appendix 3-3   Standard curve of S1P ELISA.   
 
 
 
 
 
